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1.1 Transition Metal-Catalyzed C–H Activation 
In the past several decades, transition metal-catalyzed cross-coupling reactions have been 
proved to be one of the most useful and reliable tools for C−C bond formation,[1] such as 
Negishi,[2] Suzuki-Miyaura,[3] Kumada-Corriu,[4] Stille,[5] and Hiyama cross couplings.[6] These 
reactions have already been widely applied in pharmaceutical, agrochemical, and fine chemical 
industries, as well as academic research.[7] However, the prefunctionalized organometallic 
substrates are often sensitive to air and water, relatively expensive and generate stoichiometric 
byproducts, all of which remain major disadvantages and limit their applications. According to 
the guideline of the twelve principles of green chemistry,[8] direct C−H activations are emerging 
as potential alternatives to conventional cross-coupling reactions due to their atom- and 
step-economy, which compares favorably to traditional organic synthesis (Scheme 1.1.1). 
Indeed, C−H activation has been identified to be a powerful tool for constructing complicated 
molecules from simple precursors.[9] 
 
Scheme 1.1.1 C−H Activation versus Conventional Functionalization 
The C–H bond metalation step can be accomplished by the active metal species LnM, four 
generally accepted modes of these mechanisms have been summarized by Eisenstein and 
co-workers,[10] including (a) oxidative addition with electron-rich late transition metals, (b) 
σ-bond metathesis with early transition metals, (c) electrophilic activation with 






Scheme 1.1.2 Possible Mechanisms for C−H Bond Metalation 
As early as 1955, Murahashi reported a cobalt-catalyzed chelation-assisted C–H bond 
functionalization of (E)-N,1-diphenylmethanimine (1) for the formation of 
2-phenylisoindolin-1-one (2) under high pressures of CO (100–200 atm). This carbonylation 
reaction is identified as an early example of transition metal-catalyzed C–H activation reaction 
(Scheme 1.1.3).[11]  
 
Scheme 1.1.3 Cobalt-Catalyzed C–H Carbonylation 
Thereafter, a variety of catalyzed C–H activation reactions were successfully explored, using 
palladium, platinum, rhodium, ruthenium and iridium, as well as the inexpensive, naturally 
abundant 3d base metals, such as iron, cobalt, nickel and copper. [9c-w] 
1.2 Transition Metal-Catalyzed C–H Cyanation with 
N-Cyano-4-methyl-N-phenyl benzenesulfonamide (NCTS) 
Aromatic nitriles 3 serve as one of the most important structural motifs in pharmaceuticals, 
dyes, agrochemicals and natural products.[12] Selected examples from the pharmaceutical and 





Figure 1.2.1 Selected Examples from Pharmaceutical and Agrochemical Industries 
Moreover, nitriles are versatile chemical intermediates, because the cyano group can be readily 
diversificated into amines 4, ketones 5, acids 6, aldehydes 7, amides 8, among others (Scheme 
1.2.1).[14]  
 
Scheme 1.2.1 Transformation of Cyano Group 
The earlier preparation of aryl nitriles 3 relied on classical approaches, such as the 
Sandmeyer[15] or the Rosenmund–von Braun reaction (Scheme 1.2.2),[16] and thus have been 
applied in laboratory and industry for more than a century. However, the use of stoichiometric 
or even super-stoichiometric amounts of toxic metal cyanides, such as CuCN, or Zn(CN)2, 





Scheme 1.2.2 General Process of the Sandmeyer and Rosenmund-von Braun Reactions 
Recent alternative methods include transition-metal-catalyzed cyanations[12b, 17] of aryl halides 
10 or boronic acids 12 with metal cyanides.[14a, 18] Indeed, these strategies proceed under milder 
reaction conditions and display improved functional group tolerance, but toxic metal cyanides 
are still necessary. Later on, the groups of Buchwald, Beller, Chang, Jiao, Yu, and others have 
developed the cyanation by the use of more benign and user-friendly cyano sources, such as 
K4Fe(CN)6,
[19] N,N-dimethylformamide (DMF),[20] NH3/DMF,
[21] CH3NO2
[22] in the presence of 
stoichiometric amounts of oxidants. These approaches are limited to prefunctionalized 
substrates or electron-rich arenes. 
In recent years, the bench stable readily accessible and user-friendly 
N-cyano-4-methyl-N-phenyl benzenesulfonamide (NCTS, 13) has emerged as a versatile 
cyanation reagent.[23] Notably, it can be easily prepared from inexpensive commercial available 
phenylurea (14) by dehydrative tosylation with p-toluenesulfonyl chloride (15) in high efficacy, 
as reported by Kurzer (Scheme 1.2.3).  
 
Scheme 1.2.3 The Preparation of NCTS (13) 
Although it was first synthesized as early as 1949 by Kurzer,[23] the NCTS (13) was used as the 
cyanation reagent until 2011 by the group of Beller.[24] They have demonstrated the first 
rhodium-catalyzed cyanation of prefunctionalized aryl and alkenyl boronic acids 12 by the use 
of NCTS (13) as the cyanation reagent. Aryl or alkenyl boronic acids 12 with various functional 
groups, such as chloro, bromo, ketone, ether or anilide, underwent the cyanation process to give 
the aromatic or vinyl nitriles 3 in good yields under mild conditions. It is noteworthy that 
various nitriles 3 could be readily accessed via the combination of direct borylations of arenes 





Scheme 1.2.4 Rhodium-Catalyzed Cyanation of Aryl and Alkenyl Boronic Acids 12 with 
NCTS (13) 
Hartwig and co-workers described a two-step iridium-catalyzed borylation and 
copper-mediated cyanation of arenes in 2010.[14a] In contrast to the work of Hartwig, the 
catalytic amounts of rhodium catalyst and user-friendly NCTS (13) were used instead of the 
stoichiometric amounts of copper source and toxic Zn(CN)2 in this strategy. 
[24] 
The Rosenmund–von Braun reaction requires super-stoichiometric amounts of toxic metal 
cyanides under harsh reaction conditions.[16] In order to address these limitations, Buchwald 
and co-workers developed the copper-catalyzed domino halide exchange-cyanation of aryl 
bromides 10 (Scheme 1.2.5). This new method showed significant improvements, include i) 
milder reaction condition, ii) good functional group tolerance, and iii) the use of polar solvents, 
which made the isolation and purification of the nitrile products simpler.[18d] 
 
Scheme 1.2.5 Copper-Catalyzed Cyanation of Aryl Brimides 10 with NaCN 
This approach provided significant improvements, but the toxic NaCN is used in this 
procedure.[18d] Therefore, Beller and co-workers developed a novel synthesis of various 
(hetero)aryl nitriles 3 from (hetero)aryl bromides 10 via in situ generation of Grignard reagents, 
with subsequent treatment with NCTS (13) in good to excellent yields (Scheme 1.2.6).[25] The 
toxic NaCN was replaced by the user-friendly NCTS (13) cyanation reagent. However, due to 
the required formation of Grignard reagents, important functional groups, such as ester, ketone, 
amino and alcohols were not suitable for this cyanation reaction. 
 
Scheme 1.2.6 Cyanation via in situ Generation Grignard Reagents with NCTS (13) 
In the same year, Wang and co-workers disclosed the Lewis-acid-catalyzed electrophilic 




reaction (Scheme 1.2.7).[26] The corresponding cyanation products were obtained in 40–97% 
yields with excellent regioselectivities, including NH free indoles. However, this cyanation 
procedure was limited to electron-rich substrates 17, and the electron-poor substrates failed to 
give the corresponding products because of the electrophilic nature of this reaction. 
 
Scheme 1.2.7 Lewis-Acid-Catalyzed Electrophilic Cyanation of Indoles 17 and Pyrroles 18 
with NCTS (13) 
To overcome these restrictions, Fu and coworkers developed a rhodium-catalyzed directed 
C–H cyanation of arenes with NCTS (13).[27] This strategy furnished a number of aromatic and 
heteroaromatic nitriles in moderate to excellent yields under mild conditions, with good 
tolerance of various synthetically important functional groups. Furthermore, many different 
directing groups, such as oxime, pyridine or pyrazole, proved to be suitable in this C−H 
cyanation process (Scheme 1.2.8). 
 
Scheme 1.2.8 Rhodium-Catalyzed Directed C–H Cyanation of Arenes with NCTS (13) 
A plausible catalytic cycle for this rhodium-catalyzed C–H cyanation was proposed to be 
initiated by concerted metalation–deprotonation,[28] thus forming the five-membered 
rhodacycle intermediate 20. Subsequently, seven-membered rhodacycle 21 is formed via 
NCTS (13) coordination and migratory insertion into the carbon–rhodium bond. Then, 
β-elimination furnishes the desired cyanation product 3 and a tosylaniline-coordinated Rh(III) 
complex 22. Finally, proto-demetalation of the Rh(III) complex 22 regenerates the active 





Scheme 1.2.9 Proposed Catalytic Cycle for Rhodium-Catalyzed C–H Cyanation with  
NCTS (13) 
Related work on rhodium-catalyzed directed C–H cyanation with NCTS (13) as the cyanation 
reagent was reported by Anbarasan in the same year (Scheme 1.2.10).[29] As in the work by 
Fu,[27] pyridine derivatives were used as a directing group. However, the key intermediate for 
the synthesis of naturally available alkaloid menisporphine,[30] which is isolated from 
Menispermum dauricum DC (Menispermaceae, 24),[31] could be readily synthesized by the use 
of this methodology.[29] 
 
Scheme 1.2.10 Rhodium-Catalyzed Directed C–H Cyanation of Arenes with NCTS (13) 
Subsequently, various rhodium-catalyzed directed C–H cyanations were reported using NCTS 
(13) as the efficient cyanation reagent from the groups of Jia/Zhu,[32] Anbarasan,[33] Sun,[34] 
Kim,[35] Fu,[36] Xu/Yi.[37] They independently investigated the cyanations with different 
substrates. Importantly, some of them achieved the cyanation on alkenes[33a, 36] and at the C-7 





Scheme 1.2.11 Rhodium-Catalyzed C–H Cyanation with Different Directing Groups 
This class of C–H cyanation catalysts was not limited to rhodium complexes, as the C–H 
cyanation could also be achieved by using copper catalysis. Two copper-catalyzed 
regioselective borylation/ortho-cyanation of vinylarenes 33 with NCTS (13) were more 
recently achieved by Buchwald[38] and Montgomery,[39] wherein the vinyl group underwent 
formal hydroboration simultaneously along with ortho-cyanation of the arene (Scheme 1.2.12). 
 
Scheme 1.2.12 Copper-Catalyzed Borylation/ortho-Cyanation of Vinylarenes 33 with  
NCTS (13) 
Furthermore, based on the previous work,[38] Yang reported a copper-catalyzed 
borylation/ortho-cyanation/allyl group transfer cascade reaction. This process was suggested to 
be initiated by an unconventional copper-catalyzed electrophilic dearomatization. Subsequently, 
an rearomatization-driven Cope rearrangement occurred which featured regio- and 
stereospecific 1,3-transposition of the allyl fragment. Adjacent tertiary and quaternary 
stereocenters were constructed with excellent diastereocontrol through this copper-catalyzed 





Scheme 1.2.13 Copper-Catalyzed Borylation/ortho-Cyanation/Allyl Transfer Cascade 
Transformation with NCTS (13) 
Since the Kanai group published the cobalt(III)-catalyzed hydroarylation of imines 37 and 
α,β-unsaturated ketones 38 in 2103,[41] the high valent cobalt catalyzed C–H activation has 
emerged as a salient alternative to those rhodium catalyzed C–H activation.[42] 
The cobalt-catalyzed C–H cyanation of arenes and heteroarenes was independently explored by 
the groups of Ackermann[43] and Glorius.[44] These carboxylate-assisted[28] cobalt-catalyzed 
C–H cyanation proved to have excellent chemoselectivity with high functional group tolerance, 
in that ester, ketone, bromo, fluoro and amido group were well tolerated.[43] Furthermore, this 
cobalt catalytic system was not restricted to the typical 2-phenyl pyridine derivatives. Indeed, 
the biologically relevant indole heterocycles 39 [9x, 45] also proved to be suitable substrates and 
efficiently achieved the desired cyanation products 3 (Scheme 1.2.14). It is noteworthy that the 





Scheme 1.2.14 Cobalt-Catalyzed C–H Cyanation with NCTS (13) 
Based on the experimental mechanistic studies, Ackermann and co-workers proposed the 
catalytic cycle to be initiated by a reversible and fast C–H metalation (intermolecular: kH/kD = 
1.0), thus forming the cyclometalated complex 41. The seven-membered cobaltacycle complex 
43 then undergoes migratory insertion with NCTS (13). Subsequently, β-elimination affords 
the cyanation product 3, while proto-demetalation regenerates the catalytically active cobalt(III) 





Scheme 1.2.15 Proposed Mechanism for Cobalt-Catalyzed C–H Cyanation with NCTS (13) 
A related cobalt-catalyzed C−H cyanation work was later reported by Chang and co-workers.[46] 
They used the N-cyanosuccinimide (44) as an electrophilic cyanation reagent in place of NCTS 
(13), providing the monocyanated products with high selectivity and excellent functional group 
tolerance. Notably, the substrate scope was found to be broad, and a wide range of heterocycles, 
including 6-arylpurines 45, underwent the cyanation process in high efficacy (Scheme 
1.2.16).[46] 
 
Scheme 1.2.16 Cobalt-Catalyzed C–H Cyanation with N-Cyanosuccinimide (44) 
1.3 Ruthenium-Catalyzed C–H Hydroxylation 
Oxygenated aromatic molecules can be found in a variety of useful pharmaceuticals, 
agrochemicals, polymers, and biologically active compounds (Figure 1.3.1), and are key 
intermediates in organic synthesis.[47] The importance of substituted phenols in these areas has 
resulted in a continued demand for developing versatile methods for the synthesis of substituted 
phenols. Direct catalytic C–H oxygenation represents an environmentally benign as well as 





Figure 1.3.1 Selected Biologically Active Compounds 
Since the early achievements reported by Breslow[49] and Fujiwara,[50] synthetically useful 
methods for catalytic direct oxygenation of alkanes and arenes has been broadly investigated, 
mostly using palladium,[48a, 48b, 51] or iron catalysts.[52] In contrast, readily available ruthenium 
complexes-catalyzed C–H oxygenations have been underdeveloped until recently.[9j] 
The recent ruthenium-catalyzed unactivated tertiary C–H bond oxygenations were successfully 
achieved by Du Bois and co-workers (Scheme 1.3.1).[53] They found that the catalytic efficacy 
of this ruthenium-catalyzed hydroxylation was promoted by the combination of catalytic 
[RuCl3.nH2O]
[54] and pyridine in the presence of stoichiometric amounts of KBrO3. Various 
functional groups, such as ester, epoxide, sulfone, oxazolidinone, carbamate, and sulfamate, 
could be tolerated in this oxygenation, affording the tertiary alcohol products in synthetically 
acceptable yields. Moreover, the use of H2
18O as a co-solvent resulted in the nearly quantitative 
incorporation of 18O into the corresponding alcohol, thus providing a convenient method for 
18O-atom incorporation [53b] 
 
Scheme 1.3.1 Ruthenium-Catalyzed Tertiary C–H Hydroxylation 
After further investigations, the same group discovered that the yield could be improved using 
a combination of [(Me3tacn)RuCl3] (49) as the catalyst, AgClO4 as an additive and CAN as the 
oxidant, allowing for a reduction of the catalyst loading, as well as reduced reaction 





Scheme 1.3.2 Ruthenium-Catalyzed Tertiary C–H Hydroxylation 
In recent years, numerous direct oxygenation of more stable C(sp2)–H bonds in arenes and 
heteroarenes with readily accessible ruthenium catalysts have been devised, with key 
contributions coming from the groups of Ackermann,[55] Rao[56] and others.[57] 
In 2012, the group of Ackermann reported the ruthenium-catalyzed, weakly-coordinating 
directing group directed C–H hydroxylations.[55e] The C–O bond formation process proceeded 
smoothly with the user-friendly and inexpensive [RuCl3(H2O)n] catalyst, in addition to 
PhI(OAc)2 as an oxidant (Scheme 1.3.5). However, the most satisfactory results were obtained 
when the well-defined ruthenium(II) biscarboxylate [Ru(O2CMes)2(p-cymene)] was used as 
the catalyst. Remarkably, the corresponding phenols with a variety of valuable functional 
groups could be provided through this highly efficient C(sp2)–H hydroxylation at a reasonably 
low catalyst loading of only 1.0 mol % (Scheme 1.3.3).[55e] 
 
Scheme 1.3.3 Ruthenium(II)-Catalyzed Amide-Directed C–H Hydroxylation 
A ruthenium(II)-catalyzed ortho-hydroxylation of benzoates 52 has been developed by Rao and 
coworkers.[56d] A variety of functionalized ortho-hydroxylyzed benzoates could be accessed via 
this ester-directed C–H oxygenation process. It is noteworthy that a TFA/TFAA co-solvent 
system was found to be ideal, and potassium persulfate, Selectfluor, or iodic acid was used as 
oxidants in this C–O bond formation. Moreover, important biologically compounds, such as 
Mesalazine could be synthesized in a step-economical manner by the ruthenium(II)-catalyzed 






Scheme 1.3.4 Ruthenium(II)-Catalyzed C–H Hydroxylation of Benzoates 52 
Ruthenium(II)-catalyzed anilide-directed oxidative C–O bond formations were reported by 
Rao. An efficient synthesis of mono- and dihydroxylated anilides by C(sp2)–H oxygenation 
was accomplished, featuring excellent site-selectivities and good functional group tolerance 
(Scheme 1.3.5).[56c] 
 
Scheme 1.3.5 Ruthenium(II)-Catalyzed Anilide-Directed C–H Hydroxylation 
The N-Methoxy-N-methylamides–Weinreb amides 56, which can be chemoselectively 
transformed into the corresponding ketones 5 and aldehydes 7, have been shown to be 
important in synthetic organic chemistry.[58] Based on their previous investigation,[55e] 
Ackermann and co-workers reported the C–H oxygenation of aryl Weinreb amides 56[55c] using 
[RuCl2(p-cymene)]2 as the catalyst and PhI(OAc)2 as the oxidant, which was found to enable 
the C–H hydroxylation of aryl Weinreb amides 56, affording the corresponding phenols 57 with 
ample scope under mild reaction conditions. Furthermore, the ortho-hydroxyaldehyde such as 
58 could be obtained via a facile reduction process of the ruthenium-catalyzed C–H bond 
oxygenation product (Scheme 1.3.6).[55c] 
 
Scheme 1.3.6 Ruthenium(II)-Catalyzed C–H Hydroxylation of Weinreb Amides 56 
This ruthenium-catalyzed hydroxylation was not limited to relatively strongly coordinating 
directing groups. Indeed, the much weaker coordinating directing ketones 5 (Scheme 1.3.7)[55f] 
and aldehydes 7 
[55b]
 were also shown to be applicable. It is noteworthy that when using ketone 
5 directed C–H hydroxylations, there were three related palladium-catalyzed ketone directed 
C–H hydroxylation published almost at the same time.[51c, 51f, 51g] However, the inexpensive 






Scheme 1.3.7 Ruthenium(II)-Catalyzed Ketone-Directed C–H Hydroxylation 
The ruthenium-catalyzed C–H hydroxylation bearing very weakly coordinating directing group 
aldehydes 7 should be highlighted,[55b] because of the inherent tendency of aldehydes to 
undergo over-oxidation to the corresponding carboxylic acid under the oxidizing reaction 
conditions usually, restricting the utility of aldehyde-directed C–H hydroxylation. 
Significantly, Ackermann and co-workers reported the first ruthenium-catalyzed C–H 
oxygenation by assistance of very weakly coordinating aldehydes 7.[55b] The site-selective 
hydroxylation of various benzaldehydes 7 with ample scope was accomplished efficiently in 
the presence of an inexpensive and a user-friendly ruthenium(II) complex, providing products 
which could be easily converted into various valuable heterocycles (Scheme 1.3.8). 
 
Scheme 1.3.8 Ruthenium(II)-Catalyzed Aldehyde-Directed C–H Hydroxylation 
1.4 Manganese-Catalyzed C–H Activation 
During the past decade, catalytic C–H activation reactions were successfully achieved by using 
rare and expensive 4d or 5d transition metals, such as ruthenium, rhodium, palladium, iridium 
and rhenium.[9c-p, 9r-w] In contrast, C–H activation reactions catalyzed by naturally abundant 3d 
transition metal complexes are considerably less explored until more recently, despite their 
high abundance and low cost. Recently, the 3d transition metals, such as iron, cobalt and nickel, 
catalyzed C–H bond activation reactions developed enormously.[42, 59]  
Manganese is the twelfth most abundant element and the third most abundant transition metal 
after iron and titanium in the earth’s crust.
[60]
 In addition, it is an essential trace element for life 
on earth. Thus, several manganese-containing enzymes are needed to metabolize carbohydrates, 
cholesterol and amino acids in the human body, such as arginase and manganese-containing 




to 4d and 5d transition metals mean that manganese has the potential to be a successful 
alternative to typically used transition metals, such as platinum, palladium, rhodium, iridium or 
ruthenium (Figure 1.4.1).  
 
Figure 1.4.1 Price of Selected Transition Metals[63] 
 
Scheme 1.4.1 Manganese-Catalyzed C–H Functionalization by Homolytic C–H Cleavage 
In consideration of these advantages, manganese-catalyzed C–H oxygenations,[64] 




species via a radical-type mechanism (Scheme 1.4.1). In contrast, manganese-catalyzed 
organometallic C–H activation[68] reactions are scarce.[69] 
An early example of stoichiometric manganese-mediated C–H activation was demonstrated on 
azobenzene (63), to produce the five-membered manganacycle complex 65 formation, as was 
reported by Stone, Bruce and co-workers.[70] This relatively stable complex could be isolated by 
column chromatography and was characterized by 1H NMR and IR spectroscopy (Scheme 
1.4.2). 
 
Scheme 1.4.2 Stoichiometric Manganese-Mediated C–H Activation 
Thereafter, a variety of manganacycle complexes were successfully prepared in the presence of 
stoichiometric amounts of MnR(CO)5 via C–H activation. It is noteworthy that the directing 
groups were necessary for the site-selective formation of the manganacycle complexes.[70-71]  
 
Scheme 1.4.3 Representative Manganacycle Complexes (R = Me, Bn, Ph, etc) 
With the successful preparation of a set of manganacycle, the transformations of these 





To date, only a few examples of manganese-catalyzed organometallic C–H bond activation 
have been reported. Significant progress on manganese-catalyzed organometallic C–H 
activation was achieved in 2007 by the group of Kuninobu/Takai,[75] although the first 
stoichiometric manganese-mediated C–H bond activation was disclosed by Stone, Bruce and 
co-workers as early as 1970.[70] Thus, Kuninobu/Takai reported the manganese-catalyzed, 
imidazole-directed aromatic C–H bond addition to the polar C=O bond in aldehydes 7.[75]  
They initiated their investigations by examing the stoichiometric manganese C–H activation 
reaction.[75] The polar C=O bond insertion into the aromatic C–H bond of 
1-methyl-2-phenyl-1Himidazole (66) reaction was conducted with stoichiometric amounts of 
[MnBr(CO)5] (67) and provided the corresponding benzyl alcohol 68 in 52% yield (Scheme 
1.4.4a). Only a trace amount of desired product was obtained in the presence of catalytic 
amounts of [MnBr(CO)5]. They found that catalyst turnover could be achieved in this polar 
C=O bond insertion reaction when Et3SiH (69) was introduced as the additive, therefore 
affording the corresponding silylethers 70 (Scheme 1.4.4b). 
 




They also screened some other transition metal catalysts in this C–H transformation. However, 
only [Mn2(CO)10] showed comparable catalytic activities, while MnCl2, Mn(acac)3, ReBr(CO)5, 
Ru3(CO)12, RuH2(CO)(PPh3)3, RhCl(PPh3)3, and Ir4(CO)12 failed to give any conversions. 
Remarkably, this manganese-catalyzed C–H activation reaction could be directly applied to 
diastereo-selective transformations, and the diastereomeric excess silylethers 70 were obtained 
when using chiral imidazoline as the directing groups (Scheme 1.4.4c). 
The catalytic cycle proposed by Kuninobu/Takai suggested that the C–H activation is 
accelerated by the coordination of the nitrogen atom of the imidazole to the manganese center, 
which then undergoes C=O bond insertion into the manganese–carbon bond, to form 
seven-membered manganese complex 73. Finally, the silylethers 70 is formed via release of H2 
gas and regeneration of the manganese(I) catalyst by the action of Et3SiH (69) (Scheme 1.4.5). 
 
Scheme 1.4.5 Proposed Catalytic Cycle for Manganese(I)-Catalyzed C–H  
Addition to Aldehydes 7 
The group of Wang reported that manganese-catalyzed C–H bond addition was not restricted to 
C–Het multiple bonds.[76] They developed a novel C–H alkenylation via hydroarylation of 
terminal alkynes 74 in the presence of [MnBr(CO)5] as the catalyst.
[76] Various aromatic and 
aliphatic alkynes 74 with a wide range of functional groups, including fluoro, chloro, bromo, 
iodo, ester and nitro substitutents, underwent the C–H alkenylation process to provide facile 
access to the anti-Markovnikov E-configured olefins 75 in a highly chemo-, regio-, and 
stereoselective fashion (Scheme 1.4.6). However, this C–H alkenylation protocol was limited 





Scheme 1.4.6 Manganese-Catalyzed C–H Alkenylation with Terminal Alkynes 73 
A proposed catalytic cycle for the manganese-catalyzed C–H addition onto C–C triple bond 
was established based on their experimental studies and DFT calculations (Scheme 1.4.7).  
 
Scheme 1.4.7 Proposed Catalytic Cycle for Manganese(I)-Catalyzed C–H Alkenylation 
The reaction was initiated by base-assisted deprotonative C−H activation in the presence of the 




undergoes insertion of the alkyne to provide a seven-membered manganacycle 79. Then, the 
alkenylation product 75 is furnished from intermediate 79 via a ligand-to-ligand H-transfer 
process, along with the formation of manganese species 82. Complex 78 was regenerated 
through alkynyl-assisted C−H activation. 
A related work on manganese-catalyzed C–H alkenylation with alkynes 74 was published by Li 
and co-workers.[77] Compared to Wang’s work,[76] this C–H alkenylation was not restricted to 
the terminal alkynes.[77] Indeed, both terminal and internal alkynes 74 proved to be suitable 
substrates in this protocol, providing the bis/trisubstituted indolyl-alkenes with a catalytic 
amount of acid as additive (Scheme 1.4.8a). Notably, carbazoles 83 were obtained via a [2+2+2] 
cyclization process in the absence of acid 6 (Scheme 1.4.8b). This suggested that PhCO2H (6) 
was key to success in the chemo-selectivity via an H-transfer process. 
 
Scheme 1.4.8 Manganese(I)-Catalyzed C–H Alkenylation and Cyclization of Indoles 84 
Isoquinolines 86 are key building blocks in organic synthesis and often present significant 
bioactivity, such as anti-inflammatory or antimalarial properties.[78] Developing new strategies 
for the efficient isoquinolines preparation is therefore in high demand. In 2014, Wang and 
coworkers described a highly atom-economical strategy to access isoquinoline derivatives via 
dehydrogenative [4+2] annulation of N−H imines 87 with alkynes 74 in the presence of 
MnBr(CO)5 (Scheme 1.4.9).
[79] In contrast to other well known isoquinoline synthesis through 
the noble 4d or 5d transition-metal catalyzed C−H activation,[80] this manganese-catalyzed C−H 
transformation produced H2 as the sole byproduct without any oxidants, ligands, or additives. 
Diaryl, aryl alkyl imines, aromatic and aliphatic acetylenes 74 with a wide range of functional 
groups underwent the C–H annulations to furnish the corresponding isoquinolines in high 
yields. Importantly, terminal alkynes 74, which are often challenging substrates in 
transition-metal catalyzed isoquinoline 86 synthesis,[80] were found to be suitable substrates in 





Scheme 1.4.9 Manganese(I)-Catalyzed C−H Annulation of N−H Imines 87 with Alkynes 74 
Based on their experimental mechanistic studies, Wang and co-workers proposed two 
catalytic cycles, the more favored process is shown in Scheme 1.4.10. The five-membered 
manganacycle complex 88 was formed through C–H manganation, followed by 
seven-membered manganacycle complex 90 formation via alkyne coordination and insertion 
into manganese–carbon bond of the manganese species 89. Subsequently, elimination of the 
product and generates manganese hydride species [HMn(CO)4] (91). The active manganese 
complex 88 was regenerated by coordination of the N–H imine 87 with [HMn(CO)4] (91), 
along with the release of H2. 
 
Scheme 1.4.10 Suggested Catalytic Cycle for Manganese(I)-Catalyzed C−H/N–H Annulation 
of N−H Imines 87 with Alkynes 74 




in the presence of stoichiometric amounts of [MnBr(CO)5], proved to be the key active 
intermediate through the use of catalytic or stoichiometric amounts of 88 in these C−H 
annulations (Scheme 1.4.11). Furthermore, the formation of H2 and CO was confirmed by GC 
analysis of the atmosphere above the reaction mixture. 
 
Scheme 1.4.11 C–H Annulation of N−H Imines 87 with Cyclometalated Complex 88 
The extension of these C–H addition strategies from C≡C or polar C=Het multiple bonds to 
polar C=C double bonds was accomplished by Wang and co-workers. The hydroarylation of 
α,β-unsaturated carbonyls 38 were achieved through a olefin insertion into the 
manganese−carbon bond step.[81] The addition reaction showed a broad substrate scope, good 
functional group tolerance, and complete mono-selectivity (Scheme 1.4.12).  
 
Scheme 1.4.12 Manganese(I)-Catalyzed C–H Addition to α,β-Unsaturated Carbonyls 38 
Moreover, mechanistic studies indicated that the five-membered manganacycle complex 77 
was likely the crucial intermediate in this transformation, and the key C–H cleavage step was 






Scheme 1.4.13 C–H Addition to α,β-Unsaturated Carbonyls 38 
with Cyclometalated Complex 77 
Recently, transition metal catalyzed nucleophilic C–H addition to aldehydes 7 and nitriles 3 
have been well explored.[82] However, external silanes 69 needed to be introduced to ensure 
catalytic turnover, therefore affording the corresponding silylethers 70[75, 82c, 82e, 82f] as the final 
product, or these methods were limited to electron-rich and electron-neutral arenes.[83] 
In 2015, the group of Wang developed a manganese-catalyzed nucleophilic C(sp2)–H addition 
to aldehydes 7 and nitriles 3 leading to the benzyl alcohols 68 or ketones 5 with 38–95% 
yields and excellent regio- and stereoselectivity (Scheme 1.4.14).[84] 
 
Scheme 1.4.14 Manganese-Catalyzed C–H Addition to Aldehydes 7 and Nitriles 3 
Herein, the benzyl alcohols 68 were conveniently accessed as the final products, and a broad 
range of electron-donating, -neutral and -withdrawing functional groups, such as methoxy, 
amine, fluoro, chloro, bromo, iodo, ester, trifluoromethyl were well tolerated.[84] It is 
noteworthy that both aromatic and olefinic C–H bonds were suitable to this catalytic system, 
as well as aliphatic aldehydes 7 and nitriles 3. 
In comparison to the work of Kuninobu/Takai,[75] they did not obtain the corresponding 




insertion, as the nucleophilic addition of C–H bond could also be applied to the relatively low 
propensity of the C≡N bond efficiently. 
 
Scheme 1.4.15 C–H Addition to Aldehydes 7 with Cyclometalated Complex 77 
Importantly, the formation of methane was observed by GC analysis, and ZnMe2 and ZnBr2 
were found to be essential for the product formation. Furthermore, the manganacycle complex 
77 was successfully prepared from stoichiometric manganese C–H activation, and was shown 
to be the key intermediate from the observation of comparable catalytic efficiency in both 
catalytic and stoichiometric procedures (Scheme 1.4.15). 
Then, Wang and co-workers proposed a catalytic cycle for this nucleophilic C–H addition 
reaction (Scheme 1.4.16). The manganese species [MnMe(CO)5] (64) is generated from 
[MnBr(CO)5] (67) in the presence of ZnMe2, which subsequently undergoes cyclomanganation 
with substrate 25a to afford the catalytically active manganacycle 77. Then the C=O bond 
undergoes insertion into the manganese–carbon bond by the assistance of Lewis-acid ZnBr2, 
forming the seven-membered manganacycle complex 94. The methylmanganese species 95 
was formed through ligand metathesis of 94 with Me2Zn, which reacted with 25a to generate 95 
and furnished zinc species 97. Finally, intermediate 97 was hydrolyzed to give the benzyl 
alcohols 68a, along with intramolecular C–H activation of complex 96 to regenerate catalyst 77 





Scheme 1.4.16 Proposed Catalytic Cycle for Manganese(I)-catalyzed C–H 
Addition to Aldehydes 7 
Recently, the manganese-catalyzed synthesis of isobenzofuranones 98 from aromatic esters 52 
and oxiranes 99 via C−H bond activation was developed by Kuninobu and co-workers by the 
assistance of Lewis-acid BPh3 (100) (Scheme 1.4.17).
[85] This C−H annulation occurred with 
aromatic, heteroaromatic, and olefinic C−H bonds in moderate to good yields and with high 
functional group tolerance. Importantly, this is the first example of oxygen-directed 
organometallic manganese-catalyzed C−H activation. The use of BPh3 (100) is essential to 
improve the efficiency by cooperation with the manganese catalyst. The reaction process likely 
occurs by oxirane isomerization to aldehyde 7 under Lewis acidic condition, then undergoing 
the C=O bond insertion into the formed manganese−carbon bond[85] as was demonstration 











Aromatic nitriles 3 constitute key structural motifs of important pharmaceuticals, dyes, 
agrochemicals and natural products.[12-13] The cyano group serves as a versatile functional 
group that can easily be transformed into amine, ketone, acid, aldehyde, amide, among 
others.[14] Recently, rhodium-catalyzed C–H cyanations of arenes were established with rather 
strongly coordinating directing groups.[27, 29] Herein, an alternative strategy was envisioned, 
which involves C–H cyanation with relatively inexpensive ruthenium catalyst bearing only 
weakly coordinating directing groups by the use of bench stable, less toxic and readily 
accessible N-cyano-N-phenyl-p-toluenesulfonamide (NCTS, 13) (Scheme 2.1).[86] 
 
Scheme 2.1 Ruthenium(II)-Catalyzed C–H Cyanations of Benzamides 50 
The catalytic direct oxygenation of otherwise unreactive C(sp2)–H bonds was shown to be the 
most step-economical approach to substituted phenols.
[48]
 Although ruthenium-catalyzed 
C(sp2)–H bonds direct oxygenation on arenes were reported, these notable progresses were 
mainly focused on oxygenation on electron-deficient substrates bearing electron- withdrawing 
directing groups. Therefore, a ruthenium-catalyzed C(sp2)–H bond oxygenation of the 
electron-rich phenol derivatives was wished to be demonstrated (Scheme 2.2).[55d] 
 
Scheme 2.2 Ruthenium-Catalyzed C(sp2)–H Oxygenations of Carbamates 102 
Carbocyclic β-amino acids can be found in natural products and pharmaceuticals, such as 
cispentacin and icofungipen, which possess noteworthy antifungal or antibacterial activities, 
and they are also a versatile intermediate in organic synthesis.[87] Moreover, 
manganese-catalyzed organometallic C–H activation reactions are scarce and only scattered 
examples have been reported.[69] Obviously, developing new methods for the efficient 
preparation of substituted β-amino acids is of significant importance, particularly exploiting 





Scheme 2.3 Manganese-Catalyzed Synthesis of cis-β-Amino Acid Esters 105 through 
Organometallic C–H Activation of Ketimines 104 
The easily accessible isocyanates 106 contain polar double bonds, and have been successfully 
applied to step-economical aryl amide formation through C–H activation with expensive 
rhodium,[89] rhenium,[90] ruthenium[91] or relatively inexpensive Cp*Co(III) complex.[92] Here, 
a manganese-catalyzed C–H bond addition to the C=N bond of isocyanates 106 for the access 
to aryl amide was planned (Scheme 2.4).[93] 
 
Scheme 2.4 Manganese(I)-Catalyzed C–H Amino Carbonylation of Heteroarenes with 
Isocyanates 106 
The allyl group is one of the most important and useful functionalities in organic synthesis 
because they provide readily access to various functional groups.[94] Furthermore, allyl arenes 
exist in various natural products and pharmaceuticals.[94] Due to the importance of the allyl 
group, it is significant to develop a new versatile C–H allylation in the presence of less toxic 
and inexpensive manganese catalyst, although transition metal catalyzed direct C–H 
allylation[95] reactions have been previously explored (Scheme 2.5).[96]  
 
Scheme 2.5 Manganese(I)-Catalyzed Substitutive C–H Allylation 
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3 Results and Discussion 
3.1 Ruthenium(II)-Catalyzed C–H Cyanations of Benzamides 
Aromatic nitriles are widely found in pharmaceuticals, agrochemicals and natural 
products,[12-13] and cyano groups can be readily transformed into many valuable functional 
groups, such as amines, ketones, amides, acids or aldehydes, among others.[14] Hence, it is 
important to develop new methods to introduce the cyano group onto aromatic ring. 
3.1.1 Optimization of Ruthenium(II)-Catalyzed C–H Cyanation with Benzamides 
The ruthenium(II)-catalyzed C–H cyanation was initiated by using N,N-diisopropylbenzamide 
(50a) and N-cyano-4-methyl-N-phenylbenzenesulfonamide (NCTS, 13) in the presence of 
[RuCl2(p-cymene)]2 as the catalyst. The effect of different additives and solvents was 
investigated in this reaction (Table 3.1.1). The desired cyanation product was formed in 70% 
yield with 20 mol % of AgOAc and AgSbF6 as additives in DCE (entry 1). The cyanation 
efficacy could not be increased with a higher amount of the additive, but less than 5% product 
conversion was observed without AgSbF6 (entries 2–4). Next, different solvents were screened 
and DCE was found to be the ideal (entries 1, 5–8). The background reaction experiment was 
then performed, and clearly showed that this C–H activation process did not occur without a 
ruthenium catalyst (entry 9). Subsequently, a variety of metal acetate additives were tested to 
investigate the influence of different additives, and it turned out that the NaOAc provided the 
highest catalytic efficacy (entries 10–14). 
Table 3.1.1 Optimization of Ruthenium(II)-Catalyzed C–H Cyanations with Benzamides 50[a] 
 
Entry Additive Solvent Yield (%) 
1 AgOAc DCE 77 (70) 
2[b] AgOAc DCE 80 (67) 
3[c] AgOAc DCE 67 (54) 
4[d] AgOAc DCE < 5 
5 AgOAc 1,4-dioxane 38 
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6 AgOAc o-xylene 21 
7 AgOAc PhMe 23 
8 AgOAc DMF < 2 
9[e] AgOAc DCE < 2 
10 Cu(OAc)2 DCE 30 
11 KOAc DCE < 5 
12 CsOAc DCE 17 
13 NaOAc DCE 90 (80) 
14
[f]
 NaOAc DCE 95 (84) 
[a] Reaction conditions: 50a (0.5 mmol), 13 (1.0 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), 
AgSbF6 (20 mol %), additive (20 mol %), solvent (2.0 mL), under N2, 120 °C, 18 h; 
GC-conversion, isolated yields are given in parentheses. [b] AgOAc (30 mol %). [c] AgSbF6 (30 
mol %). [d] Without AgSbF6. 
[e] Without [RuCl2(p-cymene)]2. 
[f]
 24 h. 
3.1.2 Effect of N-Substituents on C–H Cyanations 
Subsequently, the effect of the N-substituent at the amide moiety under the optimized system 
was studied (Table 3.1.1, entry 14). A set of tertiary amides 50a–50f proved to be suitable 
substrates in this ruthenium(II)-catalyzed C–H cyanation system, thus affording the 
corresponding products 101 in good yields. This cyanation reaction is not limited to a 0.5 mmol 
scale. Indeed, a 5 mmol scale reaction also afforded a comparable yield of 72% (Scheme 3.1.1). 
 
Scheme 3.1.1 Effect of N-Substituents on C–H Cyanations 
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3.1.3 Scope of Ruthenium-Catalyzed C–H Cyanation with Amides 
Next, the substrate scope of the ruthenium-catalyzed C–H cyanations of amides 100 was 
explored (Scheme 3.1.2). Under the optimized reaction conditions, various substituted 
aromatic amides 50 could undergo the cyanation process to provide the desired products 101 in 
high chemo-selectivity and good to excellent yields. Various valuable functional groups, such 
as ester, fluoro, chloro, bromo, even iodo, were well tolerated affording the corresponding 
products 101, which should allow for further diversification of the cyanation products 101. 
 
Scheme 3.1.2 Scope of Ruthenium-Catalyzed C–H Cyanations with Amides 50 
3.1.4 C–H Cyanation with Heteroaromatic Amides 
The powerful carboxylate-assisted ruthenium(II)-catalyzed direct C–H cyanation was not 
limited to simple aromatic amides 50, but also proved viable for more attractive 
heteroaromatic amides 50. For the challenging heteroaromatic amides, either C2 (Scheme 
3.1.3a) or C3 (Scheme 3.1.3b) position could be cyanated by this C–H activation strategy, 
thereby furnishing cyanated thiophenes (101q, 101u), furanes (101r), benzothiophenes (101s), 
benzofuranes (101t) and indoles (101p) in good yields and excellent chemo- and 





Scheme 3.1.3 C–H Cyanations of Heteroaromatic Amides 50 
3.1.5 Mechanistic Studies 
In order to gain details on this useful and unique chemo-selective C–H cyanation reaction, 
some mechanistic experiments were performed. First, the ruthenium(II) biscarboxylate 
complex 111 was prepared according to a literature procedure.[97] The comparable catalytic 
efficacy in 75% yield was observed when conducting the cyanation reaction in the presence of 
catalytic amount of complex 111 without NaOAc (Scheme 3.1.4). 
 
Scheme 3.1.4 Well-Defined Complex 111 as Catalyst 
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Intramolecular competition experiments with meta-substituted amides 50v–50x demonstrated 
that the site-selectivity was controlled by steric interactions, since the C–H activation 
occurred predominantly at the less hindered position. In case of the meta-methoxy and fluoro 
substituted benzamides 50w and 50x, a secondary directing group effect[10] was noted (Scheme 
3.1.5). 
 
Scheme 3.1.5 Intramolecular Competition Experiments with meta-Substituted Arenes 
Subsequently, an intermolecular competition experiment between electron-rich and 
electron-deficient amides was conducted. The results clearly showed the higher activity of 
electron-rich arenes, which indicated an base-assisted electrophilic-type (BIES)[98] C–H 
activation by the cationic ruthenium species. 
 
Scheme 3.1.6 Intermolecular Competition Experiment between Arenes 50 
Furthermore, this ruthenium(II)-catalyzed C–H cyanation reaction was carried out in the 
presence of D2O as co-solvent. H/D exchange was observed by reisolation of the starting 
material [D]n-50h and the cyanation product [D]n-101 (Scheme 3.1.7). These observations 
supported a reversible C–H activation step. 




Scheme 3.1.7 H/D Exchange Experiment 
The intermolecular kinetic isotope effect (KIE) from a one pot reaction between substrates 50a 
and [D]5-50a was found to be rather low (kH/kD ≈ 1.2) (Scheme 3.1.8). These experimental 
results indicated that the C–H ruthenation process is not the rate-determining step. 
 
Scheme 3.1.8 Kinetic Isotope Effect Study 
3.1.6 Plausible Catalytic Cycle 
Based on these mechanistic studies, a plausible catalytic cycle was proposed for this 
ruthenium(II)-catalyzed C–H cyanation (Scheme 3.1.9). After reversible and fast C–H bond 
ruthenation on amide 50 with the cationic ruthenium carboxylate species 111, the resulting 
cationic ruthenium complex 112 undergoes coordination and insertion of NCTS (13), and thus 
affords the intermediate 114. Finally, the desired cyanation product is formed and the cationic 
ruthenium(II) carboxylate catalyst is regenerated after β-elimination and proto-demetalation. 




Scheme 3.1.9 Plausible Catalytic Cycle 
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3.2 Ortho- and Para-Selective Ruthenium(II)-Catalyzed C(sp
2
)–H Oxygenations 
of Phenol Derivatives 
The catalytic oxygenation of otherwise unreactive C(sp2)–H bonds proved to be one of the 
most step-economical approaches for the synthesis of substituted phenols.[48] The 
ruthenium-catalyzed C(sp2)–H bond oxygenation on arenes bearing weakly coordinating 
directing groups, such as amides, esters, ketones, and aldehydes were previously reported by 
Ackermann[55] and Rao.[56] However, these notable advances only focused on direct 
oxygenation on electron-deficient substrates bearing electron-withdrawing directing groups. 
3.2.1 Optimization of Ruthenium(II)-Catalyzed C–H Oxygenations of Carbamates 
At the outset of this investigations on the ruthenium(II)-catalyzed C–H oxygenations of 
carbamates 102, m-tolyl diethylcarbamate (102a) was selected as the model substrate and 
[bis(trifluoroacetoxy)iodo]benzene (PIFA) as the oxidant to exam the effects of different 
ruthenium catalysts and solvents (Table 3.2.1). The background reaction experiment showed 
that the desired oxygenation product could not be obtained in the absence of a ruthenium 
catalyst (entry 1), while 39% yield of the corresponding phenol was formed in the presence of 
catalytic amounts of [Ru3(CO)12] in DCE (entry 2). These findings clearly indicated that this 
C–H oxygenation process was catalyzed by a ruthenium catalyst. Then, different ruthenium 
catalyst precursors were tested, with [RuCl2(p-cymene)]2 showing the highest catalytic 
efficacy and giving the desired oxygenation product in 65% (entries 2–6). Furthermore, other 
solvents and oxidants were explored, and PhI(TFA)2 and DCE proved to be the best choice 
among the tested solvents and oxidants, respectively (entries 6–9). It is noteworthy that the 
ruthenium-catalyzed C–H bond oxygenation could occur at a rather low reaction temperature 
under the optimized condition in a comparable yield (entry 10). 
Table 3.2.1 Optimization of C–H Oxygenation with Carbamate 102a[a] 
 
Entry [Ru] Solvent Yield (%) 
1 --- DCE --- 
2 [Ru3(CO)12] DCE 39 
3 [Ru(O2CMes)2(p-cymene)] DCE 46 
4 [RuCl2(PPh3)3] DCE 53 
5 [RuCl3(H2O)n] DCE 54 
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6 [RuCl2(p-cymene)]2 DCE 65 
7 [RuCl2(p-cymene)]2 TFA/TFAA 30
[b] 
8 [RuCl2(p-cymene)]2 1,4-dioxane 24
[c] 
9 [RuCl2(p-cymene)]2 PhMe 57 
10 [RuCl2(p-cymene)]2 DCE 67
[d] 
[a] Reaction conditions: 102a (0.5 mmol), PhI(TFA)2 (1.0 mmol), [Ru] (5.0 mol %), solvent 
(2.0 mL), 80 °C, 3 h, isolated yield. [b] K2S2O8 (2.0 equiv) instead of PhI(TFA)2. 
[c] 1H-NMR 
conversions with CH2Br2 as internal standard. 
[d] 50 °C, 24 h. 
3.2.2 Scope of ortho-Selective C–H Oxygenation with Carbamates 
With the optimized catalytic system in hand, the substrate scope of carbamates 102 was 
investigated (Scheme 3.2.1).  
 
Scheme 3.2.1 Scope of ortho-Selective C–H Oxygenation with Carbamates 102 
Fortunately, para-, meta-, and even more sterically hindered ortho-substituted aryl carbamates 
102 could be converted to corresponding phenols in moderate to good yields under this 
optimized ruthenium(II)-catalyzed ortho-selective C–H oxygenation. Moreover, a variety of 
valuable functional groups, such as fluoro, chloro, bromo, or iodo, were well tolerated, 
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affording the corresponding phenol products 103 efficiently. Notably, this transformation 
showed high chemo- and site-selectivities to furnish the ortho-substituted phenols 103. 
3.2.3 Competition Experiments 
The group of Rao reported ester directed ruthenium(II)-catalyzed C–H oxygenation to deliver 
the corresponding phenol products.[56d] Thus, it is interesting to find out the directing abilities 
of different directing groups in this oxygenation reaction system through either intramolecular 
or intermolecular competition experiments. First, an intramolecular competition experiment 
was conducted with benzoate 102w which contains two directing groups, ester and carbamate. 
The carbamate directed oxygenation product was detected as the sole product 103w in 39% 
yield, which indicated the carbamate as the more powerful directing group as compared to 
ester in this case (Scheme 3.2.2). This selectivity suggested that the less favorable 
six-membered cycle might be the crucial intermediate in this carbamate directed C–H 
activation mode. 
 
Scheme 3.2.2 Intramolecular Competition Experiment 
Then, intermolecular competition experiments between substrates with different directing 
groups were performed. From the competition experiment between amide 50 and carbamate 
102, the amide directed oxygenation product 51a was isolated in 24% as well as 4% of the 
oxygenated carbamate 103a (Scheme 3.2.3a). One further competition experiment showed 
that carbamate reacted faster than ester, which is in good agreement with the intramolecular 
competition experiment (Scheme 3.2.3b). These results provided the following directing 
ability order: amide > carbamate > ester. 




Scheme 3.2.3 Intermolecular Competition Experiments 
3.2.4 Kinetic Isotope Effect Study 
Subsequently, a kinetic isotope effect (KIE) study experiment was carried out to gain a deeper 
understanding of this carbamate directed ruthenium(II)-catalyzed C–H oxygenation reaction. 
The KIE of kH/kD ≈ 2.2 by using 102n and [D]5-102n was obtained in a one-pot reaction, and 
revealed the C–H metalation step to be kinetically relevant (Scheme 3.2.4).[99] 
 
Scheme 3.2.4 Kinetic Isotope Effect Study 
3.2.5 para-Selective C–H Oxygenation of Anisoles 
When 2-methoxyphenyl diethylcarbamate (102x) was used as the starting material in this 
oxygenation system, not only the desired ortho-oxygenation product could be observed in 50% 
yield, but also the meta-oxygenation product as the byproduct in 19% yield (Scheme 3.2.5). It 
appears that the methoxy group has a significant influence and changed the substrate 
reactivity, directing the oxygenation in para-position to the methoxy group. 




Scheme 3.2.5 C–H Oxygenation on Arene 102x  
Interestingly, this ruthenium-catalyzed C–H oxygenation could take place on simple anisole 
derivatives 115 as well, delivering para-oxygenated products 116 in moderate to good yields. 
Only 1,2-dimethoxybenzene (115c) could provide the corresponding oxygenation product in a 
very low yield without the ruthenium catalyst (Scheme 3.2.6). Moreover, under otherwise 
identical reaction conditions by the use of Lewis acids AlCl3 or FeCl3 as the catalyst furnished 
only <5% of product 116a, as determined by GC analysis. 
 
Scheme 3.2.6 para-Selective C–H Oxygenation of Anisoles 115  
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3.3 Manganese-Catalyzed Synthesis of cis-β-Amino Acid Esters through 
Organometallic C–H Activation of Ketimines 
Carbocyclic β-amino acids are widely found in many natural products and antibiotics, and 
certain carbocyclic β-amino acids, such as cispentacin, icofungipen, and BAY Y9379, possess 
important antifungal or antibacterial activities, while tilidin, a phenyl-substituted cyclohexene 
amino ester, is an analgetic.[87, 100] Amipurimycin with a five-membered carbocyclic β-amino 
acid motif is an important antibiotic (Figure 3.3.1).[87, 100] 
 
Figure 3.3.1 Selected Biologically Active β-Amino Acids 
Moreover, β-amino acids are key structural motifs in non-natural β-peptides and versatile 
intermediates in organic synthesis.[87] Therefore, developing new methods for efficient 
preparation of substituted β-amino acids is of significant importance.  
3.3.1 Optimization of Manganese-Catalyzed C–H Annulation of Acrylates by Imines 
At the outset of the studies, a variety of reaction conditions for the envisioned 
manganese-catalyzed C–H activation of ketimine 104a were tested with ethyl acrylate 38a as 
the substrate (Table 3.1). 
Table 3.3.1 Optimization of Manganese-Catalyzed C–H Annulation of Acrylate 38a[a] 
 
Entry Catalyst Solvent T [oC] Yield (%) 
1 Mn2(CO)10 PhMe 100 59 
2 Mn2(CO)10 PhMe 140 45 
3 Mn2(CO)10 PhMe 120 87 
4 MnBr(CO)5 PhMe 120 11
[b] 
5 MnCl2 DCE 120 --
[b] 
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6 Mn2(CO)10 DCE 120 94 
7 Mn2(CO)10 1,4-dioxane 120 77 
8 --- DCE 120 --- 
9 Co2(CO)8 DCE 120 <3 
10 Ni(cod)2 DCE 120 --
[b] 
[a] Reaction conditions: 104a (0.5 mmol), 38a (1.0 mmol), catalyst (5.0 mol %), solvent (1.0 
mL), under N2, 120 °C, 18 h, isolated yield. 
[b] Catalyst (10 mol %). 
We were delighted to observe that the formation of cis-β-amino acid ester 105aa occurred in 
the presence of catalytic amount of Mn2(CO)10 (entry 1). Subsequently, the effect of the 
reaction temperature was explored, and 120 oC was found to be ideal (entries 1–3). Notably, 
additional additives such as amines or metal acetates were not necessary in this 
manganese-catalyzed C–H annulation of imines 104a with acrylates 38a. The following 
optimization studies showed that other manganese catalysts were less efficient, and toluene 
and DCE were the optimal solvents (entry 4–7). A control experiment revealed that the C–H 
bond activation did not occur in the absence of Mn2(CO)10 (entry 8). No or only trace amounts 
of the desired product were observed in the presence of Co2(CO)8 or Ni(cod)2 as the catalysts 
(entries 9 and 10). 
3.3.2 Scope of Manganese-Catalyzed C–H Activation with Acrylates 
With the optimized catalytic system in hand, the scope of α,β-unsaturated esters 38 for the 
manganese-catalyzed the C–H activation of imine 104a was explored (Scheme 3.3.1). A 
variety of α,β-unsaturated esters 38a–38d were suitable substrates, affording the desired 
β-amino esters 105 in good yields with excellent regio- and diastereoselectivity. A comparably 
high yield could be achieved even on a larger 5 mmol scale. It is noteworthy that not only 
terminal acrylates 38 but also the internal acrylate (E)-38e was successfully applied to 
generate the desired product 105ae in good yield with excellent stereocontrol of all three 
contiguous stereocenters. However, the reactions with (Z)-crotonate (38g), cinnamic acid ester 
(38h) and methacrylate (38i) only gave traces of the desired products. 




Scheme 3.3.1 Manganese-Catalyzed C–H Activation with Alkenes 38 
3.3.3 Scope of Manganese-Catalyzed C–H Activation with Imines 
Next, the scope of the imine 104 under the optimized catalytic conditions was explored 
(Scheme 3.3.2). Many valuable functional groups, such as fluoro, chloro, bromo and 
cyclopropyl, were well tolerated by the catalytic system, which is instrumental for further 
derivatizations of compounds 105. Both aryl alkyl and diaryl imines 104 afforded the desired 
products 105 in good yields, whereas aldimines only gave traces of corresponding product. 
Further examination of the electronic effect of ketone group showed that electron efficient 
ones were preferable to the electron deficient substrates (105aa, 105ja, 105ka). The 
selectivity of meta-substituted arenes 104l and 104m was controlled by steric interactions, 
since the C–H activation occurred predominantly at the less hindered position (105la, 
105ma). 




Scheme 3.3.2 Manganese-Catalyzed C–H Activation with Imines 104 
3.3.4 Mechanistic Studies 
In order to shed light on the course of this new manganese-catalyzed C–H activation, a set of 
experiments towards elucidation of its mechanistic aspects were performed. First, in the 
intramolecular competition experiment with imine 104q, no significant chemoselectivity was 
observed, and the almost 1:1 ratio of the products 105qa and 105qa' revealed that 
electron-rich and electron-poor arenes have comparable activities (Scheme 3.3.3a). Second, 
intermolecular competition experiment between meta- or para-substituted methyl- and 
fluoroacetophenonimines showed that there is no significant electronic effect in this 
manganese-catalyzed C–H bond activation (Scheme 3.3.3b and c). Both intra- and 
intermolecular competition experiments indicated that the electronic effects of imines 104 had 
only a minor influence on the manganese-catalyzed alkene annulation process. 




Scheme 3.3.3 Intra/Intermolecular Competition Experiments 
Additionally, C–H bond activation performed in the presence of D2O as co-solvent revealed a 
reversible H/D-exchange, as was observed for the reisolation of the labeled substrate [D]n-5a 
after acidic work-up as well as for the labeled product [D]n-105aa(Scheme 3.3.4). 
 
Scheme 3.3.4 H/D Exchange Experiment 
Furthermore, the kinetic isotope effect (KIE) of the manganese-catalyzed C–H activation was 
found to be kH/kD ≈ 2.4, as was determined by the intramolecular competition experiment with 
isotopically labeled substrate [D]1-104b (Scheme 3.3.5a), and the intermolecular KIE of kH/kD 
≈ 2.1 which was determined by independent experiments of substrates 104b and [D]1-104b 
(Scheme 3.3.5b). Both experimental results supported a kinetically relevant C–H 





Scheme 3.3.5 Kinetic Isotope Effect Studies 
Moreover, a radical pathway was excluded by conducting the experiment either under an 
atmosphere of aif or in the presence of the radical scavenger TEMPO (Scheme 3.3.6). These 
findings strongly supported the organometallic C–H activation mode. 
 
Scheme 3.3.6 C–H activation in the Presence of Radical Scavengers 
3.3.5 Proposed Mechanism 
Based on these mechanistic studies, two plausible catalytic cycles were proposed for this 
manganese-catalyzed cis-selective β-amino ester formation. 




Scheme 3.3.7 Proposed Mechanism 
The initial rate-determining C–H metalation of ketimine 104 was proposed to generate 
intermediate 117 through base assistance, then the intermediate manganese enolate 118 is 
afforded via migratory insertion of α,β-unsaturated ester 38, which subsequently undergo the 
intramolecular cyclization by nucleophilic attack at the carbon of imine group, thereby 
affording complex 119. Finally, proto-demetalation furnishes the desired β-amino ester 105 and 
regenerates the active manganese complex (Scheme 3.3.7). Another possibility is that the 
intermediate 117 is formed via release of HMn(CO)5 and CO, then the intermediate 
manganese enolate 118 is formed via migratory insertion of α,β-unsaturated ester 38 into the 
manganese–carbon bond of 117. This intermediate subsequently undergoes the intramolecular 
cyclization by nucleophilic attack, affording complex 119. Finally, the desired product 105 is 
obtained through complex 119 reacting with 104, along with regeneration active manganese 
complex 117 (Scheme 3.3.8). 




Scheme 3.3.8 Alternative Mechanism 
3.3.6 Diversification of C–H Activation Product 
Finally, the utility of the obtained N-protected β-amino esters 105 was investigated (Scheme 
3.3.9). 
 
Scheme 3.3.9 Diversification of Product 105aa 
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As can be seen from Scheme 3.3.9, compound 105aa can be selectively deprotected by 
removing the PMP group to give β-amino ester 120, which displays the free amino group (a). 
Important organic building blocks, indenecarboxylate121 (b) and β-lactam derivative 122 (c), 
can readily be obtained from 105aa in good yields as well. 
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3.4 Manganese(I)-Catalyzed C–H Aminocarbonylation of Heteroarenes 
The step-economical aryl amide formation through C–H activation using easily accessible 
isocyanates 110 has been successfully achieved with rather expensive 4d or 5d transition metals, 
such as rhodium,[89] rhenium,[90] ruthenium[91] or Cp*CoIII complexes[92] from the groups of 
Kuninobu/Takai, Bergman/Ellman, Cheng, Li and Ackermann. Although manganese is the 
third most abundant transition metal in the earth crust, the organometallic C–H bond activation 
with manganese catalyst is still less explored compared to the noble transition metals. 
The triple or polar double bond can be inserted into the manganese-carbon bond (Scheme 
3.4.1),[75-77, 79, 81, 88] and we became attracted by the isocyanates 106 which contain polar C=Het 
double bonds. It might undergo the insertion process to form amide in the presence of a 
manganese catalyst. 
 
Scheme 3.4.1 Insertion into Manganese–Carbon Bond by Polar Multiple Bond 
3.4.1 Optimization of Manganese-Catalyzed C–H Aminocarbonylation 
Based on this hypothesis, studies with 1-(pyridin-2-yl)-1H-indole (84a) and phenyl isocyanate 
(106a) as the model substrates were initiated (Table 3.4.1). 
Table 3.4.1 Optimization of Manganese-Catalyzed C–H Activation[a] 
 
Entry [Mn] Additive Solvent T [oC] Yield [%][b] 
1 [Mn2(CO)10] --- PhMe 120 56
[c] 
2 [Mn2(CO)10] NaOAc PhMe 120 47
[c] 
3 [MnBr(CO)5] NaOAc PhMe 120 70
[c] 
4 [MnBr(CO)5] NEt3 PhMe 120 79
[c] 
5 [MnBr(CO)5] PPh3 PhMe 120 < 3
[c] 
6 [Mn2(CO)10] NaOAc Et2O 100 76 
7 [Mn2(CO)10] NaOAc 1,4-dioxane 100 33
[d] 
8 [Mn2(CO)10] NaOAc DME 100 14
[d] 
9 [MnBr(CO)5] NaOAc Et2O 100 84 
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10 [MnBr(CO)5] --- PhMe 120 61 
11 [MnBr(CO)5] --- THF 100 78 
12 [MnBr(CO)5] --- MTBE 100 80 
13 [MnBr(CO)5] --- nBu2O 100 91 
14 [MnBr(CO)5] --- Et2O 100 95 
15 [MnBr(CO)5] --- --- 100 83 
16 [Mn2(CO)10] --- Et2O 100 89 
17 --- --- Et2O 100 --- 
18 MnCl2 --- Et2O 100 --- 
19 Mn(OAc)2 --- Et2O 100 --- 
[a] Reaction conditions: 84a (0.50 mmol), 106a (0.55 mmol), [Mn] (10 mol %), additive (20 
mol %), solvent (1.0 mL), under N2, 100 °C, 16 h, isolated yield. 
[b] Isolated yield. [c] 84a (1.0 
mmol). [d] NMR conversions using CH2Br2 as internal standard. 
With [Mn2(CO)10] as the catalyst and toluene as the solvent, the desired product 107aa was 
formed in 56% yield (entry 1). Notably, this manganese-catalyzed C–H aminocarbonylation 
worked without any additional ligand or additive, in contrast to cobalt-catalyzed approaches.[92] 
Next, the influence of additives was investigated, and it was found that the yield was slightly 
improved in the presence of [MnBr(CO)5] as the catalyst and a tertiary amine as additive 
(entries 2–5). Different solvents were tested, and etheral solvents were found to be ideal (entries 
6–13). Finally, [MnBr(CO)5] as catalyst together with ethers as solvent without any additive 
were identified as the optimal reaction conditions (entries 12–16). Furthermore, the control 
experiments clearly showed that the C–H activation reaction did not occur without the catalyst 
or with simple manganese salts, such as MnCl2, Mn(OAc)2 (entries 17–19). 
3.4.2 Scope of Manganese-Catalyzed C–H Aminocarbonylation with Isocyanates 
With the optimized catalytic conditions in hand (Table 3.4.1, entries 13 and 14), the C–H 
aminocarbonylation scope with isocyanates 106 was investigated (Scheme 3.4.1). Under the 
optimized conditions, various valuable functional groups on substituted aryl isocyanates 106, 
such as fluoro, chloro, iodo and methoxy substituents, were tolerated to give the 
corresponding products 107 in good to excellent yields, which highlights the potential for 
functional groups further diversifications. It is noteworthy that the more challenging 
electron-rich and sterically hindered secondary alkyl isocyanates 106k and 106l were also 
suitable for this manganese(I) catalysis with acceptable to good yields. Moreover, the 
ortho-substituted aryl isocyanate, 1-naphthaleneisocyanate 106m and the heteroaromatic 
substrate, 2-furanisocyanate 106n, were converted into the corresponding products 107am and 
107an with comparable catalytic efficacy (Scheme 3.4.2). 




Scheme 3.4.2 Manganese-Catalyzed C–H Activation with Isocyanates 106 
3.4.3 Scope of Manganese-Catalyzed C–H Amidation with Indoles and Pyrroles 
The scope of indoles 84 and pyrroles 123 under the optimized conditions was next explored. 
The indoles 84 showed high reactivity and chemoselectivity. Besides, a variety of valuable 
functional groups, such as bromo, iodo, ester and ketone, were well tolerated in this catalytic 
system. Furthermore, the more sterically hindered C3-substituted substrate 84j was also found 
to be suitable in this manganese-catalyzed C–H aminocarbonylation process to afford the 
corresponding product in high yields. Notably, the manganese-catalyzed C–H activation 
protocol was not limited to indole substrates. Thus, pyrroles 123 underwent the process with 
high catalytic efficacy as well (Scheme 3.4.3). 




Scheme 3.4.3 Manganese-Catalyzed C–H Amidation with Indoles 84 and Pyrroles 123 
3.4.4 Mechanistic Studies 
In order to gain deeper understanding on the manganese-catalyzed C–H aminocarbonylation 
process, a set of mechanistic experiments was performed. First, H/D exchange reaction under 
the manganese(I) catalytic system was conducted in the presence of D2O as a co-solvent. Here, 
the corresponding product was not observed. Then, the reaction in the presence of D2O as 
co-solvent but without the isocyanate was performed, H/D exchange was detected in the C2 
and C3 positions of the indole substrate in the reisolated [D]n-84b. This finding revealed that 
the C–H manganesation process is reversible (Scheme 3.4.4). 




Scheme 3.4.4 H/D Exchange Experiment 
Next, the kinetic isotope effect (KIE) of the manganese-catalyzed C–H activation was 
determined by independent experiments of substrates 84a and [D]1-84a to be kH/kD ≈ 1.4 
(Scheme 3.4.5). These experimental result indicated a fast C–H manganesation step. 
 
Scheme 3.4.5 Kinetic Isotope Effect Study 
Subsequently, the intermolecular competition experiments between electron-rich and 
electron-deficient isocyanates 106 and indoles 84 were conducted. These competition 
experiments clearly showed electron-deficient isocyanates 110 and electron-rich indoles 83 to 
be preferentially converted (Scheme 3.4.6), which indicated that the insertion of the isocyanate 
C=N double bond into the manganese-carbon bond was the rate-determining step. 
 
Scheme 3.4.6 Intermolecular Competition Experiments 
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Additionally, the comparable catalytic efficiency of the manganese(I)-catalyzed C–H 
functionalizations was highlighted when conducting the experiments either under an 
atmosphere of air or in the presence of stoichiometric amounts of the radical scavenger TEMPO 
(Scheme 3.4.7). These results strongly supported the organometallic C–H activation mode. 
 
Scheme 3.4.7 C–H Activation Under Air or in the Presence of Radical Scavengers 
3.4.5 Proposed Mechanism 
Based on the mechanistic studies, we proposed a plausible catalytic cycle for this 
manganese(I)-catalyzed C–H aminocarbonylation process (Scheme 3.4.8). The catalytic cycle 
for this manganese(I)-catalyzed C–H aminocarbonylation was proposed to be initiated by the 
coordination of the pyridine moiety to the manganese catalyst. Subsequently, complex 125 
undergoes a reversible and fast C–H bond metalation, forming the cyclometalated complex 126. 
The seven-membered manganacycle complex 128 was formed after coordination and 
rate-determining insertion of the C=N bond of isocyanate 106 into the manganese-carbon bond. 
Finally, proto-demetalation released the desired product and regenerated the manganese(I) 
catalyst. 




Scheme 3.4.8 Proposed Mechanism 
3.4.6 Diversification of Aminocarbonylation Product 
Finally, in order to show the utility of the products obtained from aminocarbonylation, several 
further diversifications have been performed (Scheme 3.4.9).  
 
Scheme 3.4.9 Diversification of C–H Activation Product 
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First, the traceless removal of the pyridyl directing group was successfully achieved to release 
the NH-free indole 129 in good yield. Furthermore, the important quinoxalinones 130 can be 
conveniently synthesized from the late-stage diversification of amides 107 in a single step. 
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3.5 Manganese(I)-Catalyzed Substitutive C–H Allylation 
The allyl group is one of the most important and useful functionalities in organic synthesis 
because it provides easy access to various functional groups.
[94]
 Because of this importance of 
the allyl group, developing new allylation reactions has drawn the attention of chemist for a 
long time. Although cross-coupling reactions with prefunctionalized arenes have proven to be a 
viable method,[101] direct C–H allylation is obviously more attractive. This approach provides a 
straightforward way to introduce allyl units because of its atom- and step-economy. The 
classical Lewis acid-mediated Friedel-Crafts-type allylation of electron rich arenes is known 
and widely used for many years.[102] But there are several limitations, including: i) limited 
substarte scope, to electron-rich substrates; ii) poor regioselectivities; and iii) over allylation. 
In the recent years, transition metal-catalyzed direct C–H allylations were developed by 
different research groups. However, these reactions only occurred in the presence of rare and 
expensive 4d or 5d transition metals, such as ruthenium,[95i, 103] rhodium,[95e-g, 104] palladium,[95h, 
105] iridium[106] and rhenium[107] in most cases. Recently, C–H allylations catalyzed by 
inexpensive 3d metal, such as iron,[95a, 108] cobalt,[44, 95b, 95c, 109] nickel[95d, 110] and copper[111] have 
also been developed. In contrast, even though manganese is the twelfth most abundant element 
and the third most abundant transition metal after iron and titanium in earth crust, there is no 
report about allylation by manganese catalysis so far.  
3.5.1 Optimization of Manganese-Catalyzed C–H Allylation with Carbonate 
The studies were initiated by exploring the allylation of ketimine 104a with allyl methyl 
carbonate 108a, and various reaction conditions were tested (Table 3.5.1). 
Table 3.5.1 Optimization of Manganese-Catalyzed C–H Allylation with Carbonate 108a[a] 
 
Entry [Mn] Additive Yield (%) 
1 --- NaOAc --- 
2 MnCl2 NaOAc --- 
3 Mn(OAc)2 NaOAc --- 
4 MnBr(CO)5 NaOAc 76 
5 MnBr(CO)5 NaOMe 78 
6 MnBr(CO)5 --- 11 
7 MnBr(CO)5 KOAc 78 
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8 MnBr(CO)5 LiOAc 34 
9 MnBr(CO)5 NaOPiv 83 
10 MnBr(CO)5 KO2CMes 86 
11 Mn2(CO)10 --- 67 
12 Mn2(CO)10 KO2CMes 51 
13 Mn2(CO)10 NaOPiv 75 
14 Mn2(CO)10 KOAc 81 
15 Mn2(CO)10 NaOAc 88 
16 Mn2(CO)10 NaOAc 84
[b]
 
[a] Reaction conditions: 104a (0.5 mmol), 108a (1.5 mmol), [Mn] (10 mol %), additive (20 
mol %), 1,4-dioxane (1.0 mL), under N2, 14 h, isolated yield. 
[b] 10 mmol scale. 
The desired allylation product 109aa was not obtained in the absence of a manganese catalyst 
or when employing simple manganese salts, such as MnCl2 and Mn(OAc)2 (entries 1–3). To our 
delight, when MnBr(CO)5 was used as the catalyst in the presence of catalytic amounts of 
NaOAc, the desired product 109aa was isolated in 76% yield after hydrolysis of the allylated 
ketimine (entry 4). Then, different additives were investigated (entries 5, 7–10), and KO2CMes 
was found to be the optimal additive. The catalytic efficiency decreased dramatically without 
additives (entry 6). Likewise, the dimeric complex Mn2(CO)10 showed a comparable catalytic 
efficacy in the presence of NaOAc as the additive (entry 12). Subsequently, the reactions with 
different additives or without additive were probed, and these results indicated that NaOAc was 
ideal (entries 11–15). Notably, the optimal catalytic system could be used on a 5 mmol scale in 
a comparable high yield (entry 16). 
3.5.2 Scope of Manganese-Catalyzed C–H Allylation of Imines 
With the optimized catalytic system in hand (Table 1, entries 10 and 15), the scope of the 
carboxylate-assisted manganese(I)-catalyzed C–H allylation of imines 104 with various allyl 
carbonates 108 was studied (Scheme 3.5.1). A large variety of imines 104 were suitable for 
this transformation. Different valuable functional groups, such as amine, fluoro, chloro, 
bromo, iodo and nitrile, were tolerated to give the corresponding products. When 
meta-substituted arenes 104n–104p were employed in the allylation reaction, the 
regioselectivity was largely controlled by steric interactions except for substrates with a 
secondary directing group influence. Notably, this manganese-catalyzed C–H allylation was 
not restricted to the non-substituted allyl carbonates 108. Indeed, substitution on the α-position 
of allyl carbonates 108b and 108c proved to be suitable in this protocol to give linear 
allylation products in good yields with excellent diastereoselectivities. In all cases, a 
double-bond isomerization to the thermodynamically more stable structure derivative was not 
observed. 




Scheme 3.5.1 C–H Allylation of Imines 104 with Allyl Carbonates 108 
3.5.3 Scope of Manganese-Catalyzed C–H Allylation of Heteroarenes 
To further highlight the power of the carboxylate-assisted manganese(I)-catalyzed direct C–H 
allylation via C–O cleavage, the reaction was further explored with the biologically relevant 
indole heterocycles 84,[9x, 45] which also proved to be suitable for the C−H allylation (Scheme 
3.5.2). The indoles 84 showed excellent reactivity, and methoxy, fluoro, bromo or iodo groups 
were well tolerated. Particularly, indole-3-carbaldehyde 84k was also found to be a suitable 
substrate, and gave the desired product with excellent yield. Thus, the less stable formyl C–H 
bond remained untouched, highlighting the organometallic C–H activation process. Not only 
the non-substituted ally carbonates were suitable in this manganese-catalyzed C–H 
functionalization, but also the α-substituted allyl carbonates 104 were proved to be suitable 
substrates giving linear allylation indoles 110 with good yield. Notably, this manganese 
catalytic system was not restricted to indole substrates, but the pyrrole 123 underwent the 
C–H allylation with good yields as well. 




Scheme 3.5.2 C–H Allylation of Heteroarenes 84/123 with Allyl Carbonates 108 
3.5.4 Mechanistic Studies 
In order to gain insights into the manganese-catalyzed C–H activation reaction, a set of 
experiments towards elucidation of its mechanism were performed.  
 
Scheme 3.5.3 Intermolecular Competition Experiments 
Results and Discussion 
62 
 
The intermolecular competition experiment between electron-rich and electron-deficient 
imines 104 showed that electron-rich arenes were preferentially converted either with 
MnBr(CO)5/KO2CMes (Scheme 3.5.3a) or Mn2(CO)10/NaOAc as the catalytic systems 
(Scheme 3.5.3b). 
Subsequently, the manganese(I)-catalyzed C–H allylation reaction was conducted in the 
presence of CD3OD as the co-solvent, which revealed a reversible H/D exchange reaction, as 
was observed by reisolation of the labeled [D]n-5b and the labeled product [D]n-109ba 
(Scheme 3.5.4a). However, almost no H/D exchange in C(sp2)–H was observed in the 
Mn2(CO)10/NaOAc system (Scheme 3.5.4b). These observations revealed that the C–H 
activation might be different between the two systems. 
 
Scheme 3.5.4 H/D Exchange Experiments 
The intramolecular kinetic isotope effect (KIE) was found to be kH/kD ≈ 1.2 (Scheme 3.5.5a). 
Moreover, a similar rather low KIE of kH/kD ≈ 1.1 was observed in independent reactions 
between substrates 104b and [D]1-104b (Scheme 3.5.5b) in the MnBr(CO)5/KO2CMes 
system.  




Scheme 3.5.5 KIE Studies 
The similar KIE values were obtained in the Mn2(CO)10/NaOAc system, namely 
intramolecular kH/kD ≈ 1.0 and intermolecular kH/kD ≈ 1.0 (Scheme 3.5.6). These experimental 
findings indicated that the C–H manganesation process was not the rate-determining step in 
both catalytic systems. 
 
Scheme 3.5.6 KIE Study Experiments in Mn2(CO)10/NaOAc System 
Furthermore, a radical pathway could be excluded by conducting the experiment in the 
presence of stoichiometric amounts of radical scavengers, such as TEMPO, BHT or Ph2C=CH2 
(Scheme 3.5.7). These results strongly supported the organometallic C–H activation mode. 




Scheme 3.5.7 Evidence for an Organometallic C–H Activation Mode 
Additionally, the potential intermediate 126 was prepared by stoichiometric amounts of 
[MnBr(CO)5] through C–H activation in moderate yield. Notably, cyclometalated complex 126 
showed a high activity to afford the corresponding allylation product not only with catalytic 
amounts but also stoichiometric experiment (Scheme 3.5.8). These results reveled that this 
cyclometalated complex is the key intermediate of this C–H allylation. 
 
Scheme 3.5.8 C–H Allylations with Cyclometalated Complex 126 
3.5.5 Proposed Mechanism 
Based on these mechanistic studies, we proposed a plausible catalytic cycle for this allylation 
protocol, which is shown for the system comprising of MnBr(CO)5 and KO2CMes. The active 
manganese catalyst [Mn(O2CMes)(CO)5] was formed and then the nitrogen of substrate 104 
coordinates to the manganese center to generate the complex 133, which is followed by the 
fast C–H manganesation producing the key intermediate cyclometalated complex 117. 
Subsequently, migratory insertion of electrophile 135 occurs. The activation of the allyl 
carbonate 108 via an oxidative addition procedure could be an alternative pathway. Finally, 
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β-oxygen elimination, decarboxylation and MeOH release affords the allylation product 132 
as well as regenerates the active manganese catalyst (Scheme 3.5.9).  
 
Scheme 3.5.9 Proposed Mechanism 
3.5.6 Diversification of C–H Activation Products 
Finally, in order to show the synthetic utility of the allylation products of the 
manganese-catalyzed C–H allylation, several further diversifications were completed 
(Scheme 3.5.8). The synthetically useful cyclic ether 136, indanol 137, alcohol 138, or anilide 
139 were accessed efficiently. 




Scheme 3.5.8 Diversification of C–H Activation Product 
  




This thesis focused on the development of new methods for ruthenium- and manganese- 
catalyzed C–H activation. 
First, an unprecedented ruthenium(II)-catalyzed C–H cyanation on arenes by using bench 
stable, readily accessible and user-friendly N-cyano-N-phenyl-p-toluenesulfonamide (NCTS, 
13) as the cyanation reagent was accomplished (Scheme 3.6.1). This direct C–H cyanation on 
synthetically useful (hetero)aromatic amides 50 tolerated a variety of valuable functional 
groups with good site-selectivity and broad scope. Due to the importance of the cyano group 
which can be readily transformed to many other valuable functional groups, this present C–H 
cyanation reaction may provide a new strategy for the rapid modification of functional 
molecules.[86] 
 
Scheme 3.6.1 Ruthenium(II)-catalyzed C–H Cyanations of Benzamides 50 
Second, an ortho- and para-selective ruthenium-catalyzed C(sp
2
)–H oxygenation of phenol 
derivatives was developed, which provides a new strategy for the synthesis of phenol 
derivatives (Scheme 3.6.2). The site-selectivity could be controlled through the substrate 
modification. The ortho-C–H oxygenation proceeded on aryl carbamates 102, while C–H 
para-oxygenation occurred on anisole derivatives 115 under the ruthenium(II) catalysis. 
Furthermore, the directing group ability order was established through competition 
experiments to be amide > carbamate > ester.[55d] 
 
Scheme 3.6.2 Ortho- and Para-Selective Ruthenium-Catalyzed  
C(sp2)–H Oxygenations of Phenol Derivatives 
Third, a novel type of manganese-catalyzed annulation of acrylates by imines via 
organometallic C–H bond activation was developed, which provided a new approach to 
valuable carbocyclic β-amino acid derivatives with high efficacy, good functional group 
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tolerance and excellent cis-diastereoselectivity (Scheme 3.6.3). Furthermore, the unprotected 
β-amino ester 120 and important organic building blocks were readily accessed from these 
C–H annulation products.[88] 
 
Scheme 3.6.3 Manganese-Catalyzed Synthesis of cis-β-Amino Acid Esters 105 through 
Organometallic C–H Activation of Ketimines 104 
Fourth, the first manganese-catalyzed C–H aminocarbonylation with good yields, highly 
functional group tolerance and broad substrate scope was developed (Scheme 3.6.4). Moreover, 
the valuable quinoxalinones can be conveniently accessed from the C–H activation products 
after removal of the pyridyl group in one step. Mechanistic studies strongly suggested an 
organometallic C–H activation process, as well as a rate-determining migratory insertion 
step.[93] 
 
Scheme 3.6.4 Manganese(I)-Catalyzed C–H Amino Carbonylation of  
Heteroarenes 84 with Isocyanates 106 
Fifth, a versatile manganese(I)-catalyzed allylation of inert C–H bond with allyl carbonates by 
C–O bond cleavage has been developed (Scheme 3.6.5). A set of valuable functional groups, 
such as amine, fluoro, chloro, bromo, iodo and nitrile substituents can be tolerated to give the 
corresponding products. Notably, the reaction was not limited to ketimines 104, and the 
biologically relevant heterocycles 84 also proved to be suitable for the C−H allylation. 
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Moreover, the synthetically useful cycle ether 136, indanol 137, alcohol 138 or anilide 139 
were accessed from the C–H allylation products. Mechanistic studies strongly supported an 
organometallic C–H activation process. Importantly, the well-defined cyclometalated complex 
was prepared, and found to be the key intermediate in the process.[96]  
 




4 Experimental Section 
4.1 General Remarks 
Unless otherwise noticed, all reactions were performed under N2 atmosphere using pre-dried 
glassware and standard Schlenk techniques.  
Solvents 
All solvents for reactions involving moisture-sensitive reagents were dried, distilled and stored 
under inert atmosphere (N2) according to the following standard procedures.  
 
Solvent Drying Method 





Dried over CaH2 for 8 h, degassed and distilled under reduced 
pressure. 
Dichloromethane (DCM) 
Tetrahydrofuran (THF)  
Et2O 
Purified using a solvent purification system (SPS) from 
MBRAUN. 
Methanol (MeOH) Distilled from Mg 




Dried by distillation from sodium benzophenone ketyl. 
Vacuum  
The following pressures were measured on the used vacuum pump and were not corrected: 
membrane pump vacuum (MPV): 0.5 mbar, oil pump vacuum (OPV): 0.1 mbar.  
Melting Points (M. p.)  
Melting points were measured using a Stuart® Melting Point Apparatus SMP3 from 
BARLOWORLD SCIENTIFIC. Reported values are uncorrected.  
Chromatography  
Analytical thin layer chromatography (TLC) was performed on 0.25 mm silica gel 60F-plates 
(MACHEREY-NAGEL) with 254 nm fluorescent indicator from MERCK. Plates were 




carefully applying a heat gun. Chromatographic purification of products was accomplished by 
column chromatography on MERCK silica gel, grade 60 (0.040–0.063 mm and 0.063–0.200 
mm). 
Gas Chromatograpgy (GC)  
The conversion of the reactions was monitored applying coupled gas chromatography/mass 
spectrometry using G1760C GCDplus with mass detector HP 5971, 5890 Series II with mass 
detector HP 5972 from HEWLETT-PACKARD and 7890A GC-System with mass detector 
5975C (Triplex-Axis-Detector) from AGILENT TECHNOLOGIES equipped with HP-5MS 
columns (30 m × 0.25 mm × 0.25 m) were used.  
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear magnetic resonance (NMR) spectroscopy was performed at 300, 400 or 600 MHz (1H 
NMR), 75 or 125 MHz (13C NMR, APT) and 283 MHz (19F NMR) on BRUKER AM 250, 
VARIAN Unity-300 and Inova 500 instruments. Chemical shifts are reported as δ-values in 
ppm relative to the residual proton peak of the deuterated solvent or its carbon atom, 
respectively, or the standard tetramethylsilane (TMS) resonance. For characterization of the 
observed resonance multiplicities the following abbreviations were used: s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), dt (doublet of triplet), or 
analogue representations. The coupling constants J are reported in Hertz (Hz). 
Infrared Spectroscopy (IR) 
Infrared spectra were recorded on a BRUKER Alpha-P ATR-spectrometer. Liquid probes were 
measured as film and solid samples neat. Analysis of the spectral data was done by using the 
OPUS 6. Absorption (ṽ) is given in wave numbers (cm–1). Spectra were recorded in the range of 
4000 to 400 cm–1. In situ-IR: ReactIR™ 15, METTLER TOLEDO, iC IR 4.3 Software. 
Mass Spectrometry (MS) 
MS (EI) and HR-MS (EI) were measured on a Time-of-Flight mass spectrometer AccuTOF 
from JOEL. ESI-mass spectra were recorded on an Ion-Trap mass spectrometer LCQ from 
FINNIGAN or on a Time-of-Flight mass spectrometer microTOF from BRUKER. ESI-HR-MS 
spectra were recorded on a BRUKER APEX IV or a BRUKER DALTONIC, Fourier Transform 
Ion Cyclotron Resonance (FTICR)] mass spectrometer. The ratios of mass to charge (m/z) are 
indicated, intensities relative to the base peak (I = 100) are written in parentheses. 
Reagents 
Chemicals obtained from commercial sources with purity above 95% were used without further 
purification. The following compounds are known and were synthesized according to 
previously described methods. 
Benzamides 9 and [D]5-9a,







[115b, 117] indoles 83,[118] [D]1-83a,
[118a] 129a,[119] 129b,[120] 
110b–110o,[91a, 121] 114b–114d,[122] 114e.[123] 
4.2 General Procedures 
General Procedure A: Versatile Ruthenium(II)-Catalyzed C–H Cyanations of 
Benzamides 50. 
Benzamides 50 (0.50 mmol), N-cyano-N-phenyl-4-methylbenzenesulfonamide (13) (272 mg, 
1.0 mmol), [RuCl2(p-cymene)]2 (15.4 mg, 5.0 mol %), AgSbF6 (34.4 mg, 20 mol %), NaOAc 
(8.2 mg, 20 mol %) and DCE (2.0 mL) were placed in a 20 mL sealed tube under N2 and 
stirred at 120 °C for 24 h. At ambient temperature, the reaction mixture was diluted with H2O 
(15 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layer was dried with 
Na2SO4 and concentrated under reduced pressure. The crude products were purified by 
column chromatography on silica gel to afford the desired products 101. 
General Procedure B: ortho-Selective Ruthenium(II)-Catalyzed C(sp
2
)–H Oxygenations 
of Carbamates 102. 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), carbamate 102 (0.50 mmol), PhI(TFA)2 (430 mg, 
1.0 mmol) and DCE (2.0 mL) were placed into a 25 mL Schlenk tube equipped with a septum 
under N2. The tube was then placed into an oil bath and the reaction mixture was stirred at 
50–80 °C for 3–24 h. At ambient temperature, the reaction mixture was diluted with H2O (15 
mL) and extracted with EtOAc (3 x 15 mL). The combined organic layer was concentrated 
under reduced pressure. The crude products were purified by column chromatography on 
silica gel to afford the desired products 103. 
General Procedure C: para-Selective Ruthenium(II)-Catalyzed C(sp
2
)–H Oxygenations 
of Anisoles 115. 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), 115 (0.50 mmol), PhI(TFA)2 (240 mg, 0.55 mmol) 
and DCE (2.0 mL) were placed into a 25 mL Schlenk tube equipped with a septum under N2. 
The reaction mixture was stirred at 80 °C for 3 h. At ambient temperature, the reaction 
mixture was diluted with H2O (15 mL) and extracted with EtOAc (3 x 15 mL). The combined 
organic layer was concentrated under reduced pressure. The crude products were purified by 
column chromatography on silica gel to afford the desired products 116. 
General Procedure D: Manganese-Catalyzed Synthesis of cis-β-Amino Acid Esters 
through Organometallic C–H Activation 
Ketimines 104 (0.5 mmol), acrylates 38 (1.0 mmol), Mn2(CO)10 (9.8 mg, 5.0 mol %) and DCE 
or toluene (1.0 mL) were placed in a 25 mL Schlenk tube under N2. The mixture was stirred at 
120 °C for 18 h. At ambient temperature, the reaction mixture was transferred into a round 




chromatography on silica gel to afford the desired products 105. 
General Procedure E: Manganese(I)-Catalyzed C–H Aminocarbonylation of 
Heteroarenes 84. 
Heteroarenes 84 (0.50 mmol), isocyanates 106 (0.55 mmol), MnBr(CO)5 (13.7 mg, 10 mol %) 
and Et2O or nBu2O (1.0 mL) were placed in a 20 mL sealed tube or 25 mL Schlenk tube 
under N2. The mixture was stirred at 100 °C for 16 h. At ambient temperature, the reaction 
mixture was transferred into a round flask with CH2Cl2 (50 mL) and concentrated under 
reduced pressure and purified by column chromatography on silica gel using a mixture of 
n-hexane, EtOAc, CH2Cl2 and Et3N to afford the desired products 107. 
General Procedure F: Manganese(I)-Catalyzed C–H Allylation of Ketimines 104. 
Ketimines 104 (0.5 mmol), allyl carbonates 108 (1.5 mmol, 3.0 equiv), Mn2(CO)10 (9.8 mg, 5.0 
mol %), NaOAc (8.2 mg, 20 mol %) and 1,4-dioxane (1.0 mL) were placed in a 25 mL 
Schlenk tube under N2. The mixture was stirred at 100 °C for 14 h. At ambient temperature, 
the reaction mixture was diluted with Et2O (5 mL). Then, HCl (5 mL, 1 M) was added, the 
mixture was vigorously stirred at ambient temperature for 20 min, and the resulting mixture 
was extracted with Et2O (3 × 10 mL). The combined organic layer was washed with brine (10 
mL), and then dried over Na2SO4. After concentration under reduced pressure, purification by 
column chromatography on silica gel afforded the desired products 109. 
 
General Procedure G: Manganese-Catalyzed C–H Allylation of Heteroarenes 84 or 123. 
Heteroarenes 84 or 123 (0.5 mmol), allyl carbonates 108 (1.0 mmol, 2.0 equiv), Mn2(CO)10 
(9.8 mg, 5.0 mol %), NaOAc (8.2 mg, 20 mol %) and 1,4-dioxane (1.0 mL) were placed in a 25 
mL Schlenk tube under N2. The mixture was stirred at 100 °C for 14 h. At ambient 
temperature, the reaction mixture was transferred into a round flask with EtOAc and 
concentrated under reduced pressure, purified by column chromatography on silica gel to 
afford the desired products 110 or 131. 
4.3 Versatile Ruthenium(II)-Catalyzed C–H Cyanations of Benzamides 
Characterization Data of Products 101 
 
2-Cyano-N,N-diisopropylbenzamide (101a): The representative procedure was followed 
using N,N-diisopropylbenzamide (50a) (103 mg, 0.50 mmol). Isolation by column 




M.p. = 109–111 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 7.62 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 7.57 (ddd, J = 7.7, 7.7, 
1.3 Hz, 1H), 7.40 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 7.29 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 3.52 (hept, 
J = 6.7 Hz, 2H), 1.56 (d, J = 6.7 Hz, 6H), 1.15 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.7 (Cq), 142.4 (Cq), 133.0 (CH), 132.8 (CH), 128.5 (CH), 
125.7 (CH), 116.8 (Cq), 108.9 (Cq), 51.4 (CH), 46.1 (CH), 20.6 (CH3), 20.2 (CH3).  
IR (neat): 2964, 2225, 1625, 1437, 1341, 1031, 788, 552 cm-1.  
MS (EI) m/z (relative intensity): 230 (5) [M+], 187 (24), 173 (25), 130 (100), 102 (36).  
HR-MS (EI) m/z calcd for C14H18N2O [M
+] 230.1419, found 230.1424. 





2-Cyano-N,N-diethylbenzamide (101b): The representative procedure was followed using 
N,N-diethylbenzamide (50b) (89 mg, 0.50 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→2/1) yielded 101b (75 mg, 74%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.63 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 7.58 (ddd, J = 7.7, 7.7, 
1.3 Hz, 1H), 7.42 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 7.35 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 3.53 (q, J 
= 7.1 Hz, 2H), 3.12 (q, J = 7.1 Hz, 2H), 1.22 (t, J = 7.1 Hz, 3H), 1.03 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.0 (Cq), 140.9 (Cq), 132.8 (CH), 132.7 (CH), 129.0 (CH), 
126.6 (CH), 116.5 (Cq), 109.6 (Cq), 43.0 (CH2), 39.1 (CH2), 13.9 (CH3), 12.4 (CH3).  
IR (neat): 2976, 2228, 1628, 1429, 1292, 1080, 762, 546 cm-1.  
MS (EI) m/z (relative intensity): 202 (20) [M+], 173 (15), 130 (100), 102 (40).  
HR-MS (ESI) m/z calcd for C12H14N2NaO [M + Na
+] 225.1004, found 225.0998. 
 
 
2-Cyano-N,N-dimethylbenzamide (101c): The representative procedure was followed using 
N,N-dimethylbenzamide (50c) (75 mg, 0.50 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→1/1) yielded 101c (58 mg, 67%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.66–7.57 (m, 2H), 7.47–7.39 (m, 2H), 3.10 (s, 3H), 2.88 (s, 
3H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.5 (Cq), 140.3 (Cq), 133.0 (CH), 132.7 (CH), 129.4 (CH), 
127.4 (CH), 116.7 (Cq), 109.7 (Cq), 38.5 (CH3), 34.9 (CH3).  
IR (neat): 2933, 2228, 1632, 1396, 1069, 760, 542 cm-1.  




HR-MS (ESI) m/z calcd for C10H11N2O [M + H
+] 175.0871, found 175.0866.  





2-(Piperidine-1-carbonyl)benzonitrile (101d): The representative procedure was followed 
using phenyl(piperidin-1-yl)methanone (50d) (95 mg, 0.50 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 5/1→2/1) yielded 101d (81 mg, 76%) as a colorless solid.  
M.p. = 108–110 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.64 (d, J = 7.7 Hz, 1H), 7.59 (dd, J = 7.7, 7.6 Hz, 1H), 7.43 
(dd, J = 7.6, 7.6 Hz, 1H), 7.38 (d, J = 7.6 Hz, 1H), 3.72–3.69 (m, 2H), 3.18 (t, J = 5.6 Hz, 2H), 
1.64–1.62 (m, 4H), 1.54–1.48 (m, 2H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.0 (Cq), 140.5 (Cq), 132.9 (CH), 132.8 (CH), 129.2 (CH), 
127.1 (CH), 116.8 (Cq), 109.6 (Cq), 48.1 (CH2), 42.9 (CH2), 26.2 (CH2), 25.2 (CH2), 24.2 (CH2).  
IR (neat): 2928, 2228, 1621, 1437, 1292, 1254, 779, 554 cm-1.  
MS (EI) m/z (relative intensity): 214 (45) [M+], 213 (100), 130 (100), 102 (50), 84 (23).  
HR-MS (ESI) m/z calcd for C13H15N2O [M + H
+] 215.1184, found 215.1179. 
 
 
2-(Pyrrolidine-1-carbonyl)benzonitrile (101e): The representative procedure was followed 
using phenyl(pyrrolidin-1-yl)methanone (50e) (88 mg, 0.50 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 5/1→1/1) yielded 101e (67 mg, 66%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.68–7.52 (m, 2H), 7.46–7.40 (m, 2H), 3.60 (t, J = 6.8 Hz, 
2H), 3.22 (t, J = 6.4 Hz, 2H), 1.96–1.79 (m, 4H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.7 (Cq), 141.2 (Cq), 132.9 (CH), 132.8 (CH), 129.4 (CH), 
127.1 (CH), 116.9 (Cq), 109.5 (Cq), 48.3 (CH2), 45.8 (CH2), 25.9 (CH2), 24.1 (CH2).  
IR (neat): 2973, 2879, 2228, 1623, 1594, 1448, 760, 650 cm-1.  
MS (EI) m/z (relative intensity): 200 (55) [M+], 171 (35), 130 (100), 102 (65), 70 (50).  
HR-MS (EI) m/z calcd for C12H12N2O [M
+] 200.0950, found 200.0951. 
 
 




using N-methyl-N-phenylbenzamide (50f) (106 mg, 0.50 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 10/1→2/1) yielded 101f (63 mg, 53%) as a colorless solid.  
M.p. = 75–77 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.48–7.08 (m, 9H), 3.49 (s, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.4 (Cq), 142.8 (Cq), 140.8 (Cq), 132.7 (CH), 132.0 (CH), 
129.2 (CH), 129.1 (CH), 128.4 (CH), 127.3 (CH), 127.0 (CH), 117.1 (Cq), 110.5 (Cq), 37.7 
(CH3).  
IR (neat): 3053, 2227, 1632, 1592, 1495, 1380, 769, 699, 553 cm-1.  
MS (EI) m/z (relative intensity): 236 (35) [M+], 143 (22), 130 (100), 102 (35), 77 (18).  
HR-MS (EI) m/z calcd for C15H12N2O [M
+] 236.0950, found 236.0946. 
 
 
2-Cyano-N,N-diisopropyl-4-methylbenzamide (101g): The representative procedure was 
followed using N,N-diisopropyl-4-methylbenzamide (50g) (110 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→2/1) yielded 101g (98 mg, 80%) as a 
colorless solid.  
M.p. = 92–94 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.42 (s, 1H), 7.36 (d, J = 7.9 Hz, 1H), 7.17 (d, J = 7.9 Hz, 1H), 
3.52 (hept, J = 6.8 Hz, 2H), 2.34 (s, 3H), 1.52 (d, J = 6.8 Hz, 6H), 1.12 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.0 (Cq), 139.7 (Cq), 138.8 (Cq), 133.7 (CH), 133.0 (CH), 
125.6 (CH), 116.9 (Cq), 108.8 (Cq), 51.3 (CH), 46.0 (CH), 20.8 (CH3), 20.6 (CH3), 20.2 (CH3).  
IR (neat): 2970, 1617, 1440, 1342, 1037, 822, 597 cm-1.  
MS (EI) m/z (relative intensity): 244 (10) [M+], 201 (50), 187 (22), 144 (100), 116 (20), 89 (18).  
HR-MS (EI) m/z calcd for C15H20N2O [M
+] 244.1576, found 244.1571. 
 
 
2-Cyano-N,N-diisopropyl-4-methoxybenzamide (101h): The representative procedure was 
followed using N,N-diisopropyl-4-methoxybenzamide (50h) (118 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 5/1→1/1) yielded 101h (117 mg, 90%) as a 
colorless solid.  
M.p. = 118–120 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.19 (d, J = 8.0 Hz, 1H), 7.08 (d, J = 2.6 Hz, 1H), 7.07 (dd, J 
= 8.0, 2.6 Hz, 1H), 3.78 (s, 3H), 3.53 (sbr, 2H), 1.50 (sbr, 6H), 1.12 (sbr, 6H).  
13




117.3 (CH), 116.7 (Cq), 109.9 (Cq), 55.6 (CH3), 51.3 (CH), 46.0 (CH), 20.4 (CH3), 20.3 (CH3).  
IR (neat): 2978, 2228, 1622, 1441, 1372, 1248, 1026, 848, 593 cm-1.  
MS (EI) m/z (relative intensity): 260 (10) [M+], 217 (50), 160 (100), 117 (15), 77 (10).  
HR-MS (EI) m/z calcd for C15H20N2O2 [M
+] 260.1525, found 260.1532. 
 
 
Methyl 3-cyano-4-(diisopropylcarbamoyl)benzoate (101i): The representative procedure 
was followed using methyl 4-(diisopropylcarbamoyl)benzoate (50i) (132 mg, 0.50 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1→2/1) yielded 101i (94 mg, 65%) 
as a colorless solid.  
M.p. = 81–83 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.28 (d, J = 1.6 Hz, 1H), 8.20 (dd, J = 8.0, 1.6 Hz, 1H), 7.38 
(d, J = 8.0 Hz, 1H), 3.89 (s, 3H), 3.52 (hept, J = 6.7 Hz, 1H), 3.44 (hept, J = 6.7 Hz, 1H), 1.52 (d, 
J = 6.8 Hz, 6H), 1.13 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.8 (Cq), 164.5 (Cq), 145.8 (Cq), 134.0 (CH), 133.9 (CH), 
130.6 (Cq), 126.0 (CH), 115.9 (Cq), 109.5 (Cq), 52.6 (CH3), 51.5 (CH), 46.3 (CH), 20.5 (CH3), 
20.1 (CH3).  
IR (neat): 2958, 2231, 1719, 1635, 1433, 1295, 1261, 1107, 769, 555 cm-1.  
MS (EI) m/z (relative intensity): 288 (10) [M+], 245 (65), 231 (50), 188 (100), 101 (10).  
HR-MS (ESI) m/z calcd for C16H21N2O3 [M + H
+] 289.1552, found 289.1547. 
 
 
3-Cyano-N,N-diisopropyl-[1,1'-biphenyl]-4-carboxamide (101j): The representative 
procedure was followed using N,N-diisopropyl-[1,1'-biphenyl]-4-carboxamide (50j) (141 mg, 
0.50 mmol). Isolation by column chromatography (n-hexane/EtOAc/Et3N: 
200/10/1→200/60/1) yielded 101j (140 mg, 92%) as a colorless solid.  
M.p. = 114–116 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.81 (d, J = 1.8 Hz, 1H), 7.77 (dd, J = 8.0, 1.8 Hz, 1H), 
7.53–7.34 (m, 6H), 3.64 (hept, J = 6.7 Hz, 1H), 3.56 (hept, J = 6.7 Hz, 1H), 1.58 (d, J = 6.8 Hz, 
6H), 1.18 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.6 (Cq), 141.7 (Cq), 140.8 (Cq), 138.0 (Cq), 131.5 (CH), 
131.1 (CH), 129.0 (CH), 128.4 (CH), 126.8 (CH), 126.2 (CH), 116.8 (Cq), 109.5 (Cq), 51.4 
(CH), 46.1 (CH), 20.6 (CH3), 20.2 (CH3).  




MS (EI) m/z (relative intensity): 306 (10) [M+], 263 (60), 206 (100), 151 (15).  
HR-MS (EI) m/z calcd for C20H22N2O [M
+] 306.1732, found 306.1730. 
 
 
2-Cyano-4-fluoro-N,N-diisopropylbenzamide (101k): The representative procedure was 
followed using 4-fluoro-N,N-diisopropylbenzamide (50k) (112 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 101k (101 mg, 81%) as a 
colorless solid.  
M.p. = 129–131 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.37–7.29 (m, 3H), 3.54 (hept, J = 6.7 Hz, 2H), 1.55 (d, J = 
6.7 Hz, 6H), 1.17 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.8 (Cq), 161.3 (
1JC–F = 256 Hz, Cq), 138.9 (
4JC–F = 4 Hz, Cq), 
128.0 (3JC–F = 8 Hz, CH), 120.7 (
2JC–F = 21 Hz, CH), 119.7 (
2JC–F = 24 Hz, CH), 115.6 (
4JC–F = 3 
Hz, Cq), 110.7 (
3JC–F = 9 Hz, Cq), 51.6 (CH), 46.4 (CH), 20.8 (CH3), 20.3 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = –(110.0–110.1) (m).  
IR (neat): 2973, 2231, 1617, 1443, 1372, 1342, 1156, 1032, 829, 597 cm-1.  
MS (EI) m/z (relative intensity): 248 (5) [M+], 205 (35), 191 (40), 148 (100), 120 (25), 58 (17).  
HR-MS (EI) m/z calcd for C14H17FN2O [M
+] 248.1325, found 248.1323. 
 
 
4-Chloro-2-cyano-N,N-diisopropylbenzamide (101l): The representative procedure was 
followed using 4-chloro-N,N-diisopropylbenzamide (50l) (120 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc/Et3N: 100/10/1→100/20/1) yielded 101l (91 mg, 
68%) as a colorless solid.  
M.p. = 131–133 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.64 (d, J = 1.6 Hz, 1H), 7.57 (dd, J = 8.2, 1.6 Hz, 1H), 7.28 
(d, J = 8.2 Hz, 1H), 3.53 (hept, J = 6.0 Hz, 2H), 1.55 (d, J = 6.0 Hz, 6H), 1.17 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.7 (Cq), 140.7 (Cq), 134.5 (Cq), 133.3 (CH), 132.4 (CH), 
127.2 (CH), 115.5 (Cq), 110.7 (Cq), 51.6 (CH), 46.4 (CH), 20.8 (CH3), 20.3 (CH3).  
IR (neat): 2981, 2231, 1626, 1442, 1339, 1033, 847, 589 cm-1.  
MS (EI) m/z (relative intensity): 264 (5) [M+], 221 (48), 207 (45), 164 (100), 136 (20), 100 (10).  
HR-MS (EI) m/z calcd for C14H17ClN2O [M






4-Bromo-2-cyano-N,N-diisopropylbenzamide (101m): The representative procedure was 
followed using 4-bromo-N,N-diisopropylbenzamide (50m) (142 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc/Et3N: 100/10/1→100/20/1) yielded 101m (110 mg, 
71%) as a colorless solid.  
M.p. = 121–123 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.78 (d, J = 2.0 Hz, 1H), 7.72 (dd, J = 8.2, 2.0 Hz, 1H), 7.20 
(d, J = 8.2 Hz, 1H), 3.53 (hept, J = 6.7 Hz, 2H), 1.55 (d, J = 6.7 Hz, 6H), 1.16 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.8 (Cq), 141.2 (Cq), 136.3 (CH), 135.3 (CH), 127.3 (CH), 
122.1 (Cq), 115.5 (Cq), 110.9 (Cq), 51.6 (CH), 46.4 (CH), 20.7 (CH3), 20.3 (CH3).  
IR (neat): 2966, 2218, 1630, 1443, 1344, 1037, 850, 554 cm-1. 
MS (EI) m/z (relative intensity): 310 (10) [M+] (81Br), 308 (10) [M+] (79Br), 267 (55) (81Br), 265 
(55) (79Br), 210 (100) (81Br), 208 (100) (79Br), 182 (20) (81Br), 180 (20) (79Br).  
HR-MS (EI) m/z calcd for C14H17BrN2O [M
+] 308.0524, found 308.0529. 
 
 
2-Cyano-4-iodo-N,N-diisopropylbenzamide (101n): The representative procedure was 
followed using 4-iodo-N,N-diisopropylbenzamide (50n) (166 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/CH2Cl2: 1/1) yielded 101n (162 mg, 91%) as a colorless 
solid.  
M.p. = 157–159 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.94 (d, J = 1.6 Hz, 1H), 7.88 (dd, J = 8.1, 1.6 Hz, 1H), 7.03 
(d, J = 8.1 Hz, 1H), 3.50 (hept, J = 6.6 Hz, 2H), 1.50 (d, J = 6.6 Hz, 6H), 1.12 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.8 (Cq), 141.9 (CH), 141.5 (Cq), 140.8 (CH), 127.1 (CH), 
115.1 (Cq), 110.8 (Cq), 92.8 (Cq), 51.4 (CH), 46.2 (CH), 20.6 (CH3), 20.1 (CH3).  
IR (neat): 2966, 2223, 1631, 1439, 1338, 1034, 825, 557 cm-1.  
MS (EI) m/z (relative intensity): 356 (15) [M+], 313 (80), 299 (40), 256 (100), 227 (12), 101 
(17).  
HR-MS (EI) m/z calcd for C14H17IN2O [M







3-Cyano-N,N-diisopropyl-2-naphthamide (101o): The representative procedure was 
followed using N,N-diisopropyl-2-naphthamide (50o) (128 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→2/1) yielded 101o (109 mg, 78%) as a 
colorless solid.  
M.p. = 133–135 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 8.20 (s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.74 (s, 1H), 7.64–7.53 
(m, 2H), 3.36–3.54 (m, 2H), 1.60 (d, J = 6.0 Hz, 6H), 1.16 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.0 (Cq), 136.5 (Cq), 135.1 (CH), 134.1 (Cq), 131.4 (Cq), 
129.6 (CH), 128.2 (CH), 128.0 (CH), 127.9 (CH), 124.9 (CH), 117.1 (Cq), 106.7 (Cq), 51.4 
(CH), 46.1 (CH), 20.5 (CH3), 20.3 (CH3).  
IR (neat): 2972, 2229, 1617, 1474, 1342, 1152, 901, 756, 481 cm-1.  
MS (EI) m/z (relative intensity): 280 (20) [M+], 237 (45), 180 (100), 152 (40).  
HR-MS (EI) m/z calcd for C18H20N2O [M
+] 280.1576, found 280.1576. 
 
 
2-Cyano-N,N-diisopropyl-1-methyl-1H-indole-3-carboxamide (101p): The representative 
procedure was followed using N,N-diisopropyl-1-methyl-1H-indole-3-carboxamide (50p) (129 
mg, 0.50 mmol). Isolation by column chromatography (n-hexane/EtOAc: 10/1→10/3) yielded 
101p (122 mg, 86%) as a colorless solid.  
M.p. = 202–204 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.56 (d, J = 8.1 Hz, 1H), 7.38 (dd, J = 8.3, 6.7 Hz, 1H), 7.30 
(d, J = 8.3 Hz, 1H), 7.20 (dd, J = 8.1, 6.7 Hz, 1H), 3.83 (s, 3H), 3.73 (hept, J = 6.7 Hz, 2H), 1.39 
(sbr, 12H).  
13
C-NMR (75 MHz, CDCl3): δ = 163.2 (Cq), 137.2 (Cq), 126.4 (CH), 124.0 (Cq), 123.9 (Cq), 
121.9 (CH), 120.9 (CH), 112.2 (Cq), 110.2 (CH), 107.1 (Cq), 48.8 (CH), 31.5 (CH3), 20.9 (CH3). 
IR (neat): 2979, 2224, 1616, 1536, 1371, 1311, 1045, 745 cm-1.  
MS (EI) m/z (relative intensity): 283 (10) [M+], 240 (15), 183 (100), 128 (10).  
HR-MS (EI) m/z calcd for C17H21N3O [M






2-Cyano-N,N-diisopropylthiophene-3-carboxamide (101q): The representative procedure 
was followed using N,N-diisopropylthiophene-3-carboxamide (50q) (106 mg, 0.50 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1→3/1) yielded 101q (91 mg, 77%) 
as a colorless solid.  
M.p. = 76–78 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.58 (d, J = 5.0 Hz, 1H), 7.05 (d, J = 5.0 Hz, 1H), 3.59 (sbr, 
2H), 1.52 (sbr, 6H), 1.20 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 163.0 (Cq), 148.3 (Cq), 132.8 (CH), 126.1 (CH), 112.7 (Cq), 
106.2 (Cq), 51.4 (CH), 46.4 (CH), 20.7 (CH3), 20.5 (CH3).  
IR (neat): 3072, 2221, 1629, 1444, 1323, 1203, 1038, 776 cm-1.  
MS (EI) m/z (relative intensity): 236 (5) [M+], 221 (15), 193 (25), 179 (45), 136 (100), 58 (8).  
HR-MS (EI) m/z calcd for C12H16N2OS [M
+] 236.0983, found 236.0981. 
 
 
2-Cyano-N,N-diisopropylfuran-3-carboxamide (101r): The representative procedure was 
followed using N,N-diisopropylfuran-3-carboxamide (50r) (98 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 101r (89 mg, 81%) as a 
colorless oil.  
1
H-NMR (300 MHz, CDCl3): δ = 7.51 (d, J = 1.9 Hz, 1H), 6.50 (d, J = 1.9 Hz, 1H), 3.66 (sbr, 
2H), 1.29 (sbr, 12H).  
13
C-NMR (75 MHz, CDCl3): δ = 160.6 (Cq), 146.9 (CH), 133.8 (Cq), 123.2 (Cq), 110.7 (CH), 
110.2 (Cq), 51.3 (CH), 46.5 (CH), 20.6 (CH3).  
IR (neat): 2973, 2229, 1628, 1484, 1372, 1336, 1026, 1019, 754 cm-1.  
MS (EI) m/z (relative intensity): 220 (10) [M+], 205 (20), 177 (23), 163 (70), 120 (100), 64 (8).  
HR-MS (EI) m/z calcd for C12H16N2O2 [M
+] 220.1212, found 220.1207. 
 
 
3-Cyano-N,N-diisopropylbenzo[b]thiophene-2-carboxamide (101s): The representative 
procedure was followed using N,N-diisopropylbenzo[b]thiophene-2-carboxamide (50s) (131 
mg, 0.50 mmol). Isolation by column chromatography (n-hexane/CH2Cl2: 1/1) yielded 101s 




M.p. = 134–136 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.93 (dd, J = 7.6, 1.4 Hz, 1H), 7.85 (dd, J = 7.4, 1.3 Hz, 1H), 
7.55–7.45 (m, 2H), 3.72 (sbr, 2H), 1.40 (sbr, 12H).  
13
C-NMR (75 MHz, CDCl3): δ = 160.5 (Cq), 149.2 (Cq), 137.3 (Cq), 136.8 (Cq), 126.7 (CH), 
126.4 (CH), 122.8 (CH), 122.7 (CH), 113.0 (Cq), 104.0 (Cq), 20.6 (CH3). CH(CH3)2 is not 
detectable.  
IR (neat): 2969, 2224, 1633, 1452, 1343, 1316, 1037, 751, 611 cm-1.  
MS (EI) m/z (relative intensity): 286 (8) [M+], 271 (10), 243 (15), 186 (75), 158 (13), 114 (15), 
43 (100).  
HR-MS (EI) m/z calcd for C16H18N2OS [M
+] 286.1140, found 286.1149. 
 
 
3-Cyano-N,N-diisopropylbenzofuran-2-carboxamide (101t): The representative procedure 
was followed using N,N-diisopropylbenzofuran-2-carboxamide (50t) (123 mg, 0.50 mmol). 
Isolation by column chromatography (n-hexane/EtOAc/Et3N: 100/5/1→100/20/1) yielded 101t 
(105 mg, 78%) as a colorless solid.  
M.p. = 99–101 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.70–7.67 (m, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.48–7.36 (m, 
2H), 3.80 (sbr, 2H), 1.40 (sbr, 12H).  
13
C-NMR (75 MHz, CDCl3): δ = 157.6 (Cq), 156.9 (Cq), 153.1 (Cq), 127.5 (CH), 125.2 (CH), 
125.1 (Cq), 120.5 (CH), 112.2 (CH), 111.7 (Cq), 94.1 (Cq), 50.7 (CH), 47.4 (CH), 20.5 (CH3).  
IR (neat): 2972, 2233, 1626, 1440, 1321, 1181, 1036, 738 cm-1.  
MS (EI) m/z (relative intensity): 270 (10) [M+], 227 (30), 213 (45), 170 (100), 114 (30), 43 (45).  
HR-MS (EI) m/z calcd for C16H18N2O2 [M
+] 270.1368, found 270.1368. 
 
 
3-Cyano-N,N-diisopropylthiophene-2-carboxamide (101u): The representative procedure 
was followed using N,N-diisopropylthiophene-2-carboxamide (50u) (106 mg, 0.50 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 101u (100 mg, 
85%) as a colorless solid.  
M.p. = 99–101 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.35 (d, J = 5.2 Hz, 1H), 7.16 (d, J = 5.2 Hz, 1H), 3.71–3.62 
(m, 2H), 1.36 (sbr, 12H).  
13
C-NMR (75 MHz, CDCl3): δ = 160.5 (Cq), 148.1 (Cq), 128.4 (CH), 126.3 (CH), 113.8 (Cq), 




IR (neat): 2980, 2227, 1627, 1455, 1328, 1207, 1029, 766 cm-1.  
MS (EI) m/z (relative intensity): 236 (5) [M+], 221 (18), 193 (23), 179 (50), 136 (100), 58 (10).  
HR-MS (EI) m/z calcd for C12H16N2OS [M
+] 236.0983, found 236.0982. 
 
 
2-Cyano-N,N-diisopropyl-5-methylbenzamide (101v): The representative procedure was 
followed using N,N-diisopropyl-3-methylbenzamide (50v) (110 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→3/1) yielded 101v (95 mg, 78%) as a 
colorless solid.  
M.p. = 147–149 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.53 (d, J = 8.0 Hz, 1H), 7.22 (d, J = 8.0 Hz, 1H), 7.12 (s, 1H), 
3.57 (hept, J = 7.0 Hz, 1H), 3.54 (hept, J = 7.0 Hz, 1H), 2.40 (s, 3H), 1.57 (d, J = 6.7 Hz, 6H), 
1.17 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 167.0 (Cq), 144.2 (Cq), 142.4 (Cq), 132.7 (CH), 129.3 (CH), 
126.3 (CH), 117.1 (Cq), 105.9 (Cq), 51.4 (CH), 46.1 (CH), 21.8 (CH3), 20.7 (CH3), 20.3 (CH3).  
IR (neat): 2978, 2228, 1628, 1443, 1338, 1038, 843, 550 cm-1.  
MS (EI) m/z (relative intensity): 244 (20) [M+], 229 (20), 201 (60), 187 (35), 144 (100), 116 
(23), 89 (17).  
HR-MS (EI) m/z calcd for C15H20N2O [M
+] 244.1576, found 244.1566. 
 
 
The representative procedure was followed using N,N-diisopropyl-3-methoxybenzamide (50w) 
(118 mg, 0.50 mmol). Isolation by column chromatography (n-hexane/EtOAc: 5/1→1/1) 
yielded 101w (45 mg, 34%) and 101w’ (72 mg, 55%) as colorless solids. 
2-Cyano-N,N-diisopropyl-3-methoxybenzamide (101w): 
M.p. = 163–165 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.55 (d, J = 8.7 Hz, 1H), 6.89 (dd, J = 8.7, 2.5 Hz, 1H), 6.77 
(d, J = 2.5 Hz, 1H), 3.83 (s, 3H), 3.56 (hept, J = 6.8 Hz, 1H), 3.52 (hept, J = 6.8 Hz, 1H), 1.54 (d, 
J = 6.8 Hz, 6H), 1.15 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.6 (Cq), 162.9 (Cq), 144.3 (Cq), 134.7 (CH), 117.2 (Cq), 
114.4 (CH), 111.4 (CH), 100.5 (Cq), 55.7 (CH3), 51.4 (CH), 46.2 (CH), 20.7 (CH3), 20.2 (CH3).  
IR (neat): 2964, 2224, 1630, 1457, 1337, 1242, 1027, 850, 680 cm-1.  
MS (EI) m/z (relative intensity): 260 (20) [M+], 217 (50), 203 (35), 160 (100), 117 (14).  
HR-MS (EI) m/z calcd for C15H20N2O2 [M






2-Cyano-N,N-diisopropyl-5-methoxybenzamide (101w’):  
M.p. = 165–167 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.49 (dd, J = 8.6, 7.6 Hz, 1H), 6.90 (d, J = 8.6 Hz, 1H), 6.81 
(d, J = 7.6 Hz, 1H), 3.88 (s, 3H), 3.56 (hept, J = 6.8 Hz, 1H), 3.49 (hept, J = 6.8 Hz, 1H), 1.52 (d, 
J = 6.8 Hz, 6H), 1.12 (sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 166.5 (Cq), 161.4 (Cq), 143.8 (Cq), 134.5 (CH), 117.2 (CH), 
114.3 (Cq), 110.7 (CH), 98.3 (Cq), 56.1 (CH3), 51.3 (CH), 46.0 (CH), 20.5 (CH3), 20.1 (CH3).  
IR (neat): 2971, 2227, 1625, 1461, 1342, 1276, 1030, 800, 605 cm-1.  
MS (EI) m/z (relative intensity): 260 (13) [M+], 217 (50), 203 (25), 160 (100), 117 (18).  
HR-MS (EI) m/z calcd for C15H20N2O2 [M
+] 260.1525, found 260.1523. 
 
 
2-Cyano-3-fluoro-N,N-diisopropylbenzamide (101x): The representative procedure was 
followed using 3-fluoro-N,N-diisopropylbenzamide (50x) (112 mg, 0.50 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 5/1→1/1) yielded 101x (100 mg, 80%) as a 
colorless solid.  
M.p. = 148–150 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.58 (ddd, J = 8.5, 7.6, 5.4 Hz, 1H), 7.15 (td, J = 8.5, 1.0 Hz, 
1H), 7.08 (dd, J = 7.6, 0.9 Hz, 1H), 3.52 (hept, J = 6.7 Hz, 2H), 1.52 (d, J = 6.7 Hz, 6H), 1.14 
(sbr, 6H).  
13
C-NMR (75 MHz, CDCl3): δ = 165.3 (
4JC–F = 2 Hz, Cq), 163.1 (
1JC–F = 261 Hz, Cq), 143.9 (Cq), 
135.2 (3JC–F = 9 Hz, CH), 121.3 (
4JC–F = 3 Hz, CH), 115.8 (
2JC–F = 19 Hz, CH), 111.9 (Cq), 98.5 
(2JC–F = 16 Hz, (Cq), 51.5 (CH), 46.2 (CH), 20.5 (CH3), 20.1 (CH3).  
19
F-NMR (283 MHz, CDCl3): δ = –105.0 (q).  
IR (neat): 2980, 1629, 1442, 1344, 1256, 809, 583 cm-1.  
MS (EI) m/z (relative intensity): 248 (8) [M+], 205 (50), 191 (70), 148 (100), 120 (28).  
HR-MS (EI) m/z calcd for C14H17FN2O [M










Intermolecular Competition Experiment between 50h and 50k 
 
N,N-Diisopropyl-4-methoxybenzamide (50h) (118 mg, 0.50 mmol), 
4-fluoro-N,N-diisopropylbenzamide (50k) (112 mg, 0.50 mmol), NCTS (13) (136 mg, 0.50 
mmol), [RuCl2(p-cymene)]2 (15.4 mg, 5.0 mol %), AgSbF6 (34.4 mg, 20 mol %), NaOAc (8.2 
mg, 20 mol %) and DCE (2.0 mL) were placed into a 20 mL sealed tube under N2 and stirred 
at 120 °C for 24 h. At ambient temperature, the reaction mixture was diluted with H2O (15 
mL) and extracted with EtOAc (3 x 15 mL). The combined organic layer was dried with 
Na2SO4 and concentrated under reduced pressure, purified by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1→1/1) to afford the products 101h (84 mg, 65%) and 101k 
(15 mg, 12%). 
 
Ruthenium-Catalyzed H/D Exchange in 50h with D2O as the Co-Solvent 
 
N,N-Diisopropyl-4-methoxybenzamide (50h) (0.50 mmol), NCTS (13) (272 mg, 1.0 mmol), 
[RuCl2(p-cymene)]2 (15.4 mg, 5.0 mol %), AgSbF6 (34.4 mg, 20 mol %), NaOAc (8.2 mg, 20 
mol %), DCE (1.8 mL) and D2O (0.2 mL) were placed into a 20 mL sealed tube under N2 and 
stirred at 120 °C for 24 h. At ambient temperature, the reaction mixture was diluted with H2O 
(15 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layer was dried with 
Na2SO4 and concentrated under reduced pressure. The crude products were purified by 
column chromatography on silica gel to afford [D]n-50h (97 mg, 82%) and [D]n-101h (15 mg, 















Kinetic Isotope Effect 
 
N,N-Diisopropylbenzamide (50a) (51 mg, 0.25 mmol), [D]5-N,N-diisopropylbenzamide 
([D]5-50a) (53 mg, 0.25 mmol), NCTS (13) (68 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (7.7 mg, 
5.0 mol %), AgSbF6 (17 mg, 20 mol %), NaOAc (4.1 mg, 20 mol %) and DCE (2.0 mL) were 
placed into a 20 mL sealed tube under N2 and stirred at 120 °C for 2 h. At ambient 
temperature, the reaction mixture was diluted with H2O (15 mL) and extracted with EtOAc (3 
x 15 mL). The combined organic layer was dried with Na2SO4 and concentrated under 
reduced pressure. The crude products were purified by column chromatography on silica gel 
to afford [D]n-101a (36 mg, 62%). The kinetic isotope effect of this reaction was determined 
to be kH/kD ≈ 1.2 as estimated by 
1H-NMR spectroscopy. 
4.4 Ortho- and Para-Selective Ruthenium(II)-Catalyzed C(sp
2
)–H Oxygenations 
of Phenol Derivatives 
Characterization Data of Products 103 
 
2-Hydroxy-5-methylphenyl diethylcarbamate (103a): The representative procedure was 
followed using m-tolyl diethylcarbamate (102a) (103.5 mg, 0.50 mmol), and the reaction 
mixture was stirred at 50 °C for 24 h. Isolation by column chromatography (n-hexane/EtOAc: 
5/1→3/1) yielded 103a (67%) as a colorless solid.  
M.p. = 80–82 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.92 (s, 1H), 6.90 (d, J = 8.2 Hz, 1H), 6.87 (d, J = 8.2 Hz, 1H), 
6.82 (s, 1H), 3.46 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 Hz, 2H), 2.26 (s, 3H), 1.27 (t, J = 7.1 Hz, 
3H), 1.21 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.7 (Cq), 145.3 (Cq), 139.8 (Cq), 130.3 (Cq), 126.9 (CH), 
122.3 (CH), 118.9 (CH), 42.5 (CH2), 42.3 (CH2), 20.3 (CH3), 14.1 (CH3), 13.2 (CH3).  
IR (neat): 3333, 2974, 1684, 1163, 783 cm-1.  
MS (EI) m/z (relative intensity): 223 (33) [M
+
], 123 (13), 100 (100), 72 (76), 44 (33).  
HR-MS (EI) m/z calcd for C12H17NO3 [M






2-Hydroxy-5-methylphenyl dimethylcarbamate (103b): The representative procedure was 
followed using m-tolyl dimethylcarbamate (102b) (89.5 mg, 0.50 mmol), and the reaction 
mixture was stirred at 50 °C for 24 h. Isolation by column chromatography (n-hexane/EtOAc: 
5/1→3/1) yielded 103b (63%) as a colorless solid.  
M.p. = 98–100 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.87–6.81 (m, 4H), 3.10 (s, 3H), 3.00 (s, 3H), 2.24 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 155.1 (Cq), 145.3 (Cq), 139.6 (Cq), 130.4 (Cq), 127.0 (CH), 
122.5 (CH), 118.8 (CH), 36.8 (CH3), 36.6 (CH3), 20.4 (CH3).  
IR (neat): 3262, 2950, 1684, 1295, 1179, 796, 578 cm-1.  
MS (EI) m/z (relative intensity): 195 (25) [M+], 123 (5), 95 (3), 72 (100), 42 (8).  
HR-MS (EI) m/z calcd for C10H13NO3 [M
+] 195.0895, found 195.0891. 
 
 
2-Hydroxy-5-methylphenyl di-isopropylcarbamate (103c): The representative procedure 
was followed using m-tolyl di-isopropylcarbamate (102c) (117.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 50 °C for 24 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103c (63%) as a colorless solid.  
M.p. = 113–115 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.11 (s, 1H), 6.89–6.85 (m, 3H), 4.17–3.94 (m, 2H), 2.27 (s, 
3H), 1.36 (d, J = 6.8 Hz, 6H), 1.30 (d, J = 6.8 Hz, 6H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.2 (Cq), 145.4 (Cq), 139.8 (Cq), 130.3 (Cq), 126.9 (CH), 
122.2 (CH), 119.1 (CH), 47.2 (CH), 46.6 (CH), 21.4 (CH3), 20.3 (CH3), 20.2 (CH3).  
IR (neat): 3286, 2971, 1665, 1287, 1146, 1110, 813, 611 cm-1.  
MS (EI) m/z (relative intensity): 251 (15) [M+], 128 (80), 124 (73), 86 (100), 43 (84).  
HR-MS (EI) m/z calcd for C14H21NO3 [M
+] 251.1521, found 251.1520. 
 
 
2-Hydroxy-5-methoxyphenyl diethylcarbamate (103d): The representative procedure was 
followed using 3-methoxyphenyl diethylcarbamate (102d) (111.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 50 °C for 24 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103d (46%) as a colorless solid.  
M.p. = 79–81 °C.  
1




1H), 6.59 (d, J = 2.8 Hz, 1H), 3.73 (s, 3H), 3.46 (q, J = 7.1 Hz, 2H), 3.38 (q, J = 7.1 Hz, 2H), 
1.26 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.4 (Cq), 153.7 (Cq), 141.6 (Cq), 140.4 (Cq), 119.7 (CH), 
111.8 (CH), 107.8 (CH), 55.8 (CH3), 42.5 (CH2), 42.3 (CH2), 14.1 (CH3), 13.2 (CH3).  
IR (neat): 3343, 2981, 1694, 1518, 1274, 1147, 1031, 752 cm-1.  
MS (EI) m/z (relative intensity): 239 (15) [M+], 139 (5), 100 (100), 72 (62), 44 (13).  
HR-MS (EI) m/z calcd for C12H17NO4 [M
+] 239.1158, found 239.1161. 
 
 
5-Bromo-2-hydroxyphenyl diethylcarbamate (103e): The representative procedure was 
followed using 3-bromophenyl diethylcarbamate (102e) (135.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103e (66%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.16 (d, J = 2.4 Hz, 1H), 7.11 (dd, J = 8.6, 2.4 Hz, 1H), 7.01 (s, 
1H), 6.74 (d, J = 8.6 Hz, 1H), 3.44 (q, J = 7.1 Hz, 2H), 3.39 (q, J = 7.1 Hz, 2H), 1.26 (t, J = 7.1 
Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.4 (Cq), 147.5 (Cq), 140.5 (Cq), 129.3 (CH), 125.2 (CH), 
120.3 (CH), 111.4 (Cq), 42.7 (CH2), 42.4 (CH2), 14.0 (CH3), 13.1 (CH3).  
IR (neat): 3269, 2976, 1683, 1426, 1274, 1159, 964, 628 cm-1.  
MS (EI) m/z (relative intensity): 287 (5) [M+], 160 (5), 100 (100), 72 (55), 43 (17).  
HR-MS (EI) m/z calcd for C11H14BrNO3 [M
+] 287.0157, found 287.0169. 
 
 
2-Hydroxy-5-iodophenyl diethylcarbamate (103f): The representative procedure was 
followed using 3-iodophenyl diethylcarbamate (102f) (159.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 3 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103f (71%) as a colorless solid.  
M.p. = 106–108 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.41–7.37 (m, 2 H), 7.34 (d, J = 2.1 Hz, 1H), 6.80 (dd, J = 8.5, 
1.7 Hz, 1H), 3.46 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3 H), 1.22 (t, 
J = 7.1 Hz, 3 H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.4 (Cq), 148.4 (Cq), 140.7 (Cq), 135.3 (CH), 130.9 (CH), 
120.8 (CH), 80.6 (Cq), 42.6 (CH2), 42.4 (CH2), 14.0 (CH3), 13.2 (CH3).  
IR (neat): 3269, 2979, 1700, 1273, 1157, 825, 601 cm-1.  




HR-MS (EI) m/z calcd for C11H14INO3 [M
+] 335.0018, found 335.0018. 
 
 
2-Hydroxy-6-methylphenyl diethylcarbamate (103g): The representative procedure was 
followed using o-tolyl diethylcarbamate (102g) (103.5 mg, 0.50 mmol), and the reaction 
mixture was stirred at 80 °C for 3 h. Isolation by column chromatography (n-hexane/EtOAc: 
5/1→3/1) yielded 103g (67%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 6.96 (s, 1H), 6.87 (dd, J = 7.8, 7.8 Hz, 1H), 6.71–6.66 (m, 2H), 
3.49 (q, J = 7.1 Hz, 2H), 3.39 (q, J = 7.1 Hz, 2H), 2.21 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H), 1.20 (t, 
J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.2 (Cq), 148.2 (Cq), 138.5 (Cq), 130.9 (Cq), 125.7 (CH), 
122.1 (CH), 116.0 (CH), 42.4 (CH2), 42.0 (CH2), 16.5 (CH3), 14.0 (CH3), 13.2 (CH3).  
IR (neat): 3304, 2976, 1685, 1424, 1275, 1179, 1159, 769, 726 cm-1.  
MS (EI) m/z (relative intensity): 223 (8) [M+], 123 (5), 100 (100), 72 (50), 44 (8).  
HR-MS (EI) m/z calcd for C12H17NO3 [M
+] 223.1208, found 223.1208. 
 
 
3-Hydroxy-[1,1'-biphenyl]-2-yl diethylcarbamate (103h): The representative procedure 
was followed using [1,1'-biphenyl]-2-yl diethylcarbamate (102h) (134.5 mg, 0.50 mmol), and 
the reaction mixture was stirred at 80 °C for 6 h. Isolated by column chromatography 
(n-hexane/EtOAc: 3/1) yielded 103h (79%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.43–7.31 (m, 6H), 7.06–7.01 (m, 1H), 6.89–6.84 (m, 2H), 
3.32 (q, J = 7.1 Hz, 2H), 3.17 (q, J = 7.1 Hz, 2H), 1.12 (t, J = 7.1 Hz, 3H), 0.96 (t, J = 7.1 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.6 (Cq), 148.9 (Cq), 138.1 (Cq), 137.2 (Cq), 135.9 (Cq), 
128.9 (CH), 127.9 (CH), 127.1 (CH), 126.0 (CH), 121.9 (CH), 117.7 (CH), 42.2 (CH2), 41.8 
(CH2), 13.5 (CH3), 13.0 (CH3).  
IR (neat): 3282, 2976, 1685, 1424, 1271, 1193, 902, 755, 699 cm-1.  
MS (EI) m/z (relative intensity): 285 (20) [M+], 139 (10), 128 (15), 100 (100), 72 (60), 44 (25).  
HR-MS (EI) m/z calcd for C17H19NO3 [M






2-Hydroxy-6-isopropylphenyl diethylcarbamate (103i): The representative procedure was 
followed using 2-isopropylphenyl diethylcarbamate (102i) (117.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 3 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103i (76%) as a colorless solid.  
M.p. = 85–87 oC.  
1
H-NMR (300 MHz, CDCl3) δ = 6.92 (dd, J = 7.9, 7.9 Hz, 1H), 6.86 (s, 1H), 6.77 (dd, J = 7.9, 
1.7 Hz, 1H), 6.64 (dd, J = 7.9, 1.7 Hz, 1H), 3.49 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 Hz, 2H), 
3.10 (hept, J = 6.9 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 1.21 (d, J = 6.9 Hz, 6H), 1.20 (t, J = 7.1 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.6 (Cq), 148.2 (Cq), 141.1 (Cq), 137.6 (Cq), 125.9 (CH), 
117.3 (CH), 115.9 (CH), 42.4 (CH2), 42.0 (CH2), 27.6 (CH), 22.8 (CH3), 13.9 (CH3), 13.2 
(CH3). 
IR (neat): 3174, 2965, 1685, 1148, 1181, 964, 782, 732 cm-1.  
MS (EI) m/z (relative intensity): 251 (5) [M+], 137 (3), 100 (100), 72 (45), 43 (20).  
HR-MS (EI) m/z calcd for C14H21NO3 [M
+] 251.1521, found 251.1515. 
 
 
2-Fluoro-6-hydroxyphenyl diethylcarbamate (103j): The representative procedure was 
followed using 2-fluorophenyl diethylcarbamate (102j) (105.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103j (58%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.61 (s, 1H), 6.93–6.85 (m, 1H), 6.66–6.59 (m, 2H), 3.47 (q, J 
= 7.1 Hz, 2H), 3.38 (q, J = 7.1 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 155.1 (
1JC–F = 248 Hz, Cq), 154.2 (Cq), 150.1 (
3JC–F = 3 Hz, Cq), 
128.5 (2JC–F = 13 Hz, Cq), 125.7 (
3JC–F = 10 Hz, CH), 113.7 (
4JC–F = 3 Hz, CH), 107.6 (
2JC–F = 19 
Hz, CH), 42.7 (CH2), 42.5 (CH2), 13.8 (CH3), 13.1 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = –(130.1–130.2) (m).  
IR (neat): 3277, 2979, 1692, 1474, 1013, 768, 562 cm-1.  
MS (EI) m/z (relative intensity): 227 (10) [M+], 128 (15), 100 (100), 72 (77), 44 (32).  
HR-MS (EI) m/z calcd for C11H14FNO3 [M






2-Chloro-6-hydroxyphenyl diethylcarbamate (103k): The representative procedure was 
followed using 2-chlorophenyl diethylcarbamate (102k) (113.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103k (52%) as a colorless solid.  
M.p. = 75–77 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.50 (s, 1H), 6.92–6.80 (m, 2H), 6.68 (dd, J = 7.3, 2.4 Hz, 1H), 
3.52 (q, J = 7.1 Hz, 2H), 3.39 (q, J = 7.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H), 1.19 (t, J = 7.1 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 153.9 (Cq), 150.1 (Cq), 136.5 (Cq), 127.2 (Cq), 126.3 (CH), 
121.0 (CH), 116.9 (CH), 42.6 (CH2), 42.3 (CH2), 13.9 (CH3), 13.1 (CH3).  
IR (neat): 3298, 2981, 1694, 1425, 1211, 1159, 910, 773, 718 cm-1.  
MS (EI) m/z (relative intensity): 243 (10) [M+], 144 (15), 100 (100), 72 (75), 44 (33).  
HR-MS (EI) m/z calcd for C11H14ClNO3 [M
+] 243.0662, found 243.0655. 
 
 
2-Bromo-6-hydroxyphenyl diethylcarbamate (103l): The representative procedure was 
followed using 2-bromophenyl diethylcarbamate (102l) (135.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103l (57%) as a colorless solid.  
M.p. = 107–109 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.39 (s, 1H), 7.06 (dd, J = 8.0, 1.7 Hz, 1H), 6.84 (dd, J = 8.0, 
8.0 Hz, 1H), 6.77 (dd, J = 8.0, 1.7 Hz, 1H), 3.56 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 Hz, 2H), 
1.30 (t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 153.8 (Cq), 149.9 (Cq), 137.8 (Cq), 127.0 (CH), 124.3 (CH), 
118.0 (CH), 116.4 (Cq), 42.6 (CH2), 42.3 (CH2), 14.0 (CH3), 13.1 (CH3).  
IR (neat): 3177, 2979, 1690, 1424, 1209, 1162, 885, 751 cm-1.  
MS (EI) m/z (relative intensity): 287 (3) [M+], 188 (3), 100 (100), 72 (40), 44 (5).  
HR-MS (EI) m/z calcd for C11H14BrNO3 [M







2-Hydroxy-6-iodophenyl diethylcarbamate (103m): The representative procedure was 
followed using 2-iodophenyl diethylcarbamate (102m) (159.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103m (42%) as a colorless solid.  
M.p. = 118–120 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.31 (d, J = 8.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 1H), 6.76 (s, 1H), 
6.73 (dd, J = 8.0, 8.0 Hz, 1H), 3.62 (q, J = 7.1 Hz, 2H), 3.42 (q, J = 7.1 Hz, 2H), 1.33 (t, J = 7.1 
Hz, 3H), 1.23 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 153.7 (Cq), 148.9 (Cq), 140.5 (Cq), 130.5 (CH), 127.9 (CH), 
119.1 (CH), 90.6 (Cq), 42.5 (CH2), 42.4 (CH2), 14.1 (CH3), 13.1 (CH3).  
IR (neat): 3207, 2978, 1688, 1422, 1207, 1160, 871, 749 cm-1.  
MS (EI) m/z (relative intensity): 335 (6) [M+], 235 (5), 206 (4), 100 (100), 72 (37).  
HR-MS (EI) m/z calcd for C11H14INO3 [M
+] 335.0018, found 335.0034. 
 
 
2-Hydroxyphenyl diethylcarbamate (103n): The representative procedure was followed 
using phenyl diethylcarbamate (102n) (96.5 mg, 0.50 mmol), and the reaction mixture was 
stirred at 80 °C for 6 h. Isolation by column chromatography (n-hexane/EtOAc: 5/1→3/1) 
yielded 103n (42%) as a colorless solid.  
M.p. = 69–71 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.31 (s, 1H), 7.07–6.93 (m, 3H), 6.88–6.82 (m, 1H), 3.46 (q, J 
= 7.2 Hz, 2H), 3.39 (q, J = 7.2 Hz, 2H), 1.26 (t, J = 7.2 Hz, 3H), 1.19 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.7 (Cq), 147.9 (Cq), 140.2 (Cq), 126.5 (CH), 122.0 (CH), 
120.7 (CH), 119.3 (CH), 42.6 (CH2), 42.3 (CH2), 14.1 (CH3), 13.2 (CH3).  
IR (neat): 3289, 2976, 1684, 1278, 1161, 1097, 938, 744 cm-1.  
MS (EI) m/z (relative intensity): 209 (15) [M+], 110 (15), 100 (100), 72 (80), 44 (36).  
HR-MS (EI) m/z calcd for C11H15NO3 [M
+] 209.1052, found 209.1054.  
The spectral data are in accordance with those reported in the literature.[126] 
 
 
3-Hydroxy-[1,1'-biphenyl]-4-yl diethylcarbamate (103o): The representative procedure was 




reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1) yielded 103o (51%) as a colorless solid.  
M.p. = 81–83 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.57 (s, 1H), 7.51–7.47 (m, 2H), 7.42–7.29 (m, 3H), 7.22 (d, J 
= 1.7 Hz, 1H), 7.11–7.04 (m, 2H), 3.50 (q, J = 7.1 Hz, 2H), 3.43 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 
7.1 Hz, 3H), 1.23 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.8 (Cq), 148.0 (Cq), 140.1 (Cq), 139.7 (Cq), 139.5 (Cq), 
128.5 (CH), 127.1 (CH), 126.9 (CH), 122.2 (CH), 119.2 (CH), 117.7 (CH), 42.6 (CH2), 42.3 
(CH2), 14.0 (CH3), 13.2 (CH3).  
IR (neat): 3213, 2978, 1681, 1413, 1240, 1167, 754, 696 cm-1.  
MS (EI) m/z (relative intensity): 285 (10) [M+], 128 (8), 100 (100), 72 (47), 44 (10).  
HR-MS (EI) m/z calcd for C17H19NO3 [M
+] 285.1365, found 285.1364. 
 
 
2-Hydroxy-4-methoxyphenyl diethylcarbamate (103p): The representative procedure was 
followed using 4-methoxyphenyl diethylcarbamate (102p) (111.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 3 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103p (46%) as a colorless solid.  
M.p. = 86–88 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.51 (s, 1H), 6.88 (d, J = 8.8 Hz, 1H), 6.47 (d, J = 3.0 Hz, 1H), 
6.38 (dd, J = 8.8, 3.0 Hz, 1H), 3.69 (s, 3H), 3.44 (q, J = 7.1 Hz, 2H), 3.37 (q, J = 7.1 Hz, 2H), 
1.24 (t, J = 7.1 Hz, 3H), 1.18 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 158.0 (Cq), 155.2 (Cq), 148.6 (Cq), 134.1 (Cq), 122.2 (CH), 
106.3 (CH), 104.2 (CH), 55.4 (CH3), 42.6 (CH2), 42.3 (CH2), 14.1 (CH3), 13.2 (CH3).  
IR (neat): 3212, 2983, 1671, 1428, 1205, 1166, 1030, 833 cm-1.  
MS (EI) m/z (relative intensity): 239 (15) [M+], 111 (12), 100 (100), 72 (65), 43 (25).  
HR-MS (EI) m/z calcd for C12H17NO4 [M
+] 239.1158, found 239.1155. 
 
 
4-Fluoro-2-hydroxyphenyl diethylcarbamate (103q): The representative procedure was 
followed using 4-fluorophenyl diethylcarbamate (102q) (105.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103q (48%) as a colorless solid.  
M.p. = 83–85 °C.  
1




3.46 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 160.5 (
1JC–F = 243 Hz, Cq), 154.9 (Cq), 149.2 (
3JC–F = 13 Hz, 
Cq), 136.2 (
4JC–F = 3 Hz, Cq), 122.6 (
3JC–F = 13 Hz, CH), 106.8 (
2JC–F = 24 Hz, CH), 106.1 (
2JC–F 
= 24 Hz, CH), 42.6 (CH2), 42.3 (CH2), 14.0 (CH3), 13.2 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = –(115.8–115.9) (m).  
IR (neat): 3170, 2984, 1675, 1426, 1227, 1154, 963, 850, 561 cm-1.  
MS (EI) m/z (relative intensity): 227 (8) [M+], 128 (12), 100 (100), 72 (83), 44 (40).  
HR-MS (EI) m/z calcd for C11H14FNO3 [M
+] 227.0958, found 227.0957. 
 
 
4-Hydroxy-[1,1'-biphenyl]-3-yl dimethylcarbamate (103r): The representative procedure 
was followed using [1,1'-biphenyl]-3-yl dimethylcarbamate (102r) (120.5 mg, 0.50 mmol), 
and the reaction mixture was stirred at 50 °C for 24 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103r (75%) as a colorless solid.  
M.p. = 127–129 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.52 (d, J = 7.2 Hz, 2H), 7.43–7.38 (m, 2H), 7.33–7.26 (m, 
3H), 7.02 (d, J = 8.7 Hz, 1H), 3.16 (s, 3H), 3.06 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 155.2 (Cq), 147.3 (Cq), 140.2 (Cq), 140.1 (Cq), 134.2 (Cq), 
128.7 (CH), 126.8 (CH), 126.6 (CH), 125.2 (CH), 120.7 (CH), 119.4 (CH), 36.9 (CH3), 36.8 
(CH3).  
IR (neat): 3210, 1682, 1296, 1180, 752, 690 cm-1.  
MS (EI) m/z (relative intensity): 257 (15) [M+], 157 (8), 128 (10), 72 (100), 42 (6).  
HR-MS (EI) m/z calcd for C15H15NO3 [M
+] 257.1052, found 257.1059. 
 
 
2-Hydroxy-4,5-dimethylphenyl diethylcarbamate (103s): The representative procedure was 
followed using 3,4-dimethylphenyl diethylcarbamate (102s) (110.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 3 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103s (52%) as a colorless solid.  
M.p. = 82–84 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.08 (s, 1H), 6.78 (s, 1H), 6.74 (s, 1H), 3.46 (q, J = 7.1 Hz, 
2H), 3.40 (q, J = 7.1 Hz, 2H), 2.15 (s, 3H), 2.14 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 
Hz, 3H).  
13




122.6 (CH), 120.2 (CH), 42.5 (CH2), 42.2 (CH2), 19.1 (CH3), 18.7 (CH3), 14.1 (CH3), 13.2 
(CH3).  
IR (neat): 3270, 2977, 1690, 1417, 1305, 1165, 1084, 883, 758 cm-1.  
MS (EI) m/z (relative intensity): 237 (25) [M+], 137 (10), 100 (100), 72 (75), 44 (22).  
HR-MS (EI) m/z calcd for C13H19NO3 [M
+] 237.1365, found 237.1359. 
 
 
2-Hydroxy-4,6-dimethylphenyl diethylcarbamate (103t): The representative procedure was 
followed using 2,4-dimethylphenyl diethylcarbamate (102t) (110.5 mg, 0.50 mmol), and the 
reaction mixture was stirred at 80 °C for 6 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103t (73%) as a colorless solid.  
M.p. = 109–111 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.88 (s, 1H), 6.52 (d, J = 2.6 Hz, 1H), 6.52 (d, J = 2.6 Hz, 1H), 
3.50 (q, J = 7.1 Hz, 2H), 3.41 (q, J = 7.1 Hz, 2H), 2.18 (s, 3H), 2.17 (s, 3H), 1.28 (t, J = 7.1 Hz, 
3H), 1.21 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.5 (Cq), 147.7 (Cq), 136.4 (Cq), 135.5 (Cq), 130.3 (Cq), 
122.9 (CH), 116.7 (CH), 42.4 (CH2), 42.0 (CH2), 20.8 (CH3), 16.5 (CH3), 14.0 (CH3), 13.2 
(CH3).  
IR (neat): 3253, 2981, 1673, 1276, 1157, 831, 569 cm-1.  
MS (EI) m/z (relative intensity): 237 (25) [M+], 137 (30), 100 (100), 72 (65), 44 (15).  
HR-MS (EI) m/z calcd for C13H19NO3 [M
+] 237.1365, found 237.1364. 
 
 
2-Hydroxy-5,6-dimethylphenyl diethylcarbamate (103u): The representative procedure 
was followed using 2,3-dimethylphenyl diethylcarbamate (102u) (110.5 mg, 0.50 mmol), and 
the reaction mixture was stirred at 80 °C for 3 h. Isolation by column chromatography 
(n-hexane/EtOAc: 5/1→3/1) yielded 103u (66%) as a colorless solid.  
M.p. = 81–83 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.81 (d, J = 8.1 Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 6.51 (s, 1H), 
3.52 (q, J = 7.2 Hz, 2H), 3.41 (q, J = 7.2 Hz, 2H), 2.20 (s, 3H), 2.12 (s, 3H), 1.29 (t, J = 7.2 Hz, 
3H), 1.21 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.2 (Cq), 146.0 (Cq), 138.4 (Cq), 129.3 (Cq), 129.0 (Cq), 





IR (neat): 3337, 2977, 1684, 1423, 1274, 1159, 1025, 729, 654 cm-1.  
MS (EI) m/z (relative intensity): 237 (10) [M+], 137 (5), 100 (100), 72 (50), 44 (10).  
HR-MS (EI) m/z calcd for C13H19NO3 [M
+] 237.1365, found 237.1372. 
 
 
2-Bromo-6-hydroxy-4-methylphenyl diethylcarbamate (103v): The representative 
procedure was followed using 2-bromo-4-methylphenyl diethylcarbamate (102v) (142.5 mg, 
0.50 mmol), and the reaction mixture was stirred at 80 °C for 6 h. Isolation by column 
chromatography (n-hexane/EtOAc: 5/1→3/1) yielded 103v (54%) as a colorless solid.  
M.p. = 83–85 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.42 (s, 1H), 6.87 (d, J = 1.9 Hz, 1H), 6.50 (d, J = 1.9 Hz, 1H), 
3.55 (q, J = 7.1 Hz, 2H), 3.41 (q, J = 7.1 Hz, 2H), 2.14 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H), 1.22 (t, 
J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3): δ = 154.1 (Cq), 149.4 (Cq), 137.0 (Cq), 135.4 (Cq), 124.4 (CH), 
118.4 (CH), 115.8 (Cq), 42.6 (CH2), 42.3 (CH2), 20.6 (CH3), 14.0 (CH3), 13.2 (CH3).  
IR (neat): 3239, 2976, 1686, 1426, 1305, 1269, 800, 577 cm-1.  
MS (EI) m/z (relative intensity): 301 (3) [M+], 200 (3), 100 (100), 72 (45), 43 (36).  
HR-MS (EI) m/z calcd for C12H16BrNO3 [M
+] 301.0314, found 301.0304. 
Intramolecular Competition Experiment 
 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), PhI(TFA)2 (430 mg, 1.0 mmol), 102w (132.5 mg, 
0.50 mmol) and DCE (2.0 mL) were placed into a 25 mL schlenk tube equipped with a 
septum under N2. The reaction mixture was stirred at 80 °C for 6 h. At ambient temperature, 
the reaction mixture was diluted with H2O (15 mL) and extracted with EtOAc (3 x 15 mL). 
The combined organic layer was concentrated under reduced pressure. The crude product was 
purified by column chromatography on silica gel (n-hexane/EtOAc: 5/1→3/1) to afford the 








Ethyl 4-[(diethylcarbamoyl)oxy]-3-hydroxybenzoate (103w):  
1
H-NMR (300 MHz, CDCl3) δ = 7.64 (d, J = 2.0 Hz, 1H), 7.56 (dd, J = 8.4, 2.0 Hz, 1H), 7.47 (s, 
1H), 7.05 (d, J = 8.4 Hz, 1H), 4.33 (q, J = 7.1 Hz, 2H), 3.47 (q, J = 7.1 Hz, 2H), 3.40 (q, J = 7.1 
Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 165.8 (Cq), 154.1 (Cq), 147.8 (Cq), 143.6 (Cq), 128.5 (Cq), 
122.1 (CH), 122.0 (CH), 120.1 (CH), 61.0 (CH2), 42.7 (CH2), 42.5 (CH2), 14.3 (CH3), 14.1 
(CH3), 13.3 (CH3).  
IR (neat): 3274, 2979, 1687, 1427, 1279, 1214, 1094, 759 cm-1.  
MS (EI) m/z (relative intensity): 281 (3) [M+], 236 (5), 100 (100), 72 (50), 44 (10).  
HR-MS (EI) m/z calcd for C14H19NO5 [M
+] 281.1263, found 281.1264. 
 
Intermolecular Competition Experiments 
 
[RuCl2(p-cymene)]2 (7.7 mg, 2.5 mol %), PhI(TFA)2 (430 mg, 1.0 mmol), 102n (96.5 mg, 0.50 
mmol), 53a (75.0 mg, 0.50 mmol) and DCE (2.0 mL) were placed into a 25 mL Schlenk tube 
equipped with a septum under N2. The reaction mixture was stirred at 80 °C for 6 h. At 
ambient temperature, the reaction mixture was diluted with H2O (15 mL) and extracted with 
EtOAc (3 x 15 mL). The combined organic layer was concentrated under reduced pressure, 
purified by column chromatography on silica gel (n-hexane/EtOAc: 5/1→3/1) to afford the 
desired product 103n (38%). 
 
[RuCl2(p-cymene)]2 (7.65 mg, 2.5 mol %), PhI(TFA)2 (430 mg, 1.0 mmol), 102n (96.5 mg, 




tube equipped with a septum under N2. The reaction mixture was stirred at 80 °C for 6 h. At 
ambient temperature, the reaction mixture was diluted with H2O (15 mL) and extracted with 
EtOAc (3 x 15 mL). The combined organic layer was concentrated under reduced pressure, 
purified by column chromatography on silica gel (n-hexane/EtOAc: 5/1→3/1) to afford the 
desired products 51a (24%) and 103n (4%). 
 
 
N,N-Diethyl-2-hydroxybenzamide (51a):  
1
H-NMR (300 MHz, CDCl3) δ = 9.44 (s, 1H), 7.27–7.19 (m, 2H), 6.93 (dd, J = 8.3, 1.3 Hz, 
1H), 6.82 (dd, J = 8.2, 6.9 Hz, 1H), 3.46 (q, J = 7.1 Hz, 4H), 1.22 (t, J = 7.1 Hz, 6H).  
13
C-NMR (75 MHz, CDCl3) δ = 171.2 (Cq), 157.9 (Cq), 131.9 (CH), 127.2 (CH), 118.6 (Cq), 
118.5 (CH), 117.7 (CH) 42.0, (CH2), 13.3 (CH3).  
IR (neat): 3165, 2978, 1610, 1582, 1247, 881 cm-1.  
MS (EI) m/z (relative intensity): 193 (35) [M+], 192 (55), 121 (100).  
HR-MS (EI) m/z calcd for C11H14NO2 [M
+] 193.1103, found 193.1103.  




Preparation of the substrate [D]5-102n
[113-114]
 
A sealed tube equipped with a magnetic stirring bar was charged with CuI (37.8 mg, 10 mol %) 
and NaI (59.6 mg, 20 mol %). The tube was evacuated and back-filled with nitrogen. Then 
[D]5-bromobenzene (322.0 mg, 2.0 mmol, 1.0 equiv), DMEDA (88.5 mg, 1.0 mol) and 
1,4-dioxane (2.0 mL) were added. The tube was sealed under N2, and the reaction mixture was 
stirred at 110 °C. After 6 h, under a stream of N2, CsOH·H2O (1008 mg, 6.0 mol) and D2O (2 
mL) were added. The tube was sealed under N2, stirred and heated to 130 °C for 24 h. At 
ambient temperature, CH2Cl2 (10 mL) and HCl (2 mL, 37%) were added. The reaction mixture 
was stirred for 2 h, then extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were 
dried over Na2SO4. After filtration and evaporation of the solvents in vacuo, the crude product 
was obtained without further purification. The crude product was dissolved in DMF (5.0 mL). 
Then NaH (125 mg, 60% dispersion, 3.0 mmol) was added, the solution was stirred for 15 min 
at ambient temperature and diethylcarbamoyl chloride (272 mg, 2.0 mmol) was added. After 
stirring for 2 h at ambient temperature, the reaction mixture was carefully reacted with ice and 
extracted with Et2O (3 x 15 mL). The organic layer was washed with brine, dried over Na2SO4 
and concentrated under reduced pressure. The crude product was purified by column 





Kinetic Isotope Effect 
 
[RuCl2(p-cymene)]2 (3.9 mg, 2.5 mol %), PhI(TFA)2 (215 mg, 0.50 mmol), [D5]-102n (50.0 
mg, 0.25 mmol), 102n (48.5 mg, 0.25 mmol), DCE (2.0 mL) were placed into a 25 mL 
Schlenk tube equipped with a septum under N2. The reaction mixture was stirred at 80 °C for 
1 h. At ambient temperature, the reaction mixture was diluted with H2O (15 mL) and 
extracted with EtOAc (3 x 15 mL). The combined organic layer was concentrated under 
reduced pressure. The crude product was purified by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1→3/1) to afford the desired product [Dn]-103n (11%). The ratio of 




Characterization Data of Products 116 
 
4-Methoxyphenol (116a): The representative procedure was followed using anisole (115a) 




116a (71%) as a colorless solid.  
M.p. = 56–58 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.80 (d, J = 8.8 Hz, 2H), 6.77 (d, J = 8.8 Hz, 2H), 5.47 (sbr, 
1H), 3.77 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 153.6 (Cq), 149.5 (Cq), 116.1 (CH), 114.9 (CH), 55.8 (CH3).  
IR (neat): 3401, 2953, 1512, 1277, 1235, 1039, 807, 736 cm-1.  
MS (EI) m/z (relative intensity): 124.1 (90) [M+], 109.0 (100), 81 (50), 53 (27).  
HR-MS (EI) m/z calcd for C7H8O2 [M
+] 124.0524, found 124.0528. 





2,4-Dimethoxyphenol (116b): The representative procedure was followed using 
1,3-dimethoxybenzene (115b) (69.0 mg, 0.50 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 116b (84%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 6.82 (d, J = 8.6 Hz, 1H), 6.48 (d, J = 2.8 Hz, 1H), 6.37 (dd, J 
= 8.6, 2.8 Hz, 1H), 5.32 (sbr, 1H), 3.83 (s, 3H), 3.74 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 153.4 (Cq), 147.0 (Cq), 139.7 (Cq), 114.0 (CH), 104.1 (CH), 
99.4 (CH), 55.8 (CH3), 55.7 (CH3).  
IR (neat): 3437, 2940, 1506, 1201, 1150, 1026, 789 cm-1.  
MS (EI) m/z (relative intensity): 154 (100) [M+], 139 (95), 111 (85), 96 (15), 79 (15), 53 (15).  
HR-MS (EI) m/z calcd for C118H10O3 [M
+] 154.0630, found 154.0629.  





3,4-Dimethoxyphenol (116c): The representative procedure was followed using 
1,2-dimethoxybenzene (115c) (69.0 mg, 0.50 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 116c (56%) as a colorless solid.  
M.p. = 79–81 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.70 (d, J = 8.6 Hz, 1H), 6.44 (d, J = 2.8 Hz, 1H), 6.33 (dd, J 
= 8.6, 2.8 Hz, 1H), 5.48 (sbr, 1H), 3.78 (s, 3H), 3.77 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 150.2 (Cq), 149.8 (Cq), 142.9 (Cq), 112.4 (CH), 105.8 (CH), 
100.6 (CH), 56.5 (CH3), 55.7 (CH3).  
IR (neat): 3417, 2937, 1509, 1220, 1195, 1024, 952, 765 cm-1.  




HR-MS (EI) m/z calcd for C118H10O3 [M
+] 154.0630, found 154.0634. 





4-Methoxy-3-methylphenol (116d): The representative procedure was followed using 
1-methoxy-2-methylbenzene (115d) (61.0 mg, 0.50 mmol), PhI(TFA)2 (430 mg, 1.0 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1) yielded 116d (47%) as a 
colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 6.68 (d, J = 8.5 Hz, 1H), 6.64 (d, J = 2.9 Hz, 1H), 6.60 (dd, J 
= 8.5, 2.9 Hz, 1H), 4.29 (sbr, 1H), 3.76 (s, 3H), 2.16 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 151.9 (Cq), 149.0 (Cq), 128.0 (Cq), 117.9 (CH), 112.5 (CH), 
111.3 (CH), 56.0 (CH3), 16.2 (CH3).  
IR (neat): 3382, 2950, 1503, 1465, 1219, 1035, 738 cm-1.  
MS (EI) m/z (relative intensity): 138 (85) [M+], 123 (100), 95 (15), 77 (15), 67 (17).  
HR-MS (EI) m/z calcd for C8H10O2 [M
+] 138.0681, found 138.0677. 
The spectral data are in accordance with those reported in the literature.
[127]
 
4.5 Manganese(I)-Catalyzed Synthesis of cis-β-Amino Acid Esters through 
Organometallic C–H Activation 




(105aa): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 0.50 mmol) and ethyl 
acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
10/1→5/1) yielded 105aa (159 mg, 94%) as a colorless solid.  
M.p. = 64–65 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.15–6.84 (m, 3H), 6.58 (dd, J = 8.8, 1.8 Hz, 2H), 6.32 (dd, J 
= 8.8, 1.8 Hz, 2H), 4.16 (q, J = 7.2 Hz, 2H), 3.79 (sbr, 1H), 3.70 (s, 3H), 3.27–3.13 (m, 2H), 
3.09–2.91 (m, 1H), 2.37 (s, 3H), 1.76 (s, 3H), 1.26 (t, J = 7.2 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 172.5 (Cq), 154.3 (Cq), 143.2 (Cq), 141.1 (Cq), 138.6 (Cq), 




55.5 (CH3), 55.3 (CH), 33.0 (CH2), 28.4 (CH3), 21.4 (CH3), 14.2 (CH3).  
IR (neat): 2984, 1722, 1504, 1222, 1180, 1030, 806, 569 cm-1.  
MS (EI) m/z (relative intensity): 339 (5) [M+], 216 (60), 171 (20), 143 (100), 128 (75), 108 (53).  
HR-MS (ESI) m/z calcd for C21H25NO3 [M




(105ab): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 0.50 mmol) and n-butyl 
acrylate (38b) (128 mg, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
10/1→5/1) yielded 105ab (163 mg, 89%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.07–6.97 (m, 3H), 6.59 (dd, J = 8.9, 1.2 Hz, 2H), 6.32 (dd, J 
= 8.9, 1.2 Hz, 2H), 4.12 (d, J = 6.7 Hz, 2H), 3.80 (sbr, 1H), 3.70 (s, 3H), 3.30–3.15 (m, 2H), 
3.09–2.97 (m, 1H), 2.38 (s, 3H), 1.76 (s, 3H), 1.63 (tt, J = 7.9, 5.9 Hz, 2H), 1.48–1.35 (m, 2H), 
0.96 (t, J = 7.4 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.7 (Cq), 154.4 (Cq), 143.2 (Cq), 141.2 (Cq), 138.6 (Cq), 
137.8 (Cq), 127.3 (CH), 125.2 (CH), 123.6 (CH), 123.1 (CH), 113.4 (CH), 67.4 (Cq), 64.3 (CH2), 
55.4 (CH3), 55.1 (CH), 32.9 (CH2), 30.5 (CH2), 28.2 (CH3), 21.3 (CH3), 19.2 (CH2), 13.6 (CH3).  
IR (neat): 2958, 1721, 1507, 1462, 1234, 1182, 1036, 817 cm-1.  
MS (EI) m/z (relative intensity): 367 (35) [M+], 244 (60), 143 (95), 123 (100), 108 (70), 80 (40).  
HR-MS (ESI) m/z calcd for C23H29NO3 [M




(105ac): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 0.50 mmol) and benzyl 
acrylate (38c) (150 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
10/1→5/1) yielded 105ac (176 mg, 88%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.44–7.34 (m, 4H), 7.10–7.01 (m, 3H), 6.60–6.56 (m, 2H), 
6.32–6.27 (m, 2H), 5.17 (s, 2H), 3.80 (sbr, 1H), 3.72 (s, 3H), 3.39–3.21 (m, 2H), 3.06 (dd, J = 
16.3, 8.4 Hz, 1H), 2.41 (s, 3H), 1.81 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.4 (Cq), 154.4 (Cq), 143.2 (Cq), 141.1 (Cq), 138.5 (Cq), 
137.9 (Cq), 135.8 (Cq), 128.4 (CH), 128.2 (CH), 128.1 (CH), 127.5 (CH), 125.2 (CH), 123.6 




(CH3), 21.3 (CH3).  
IR (neat): 2934, 1725, 1507, 1233, 1178, 1036, 813, 747, 696 cm-1.  
MS (EI) m/z (relative intensity): 401 (15) [M+], 279 (10), 233 (15), 123 (75), 91 (100).  
HR-MS (ESI) m/z calcd for C26H27NO3 [M




(105ad): The representative procedure was followed using N-(4-methoxyphenyl)-1-(p-tolyl) 
ethan-1-imine (104a) (120 mg, 0.50 mmol) and allyl acrylate (38d) (133 μL, 1.0 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 105ad (118 mg, 
67%) as a colorless solid.  
M.p. = 63–64 °C.  
1
H-NMR (400 MHz, CDCl3) δ = 7.04 (s, 1H), 7.02–6.95 (m, 2H), 6.58–6.54 (m, 2H), 
6.31–6.27 (m, 2H), 5.90 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.33 (dq, J = 17.2, 1.6 Hz, 1H), 5.23 
(dq, J = 10.4, 1.3 Hz, 1H), 4.58 (dt, J = 5.7, 1.4 Hz, 2H), 3.75 (sbr, 1H), 3.68 (s, 3H), 3.29–3.16 
(m, 2H), 3.00 (dd, J = 15.7, 8.3Hz, 1H), 2.35 (s, 3H), 1.76 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 172.4 (Cq), 154.5 (Cq), 143.2 (Cq), 141.1 (Cq), 138.5 (Cq), 
137.9 (Cq), 132.2 (CH), 127.5 (CH), 125.3 (CH), 123.7 (CH), 123.1 (CH), 118.2 (CH2), 113.5 
(CH), 67.6 (Cq), 65.2 (CH2), 55.5 (CH3), 55.3 (CH), 33.0 (CH2), 28.3 (CH3), 21.3 (CH3).  
IR (neat): 2946, 1725, 1504, 1439, 1222, 1178, 1031, 818, 569 cm-1.  
MS (EI) m/z (relative intensity): 351 (15) [M+], 229 (40), 144 (85), 129 (43), 123 (100), 108 
(20).  
HR-MS (ESI) m/z calcd for C22H25NO3 [M




te (105ae): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 0.50 mmol), methyl 
(E)-but-2-enoate (38e) (107 μL, 1.0 mmol) and Mn2(CO)10 (19.6 mg, 10 mol %). Isolation by 
column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 105ae (108 mg, 64%) as a 
colorless solid.  
M.p. = 99–100 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.15 (d, J = 7.7 Hz, 1H), 7.06 (d, J = 7.7 Hz, 1H), 6.99 (s, 1H), 




J = 6.5 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.6 (Cq), 153.6 (Cq), 145.9 (Cq), 143.9 (Cq), 139.2 (Cq), 
137.7 (Cq), 127.8 (CH), 123.7 (CH), 122.0 (CH), 121.0 (CH), 114.0 (CH), 66.6 (Cq), 61.4 (CH), 
55.5 (CH3), 50.9 (CH3), 39.4 (CH), 26.7 (CH3), 21.4 (CH3), 15.1 (CH3).  
IR (neat): 3398, 2966, 1730, 1508, 1246, 1162, 808, 555, 514 cm-1.  
MS (EI) m/z (relative intensity): 339 (15) [M+], 216 (45), 157 (100), 142 (55), 123 (65), 108 
(45). 
HR-MS (ESI) m/z calcd for C22H26NO3 [M + H




(105ba): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-phenylethan-1-imine (104b) (113 mg, 0.50 mmol) and ethyl acrylate 
(38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) 
yielded 105ba (158 mg, 97%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.30–7.17 (m, 3H), 7.08 (d, J = 7.3 Hz, 1H), 6.57 (d, J = 8.9 
Hz, 2H), 6.29 (d, J = 8.9 Hz, 2H), 4.16 (q, J = 7.2 Hz, 2H), 3.80 (s, 1H), 3.69 (s, 3H), 3.29–3.18 
(m, 2H), 3.10–2.99 (m, 1H), 1.79 (s, 3H), 1.26 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.6 (Cq), 154.5 (Cq), 146.1 (Cq), 141.0 (Cq), 138.5 (Cq), 
128.1 (CH), 126.5 (CH), 124.6 (CH), 123.9 (CH), 123.1 (CH), 113.4 (CH), 67.7 (Cq), 60.4 
(CH2), 55.2 (CH3), 55.2 (CH), 33.0 (CH2), 28.1 (CH3), 14.1 (CH3).  
IR (neat): 2977, 1719, 1507, 1224, 1181, 1034, 826, 758 cm-1.  
MS (EI) m/z (relative intensity): 325 (15) [M+], 202 (25), 129 (100), 123 (95), 108 (48), 80 (20).  
HR-MS (ESI) m/z calcd for C20H23NO3 [M




carboxylate (105ca): The representative procedure was followed using 1-(4-fluorophenyl)-N- 
(4-methoxyphenyl)ethan-1-imine (104c) (122 mg, 0.50 mmol) and ethyl acrylate (38a) (107 
μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 
105ca (129 mg, 75%) as a colorless solid.  
M.p. = 78–79 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.01–6.96 (m, 1H), 6.93–6.83 (m, 2H), 6.57 (dd, J = 8.8, 1.6 




3.29–3.12 (m, 2H), 3.00 (dd, J = 16.0, 8.4 Hz, 1H), 1.76 (s, 3H), 1.26 (t, J = 7.4 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.3(Cq), 162.9 (
1JC–F = 244 Hz, Cq), 154.7 (Cq), 143.3 (
3JC–F 
= 9 Hz, Cq), 141.7 (
4JC–F = 2 Hz, Cq), 138.3 (Cq), 125.2 (
3JC–F = 9 Hz, CH), 123.5 (CH), 113.6 
(2JC–F = 23 Hz, CH), 113.5 (CH), 111.5 (
2JC–F = 22 Hz, CH,), 67.1 (Cq), 60.6 (CH2), 55.5 (CH3), 
55.3 (CH), 32.9 (4JC–F = 2 Hz, CH2), 28.2 (CH3), 14.1 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = -(114.5–114.6) (m).  
IR (neat): 2988, 1719, 1505, 1238, 1181, 827, 807, 699 cm-1.  
MS (EI) m/z (relative intensity): 343 (15) [M+], 221 (20), 147 (65), 123 (100), 108 (25).  
HR-MS (ESI) m/z calcd for C20H22FNO3 [M




carboxylate (105da): The representative procedure was followed using 
1-(4-chlorophenyl)-N-(4-methoxyphenyl)ethan-1-imine (104d) (130 mg, 0.50 mmol) and 
ethyl acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 10/1→5/1) yielded 105da (120 mg, 67%) as a colorless solid.  
M.p. = 79–80 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.21 (d, J = 2.0 Hz, 1H), 7.15 (dd, J = 8.0, 2.0 Hz, 1H), 6.94 (d, 
J = 8.0 Hz, 1H), 6.58 (dd, J = 8.6, 2.0 Hz, 2H), 6.30 (dd, J = 8.6, 2.0 Hz, 2H), 4.15 (q, J = 7.1 Hz, 
2H), 3.72 (sbr, 1H), 3.70 (s, 3H), 3.27–3.16 (m, 2H), 3.06–2.95 (m, 1H), 1.74 (s, 3H), 1.25 (t, J 
= 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.2 (Cq), 154.8 (Cq), 144.7 (Cq), 142.9 (Cq), 138.1 (Cq), 
133.7 (Cq), 126.8 (CH), 125.1 (CH), 124.8 (CH), 123.5 (CH), 113.6 (CH), 67.2 (Cq), 60.6 (CH2), 
55.3 (CH3), 55.3 (CH), 32.8 (CH2), 28.0 (CH3), 14.1 (CH3).  
IR (neat): 2984, 1718, 1505, 1437, 1222, 1180, 1030, 823, 806, 567, 459 cm-1.  
MS (EI) m/z (relative intensity): 359 (15) [M+], 236 (40), 163 (90), 128 (75), 123 (100), 108 
(65).  
HR-MS (ESI) m/z calcd for C20H23ClNO3 [M + H




carboxylate (105ea): The representative procedure was followed using 1-(4-bromophenyl)-N- 
(4-methoxyphenyl)ethan-1-imine (104e) (152 mg, 0.50 mmol) and ethyl acrylate (38a) (107 




105ea (137 mg, 68%) as a colorless solid.  
M.p. = 65–66 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.37 (s, 1H), 7.30 (d, J = 8.2 Hz, 1H), 6.88 (dd, J = 8.2, 1.5 Hz, 
1H), 6.58 (dd, J = 8.8, 1.7 Hz, 2H), 6.31 (dd, J = 8.8, 1.7 Hz, 2H), 4.14 (q, J = 7.1 Hz, 2H), 3.71 
(sbr, 1H), 3.69 (s, 3H), 3.27–3.17 (m, 2H), 3.06–2.95 (m, 1H), 1.73 (s, 3H), 1.25 (t, J = 7.1 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.1 (Cq), 154.8 (Cq), 145.2 (Cq), 143.3 (Cq), 138.0 (Cq), 
129.6 (CH), 127.8 (CH), 125.5 (CH), 123.5 (CH), 121.8 (Cq), 113.6 (CH), 67.3 (Cq), 60.6 (CH2), 
55.3 (CH3), 55.2 (CH), 32.8 (CH2), 27.9 (CH3), 14.1 (CH3).  
IR (neat): 2985, 1718, 1504, 1221, 1179, 1030, 824, 697, 454 cm-1.  
MS (EI) m/z (relative intensity): 405 (8) [M+] (81Br), 403 (10) [M+] (79Br), 282 (30) (81Br), 280 
(30) (79Br), 209 (45) (81Br), 207 (45) (79Br), 128 (100), 123 (85).  
HR-MS (ESI) m/z calcd for C20H23BrNO3 [M + H




carboxylate (105fa): The representative procedure was followed using 
1-([1,1'-biphenyl]-4-yl)-N-(4-methoxyphenyl)ethan-1-imine (104f) (151 mg, 0.50 mmol) and 
ethyl acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 10/1→5/1) yielded 105fa (151 mg, 75%) as a colorless oil.  
1
H-NMR (400 MHz, CDCl3) δ = 7.63–7.60 (m, 2H), 7.48–7.42 (m, 4H), 7.37–7.33 (m, 1H), 
7.14 (dd, J = 7.8, 0.6 Hz, 1H), 6.59 (dd, J = 9.0, 2.3 Hz, 2H), 6.37 (dd, J = 9.0, 2.3 Hz, 2H), 
4.23–4.10 (m, 2H), 3.81 (sbr, 1H), 3.70 (s, 3H), 3.34–3.27 (m, 2H), 3.14–3.07 (m, 1H), 1.82 (s, 
3H), 1.28 (t, J = 7.1 Hz, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 172.6 (Cq), 154.6 (Cq), 145.3 (Cq), 141.7 (Cq), 141.3 (Cq), 
141.0 (Cq), 138.5 (Cq), 128.7 (CH), 127.2 (CH), 127.1 (CH), 125.7 (CH), 124.2 (CH), 123.3 
(CH), 123.2 (CH), 113.5 (CH), 67.5 (Cq), 60.5 (CH2), 55.5 (CH3), 55.3 (CH), 33.1 (CH2), 28.1 
(CH3), 14.2 (CH3).  
IR (neat): 2976, 1720, 1507, 1227, 1182, 1034, 827, 762, 696 cm-1.  
MS (EI) m/z (relative intensity): 401 (5) [M+], 278 (70), 205 (100), 123 (30), 108 (30).  
HR-MS (ESI) m/z calcd for C26H27NO3 [M








Ethyl 1-ethyl-1-[(4-methoxyphenyl)amino]-2,3-dihydro-1H-indene-2-carboxylate (105ga): 
The representative procedure was followed using 
N-(4-methoxyphenyl)-1-phenylpropan-1-imine (104g) (120 mg, 0.50 mmol) and ethyl 
acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
10/1→5/1) yielded 105ga (144 mg, 85%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.29–7.16 (m, 3H), 7.06 (d, J = 7.7 Hz, 1H), 6.56 (d, J = 8.8 
Hz, 2H), 6.28 (d, J = 8.8 Hz, 2H), 4.05 (q, J = 7.1 Hz, 2H), 3.91 (sbr, 1H), 3.68 (s, 3H), 
3.44–3.36 (m, 1H), 3.30–3.22 (m, 1H), 3.08 (dd, J = 16.2, 8.7 Hz, 1H), 2.28–2.08 (m, 2H), 1.19 
(t, J = 7.1 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 173.0 (Cq), 153.9 (Cq), 143.9 (Cq), 141.8 (Cq), 138.5 (Cq), 
128.1 (CH), 126.4 (CH), 124.6 (CH), 124.4 (CH), 121.7 (CH), 113.5 (CH), 71.8 (Cq), 60.4 
(CH2), 55.3 (CH3), 50.7 (CH), 33.3 (CH2), 31.9 (CH2), 14.0 (CH3), 8.8 (CH3).  
IR (neat): 2967, 1720, 1507, 1233, 1179, 1036, 756 cm-1.  
MS (EI) m/z (relative intensity): 339 (35) [M+], 310 (25), 143 (90), 123 (100).  
HR-MS (ESI) m/z calcd for C21H25NO3 [M




(105ha): The representative procedure was followed using 
N-(4-methoxyphenyl)-1,1-diphenylmethanimine (104h) (144 mg, 0.50 mmol) and ethyl 
acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
10/1→5/1) yielded 105ha (145 mg, 75%) as a colorless solid.  
M.p. = 117–118 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.58 (d, J = 8.0 Hz, 2H), 7.40–7.18 (m, 6H), 7.13–7.08 (m, 
1H), 6.58 (dd, J = 9.1, 1.0 Hz, 2H), 6.41 (dd, J = 9.0, 1.0 Hz, 2H), 4.77 (s, 1H), 4.17–3.99 (m, 
2H), 3.67 (s, 3H), 3.63–3.51 (m, 2H), 3.27 (dd, J = 15.8, 7.6 Hz, 1H), 1.13 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.6 (Cq), 152.7 (Cq), 145.2 (Cq), 143.8 (Cq), 141.2 (Cq), 
138.8 (Cq), 128.1 (CH), 128.0 (CH), 127.0 (CH), 127.0 (CH), 126.3 (CH), 125.5 (CH), 124.7 
(CH), 118.6 (CH), 113.8 (CH), 73.5 (Cq), 60.7 (CH2), 58.9 (CH2), 55.4 (CH), 34.2 (CH2), 13.9 
(CH3).  
IR (neat): 2926, 1717, 1508, 1225, 820, 751, 701, 523 cm-1.  
MS (EI) m/z (relative intensity): 387 (20) [M+], 265 (100), 191 (60), 123 (65), 115 (40).  
HR-MS (ESI) m/z calcd for C25H25NO3 [M







(105ia): The representative procedure was followed using 
1-cyclopropyl-N-(4-methoxyphenyl)-1-phenyl methanimine (104i) (126 mg, 0.50 mmol) and 
ethyl acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 20/1→5/1) yielded 105ia (154 mg, 87%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.30–7.16 (m, 4H), 6.57 (dd, J = 8.3, 1.3 Hz, 2H), 6.39 (dd, J 
= 8.3, 1.3 Hz, 2H), 4.17 (s, 1H), 4.02–3.83 (m, 2H), 3.68 (s, 3H), 3.35–3.22 (m, 2H), 3.12 (dd, 
J = 15.7, 8.3 Hz, 1H), 1.63–1.53 (m, 1H), 1.12 (t, J = 7.4 Hz, 3H), 0.59–0.41 (m, 3H), 0.28–0.20 
(m, 1H).  
13
C-NMR (75 MHz, CDCl3) δ = 173.2 (Cq), 153.0 (Cq), 143.5 (Cq), 141.8 (Cq), 139.3 (Cq), 
128.2 (CH), 126.3 (CH), 124.7 (CH), 124.5 (CH), 119.8 (CH), 113.6 (CH), 71.0 (Cq), 60.4 
(CH2), 55.3 (CH3), 53.4 (CH), 33.9 (CH2), 22.3 (CH), 13.9 (CH3), 1.9 (CH2), 1.4 (CH2).  
IR (neat): 2981, 1720, 1507, 1233, 1179, 1036, 821, 759 cm-1.  
MS (EI) m/z (relative intensity): 351 (10) [M+], 228 (30), 155 (100), 123 (55), 108 (45).  
HR-MS (ESI) m/z calcd for C22H26NO3 [M + H
+] 352.1913, found 352.1907. 
 
 
Ethyl 1,5-dimethyl-1-(phenylamino)-2,3-dihydro-1H-indene-2-carboxylate (105ja): The 
representative procedure was followed using N-phenyl-1-(p-tolyl)ethan-1-imine (104j) (105 
mg, 0.50 mmol) and ethyl acrylate (38a) (107 μL, 1.0 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 20/1→10/1) yielded 105ja (142 mg, 92%) as a colorless 
oil. 
1
H-NMR (400 MHz, CDCl3) δ = 7.25–7.06 (m, 3H), 7.03–6.98 (m, 2H), 6.76–6.72 (m, 1H), 
6.41–6.38 (m, 2H), 4.14 (s, 1H), 4.03 (dq, J = 7.1, 1.8 Hz, 2H), 3.37–3.30 (m, 2H), 3.12–3.05 
(m, 1H), 2.40 (s, 3H), 1.83 (s, 3H), 1.16 (t, J = 7.1 Hz, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 172.6 (Cq), 145.8 (Cq), 143.4 (Cq), 140.9 (Cq), 138.0 (Cq), 
128.3 (CH), 127.7 (CH), 125.3 (CH), 123.3 (CH), 119.4 (CH), 118.5 (CH), 67.2 (Cq), 60.4 
(CH2), 55.3 (CH), 33.3 (CH2), 29.8 (CH3), 21.3 (CH3), 13.9 (CH3).  
IR (neat): 2977, 1718, 1599, 1495, 1184, 1034, 748, 693 cm-1.  
MS (EI) m/z (relative intensity): 309 (5) [M+], 216 (40), 143 (100), 128 (55), 93 (45).  
HR-MS (ESI) m/z calcd for C20H23NO2 [M







(105ka): The representative procedure was followed using 
N-(4-fluorophenyl)-1-(p-tolyl)ethan-1-imine (104k) (114 mg, 0.50 mmol) and ethyl acrylate 
(38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 20/1→10/1) 
yielded 105ka (131 mg, 80%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.13–6.99 (m, 3H), 6.70 (td, J = 8.7, 1.4 Hz, 2H), 6.29 (ddd, J 
= 8.9, 4.7, 1.4 Hz, 2H), 4.11 (q, J = 7.2 Hz, 2H), 3.97 (s, 1H), 3.31–3.17 (m, 2H), 3.04 (dd, J = 
14.9, 7.6 Hz, 1H), 2.38 (s, 3H), 1.79 (s, 3H), 1.23 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.5 (Cq), 157.5 (
1JC-F = 240 Hz, Cq), 142.9 (Cq), 141.6 (
4JC-F 
= 2 Hz, Cq), 141.1 (Cq), 138.1 (Cq), 127.6 (CH), 125.3 (CH), 123.5 (CH), 121.5 (
3JC-F = 8 Hz, 
CH), 114.7 (2JC-F = 22 Hz, CH), 67.4 (Cq), 60.5 (CH2), 55.4 (CH), 33.2 (CH2), 29.0 (CH3), 21.4 
(CH3), 14.2 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = –(124.0–124.2) (m).  
IR (neat): 2977, 1719, 1505, 1212, 1186, 1035, 818 cm-1.  
MS (EI) m/z (relative intensity): 327 (10) [M+], 216 (65), 171 (20), 143 (100), 128 (75), 111 
(55).  
HR-MS (ESI) m/z calcd for C20H23FNO2 [M + H
+] 328.1713, found 328.1707. 
 
 
The representative procedure was followed using N-(4-methoxyphenyl) 
-1-(naphthalen-2-yl)ethan-1-imine (104l) (138 mg, 0.50 mmol) and ethyl acrylate (38a) (107 
μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 
105la and 105la’ (154 mg, 82%, 5:1) as a colorless oil.  
IR (neat): 2977, 1720, 1506, 1235, 1176, 1033, 828, 746, 477 cm-1.  
MS (EI) m/z (relative intensity): 375 (30) [M+], 253 (55), 179 (100), 165 (65), 123 (88), 108 
(15).  
HR-MS (ESI) m/z calcd for C24H25NO3 [M
+] 375.1834, found 375.1818. 
Ethyl 1-[(4-methoxyphenyl)amino]-1-methyl-2,3-dihydro-1H-cyclopenta[b]naphthalene 
-2-carboxylate (105la, major product):  
1
H-NMR (500 MHz, CDCl3) δ = 7.80 (d, J = 8.2 Hz, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.69 (s, 1H), 
7.47 (s, 1H), 7.46–7.39 (m, 2H), 6.59–6.56 (m, 2H), 6.39–6.36 (m, 2H), 4.24–4.12 (m, 2H), 
3.89 (sbr, 1H), 3.68 (s, 3H), 3.48–3.41 (m, 1H), 3.33 (dd, J = 9.1, 8.0 Hz, 1H), 3.23 (dd, J = 16.0, 





C-NMR (125 MHz, CDCl3) δ = 172.4 (Cq), 154.6 (Cq), 145.2 (Cq), 139.4 (Cq), 138.2 (Cq), 
133.6 (Cq), 132.5 (Cq), 128.1 (CH), 127.3 (CH), 125.6 (CH), 125.0 (CH), 123.7 (CH), 122.7 
(CH), 122.4 (CH), 113.5 (CH), 67.2 (Cq), 60.6 (CH2), 55.9 (CH3), 55.3 (CH), 32.9 (CH2), 27.5 
(CH3), 14.3 (CH3). 
 
Ethyl 3-[(4-methoxyphenyl)amino]-3-methyl-2,3-dihydro-1H-cyclopenta[a]naphthalene- 
2-carboxylate (105la’, minor product):  
1
H-NMR (500 MHz, CDCl3) δ = 7.89 (dd, J = 8.3, 1.3 Hz, 1H), 7.83 (d, J = 8.1 Hz, 1H), 7.74 (d, 
J = 8.4 Hz, 1H), 7.56–7.48 (m, 2H), 7.28 (d, J = 8.4 Hz, 1H), 6.51–6.47 (m, 2H), 6.29–6.22 (m, 
2H), 4.24–4.12 (m, 2H), 3.89 (sbr, 1H), 3.64 (s, 3H), 3.53–3.41 (m, 3H), 1.88 (s, 3H), 1.28 (t, J 
= 7.1 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 172.4 (Cq), 154.1 (Cq), 142.9 (Cq), 138.6 (Cq), 136.9 (Cq), 
133.5 (Cq), 129.9 (Cq), 128.3 (CH), 127.4 (CH), 126.1 (CH), 125.6 (CH), 124.3 (CH), 122.2 
(CH), 121.9 (CH), 113.5 (CH), 68.7 (Cq), 60.6 (CH2), 55.3 (CH3), 54.9 (CH), 31.5 (CH2), 29.5 
(CH3), 14.2 (CH3). 
 
 
The representative procedure was followed using N-(4-methoxyphenyl)-1-(m-tolyl) 
ethan-1-imine (104m) (120 mg, 0.50 mmol) and ethyl acrylate (38a) (107 μL, 1.0 mmol). 
Isolation by column chromatography (n-hexane/EtOAc: 10/1→5/1) yielded 105ma and 105ma’ 
(126 mg, 74%, 4:1) as a colorless solid.  
M.p. = 63–64 °C.  
IR (neat): 2977, 1720, 1507, 1231, 1171, 1035, 812, 449 cm-1.  
MS (EI) m/z (relative intensity): 339 (20) [M+], 217 (25), 143 (65), 123 (100), 108 (15).  
HR-MS (ESI) m/z calcd for C21H25NO3 [M





H-NMR (300 MHz, CDCl3) δ = 7.12–7.10 (m, 2H), 6.96 (s, 1H), 6.58 (dd, J = 8.9, 1.7 Hz, 2H), 
6.29 (dd, J = 8.9, 1.7 Hz, 2H), 4.14 (q, J = 7.2 Hz, 2H), 3.82 (s, 1H), 3.70 (s, 3H), 3.25 (dd, J = 
8.5, 8.8 Hz, 1H), 3.16–2.96 (m, 2H), 2.34 (s, 3H), 1.79 (s, 3H), 1.25 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.7 (Cq), 154.4 (Cq), 146.2 (Cq), 138.5 (Cq), 138.1 (Cq), 
136.2 (Cq), 129.0 (CH), 124.4 (CH), 124.3 (CH), 122.7 (CH), 113.4 (CH), 67.6 (Cq), 60.4 (CH2), 








H-NMR (300 MHz, CDCl3) δ = 7.16–7.08 (m, 2H), 6.94 (d, J = 7.4 Hz, 1H), 6.58 (dd, J = 8.9, 
1.7 Hz, 2H), 6.29 (dd, J = 8.9, 1.7 Hz, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.82 (s, 1H), 3.70 (s, 3H), 
3.25 (dd, J = 8.5, 8.8 Hz, 1H), 3.16–2.96 (m, 2H), 2.28 (s, 3H), 1.78 (s, 3H), 1.27 (t, J = 7.2 Hz, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.7 (Cq), 154.5 (Cq), 145.8 (Cq), 139.8 (Cq), 138.3 (Cq), 
133.9 (Cq), 128.8 (CH), 126.7 (CH), 123.1 (CH), 121.3 (CH), 113.4 (CH), 68.0 (Cq), 60.5 (CH2), 




dioxole-7-carboxylate (105na): The representative procedure was followed using 
1-(benzo[d][1,3]dioxol-5-yl)-N-(4-methoxyphenyl)ethan-1-imine (104n) (135 mg, 0.50 mmol) 
and ethyl acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 20/1→10/1) yielded 105na (147 mg, 80%) as a colorless solid. 
M.p. = 85–86 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 6.67 (d, J = 7.9 Hz, 1H), 6.59 (dd, J = 8.2, 2.3 Hz, 2H), 6.52 (d, 
J = 7.9 Hz, 1H), 6.33 (dd, J = 8.2, 2.3 Hz, 2H), 5.98 (d, J = 11 Hz, 1H), 5.97 (d, J = 11 Hz, 1H), 
4.15 (q, J = 7.1 Hz, 2H), 3.73 (sbr, 1H), 3.70 (s, 3H), 3.25 (t, J = 8.8 Hz, 1H), 3.15–2.97 (m, 2H), 
1.73 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.3 (Cq), 154.6 (Cq), 147.4 (Cq), 142.9 (Cq), 141.5 (Cq), 
138.3 (Cq), 123.4 (CH), 121.7 (Cq), 116.7 (CH), 113.5 (CH), 106.9 (CH), 101.0 (CH2), 67.4 
(Cq), 60.5 (CH2), 55.9 (CH3), 55.2 (CH), 28.8 (CH2), 28.1 (CH3), 14.1 (CH3).  
IR (neat): 2976, 1721, 1508, 1462, 1233, 1035, 823, 513 cm-1.  
MS (EI) m/z (relative intensity): 369 (20) [M+], 247 (75), 173 (100), 143 (40), 123 (70), 108 
(55), 80 (30).  
HR-MS (ESI) m/z calcd for C21H23NO5 [M




2-carboxylate (105oa): The representative procedure was followed using 




ethyl acrylate (38a) (107 μL, 1.0 mmol) and Mn2(CO)10 (19.6 mg, 10 mol %). Isolation by 
column chromatography (n-hexane/EtOAc: 20/1→5/1) yielded 105oa (154 mg, 73%) as a 
colorless solid.  
M.p. = 141–142 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.54–7.49 (m, 2H), 7.08–6.95 (m, 4H), 6.80–6.74 (m, 1H), 
6.58 (dd, J = 9.0, 1.1 Hz, 2H), 6.37 (dd, J = 9.0, 1.1 Hz, 2H), 4.66 (sbr, 1H), 4.20–4.01 (m, 2H), 
3.66 (s, 3H), 3.65–3.48 (m, 2H), 3.25–3.13 (m, 1H), 1.15 (t, J = 7.2 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 172.0 (Cq), 162.7 (
1JC-F = 246 Hz, Cq), 162.0 (
1JC-F = 246 Hz, 
Cq), 153.0 (Cq), 143.5 (
3JC-F = 8 Hz, Cq), 140.6 (
4JC-F = 3 Hz, Cq), 139.4 (
4JC-F = 3 Hz, Cq), 138.6 
(Cq), 128.9 (
3JC-F = 8 Hz, CH), 126.6 (
3JC-F = 9 Hz, CH), 119.0 (CH), 115.0 (
2JC-F = 22 Hz, CH), 
113.9 (CH), 113.3 (2JC-F = 23 Hz, CH), 112.9 (
2JC-F = 23 Hz, CH), 72.4 (Cq), 60.9 (CH2), 59.7 
(CH3), 55.4 (CH), 33.8 (
4JC-F = 2 Hz, CH2), 14.0 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = –(114.2–114.3) (m), –(115.6–115.8) (m).  
IR (neat): 3359, 1718, 1511, 1241, 1180, 1037, 810, 574, 475 cm-1.  
MS (EI) m/z (relative intensity): 423 (10) [M+], 300 (45), 227 (100), 201 (25), 123 (35), 108 
(30).  
HR-MS (ESI) m/z calcd for C25H23F2NO3 [M




xylate (105pa): The representative procedure was followed using 
N-(4-methoxyphenyl)-1,1-di-p-tolylmethanimine (104p) (158 mg, 0.50 mmol) and ethyl 
acrylate (38a) (107 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
20/1→5/1) yielded 105pa (149 mg, 72%) as a colorless solid.  
M.p. = 118–119 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.46 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 7.9 Hz, 2H), 7.11–7.09 
(m, 2H), 6.93 (d, J = 7.8 Hz, 1H), 6.59 (dd, J = 9.0, 2.2 Hz, 2H), 6.42 (dd, J = 9.0, 2.2 Hz, 2H), 
4.74 (sbr, 1H), 4.14–4.04 (m, 2H), 3.67 (s, 3H), 3.63 (dd, J = 8.4, 7.8 Hz, 1H), 3.52 (dd, J = 16.0, 
8.4 Hz, 1H), 3.22 (dd, J = 16.0, 7.8 Hz, 1H), 2.39 (s, 3H), 2.32 (s, 3H), 1.14 (t, J = 7.1 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 172.6 (Cq), 152.3 (Cq), 142.6 (Cq), 141.1 (Cq), 141.0 (Cq), 
139.1 (Cq), 137.5 (Cq), 136.3 (Cq), 128.7 (CH), 127.0 (CH), 126.8 (CH), 125.2 (CH), 125.1 
(CH), 118.2 (CH), 113.7 (CH), 72.9 (Cq), 60.6 (CH2), 59.1 (CH3), 55.4 (CH), 34.1 (CH2), 21.2 
(CH3), 21.0 (CH3), 14.1 (CH3).  
IR (neat): 2984, 1711, 1510, 1229, 1183, 1037, 823, 809, 528 cm-1.  




HR-MS (ESI) m/zcalcd for C27H29NO3 [M
+] 415.2147, found 415.2135. 
 
Intramolecular Competition Experiment of 104q 
 
N-[(4-Fluorophenyl)(p-tolyl)methylene]-4-methoxyaniline (104q) (160 mg, 0.5 mmol), ethyl 
acrylate (38a) (107 μL, 1.0 mmol), Mn2(CO)10 (9.8 mg, 5.0 mol %) and DCE (1.0 mL) were 
placed in a 25 mL Schlenk tube under N2 and then stirred at 120 °C for 18 h. At ambient 
temperature, the crude GC-MS was measured to obtain the product ratio of 52:48. Then, the 
reaction mixture was transferred into a round bottom flask with EtOAc (20 mL) and 
concentrated under reduced pressure, purified by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1→5/1) to afford the mixture of products 105qa and 105qa’ (160 mg, 
76%). 
1
H-NMR (300 MHz, CDCl3) δ = 7.53–7.49 (m, 2H), 7.43–7.39 (m, 2H), 7.18–7.14 (m, 2H), 
7.10–6.88 (m, 7H), 6.80–6.73 (m, 1H), 6.59–6.53 (m, 4H), 6.40–6.34 (m, 4H), 4.68 (s, 2H), 
4.17–3.98 (m, 4H), 3.69–3.41 (m, 10H), 3.24–3.12 (m, 2H), 2.37 (s, 3H), 2.30 (s, 3H), 1.13 (t, J 
= 7.1 Hz, 6H).  
13
C-NMR (125 MHz, CDCl3) δ = 172.3 (Cq), 172.2 (Cq), 162.6 (
1J C-F = 244 Hz, Cq), 161.8 (
1J 
C-F = 245 Hz, Cq), 152.7 (Cq), 152.6 (Cq), 143.3 (
3J C-F = 8 Hz, Cq), 142.0 (Cq), 141.2 (Cq), 141.1 
(4J C-F = 2 Hz, Cq), 140.8 (Cq), 139.6 (
4J C-F = 3 Hz, Cq), 138.8 (
3J C-F = 8 Hz, Cq), 137.8 (Cq), 
136.6 (Cq), 128.9 (CH), 128.8 (
3J C-F = 8 Hz, CH), 127.1 (CH), 126.8 (CH), 126.5 (
3J C-F = 8 Hz, 
CH), 125.4 (CH), 125.1 (CH), 118.7 (CH), 118.4 (CH), 114.8 (2J C-F = 22 Hz, CH), 113.8 (CH), 
113.3 (2J C-F = 22 Hz, CH), 111.6 (
2J C-F = 22 Hz, CH), 72.7 (Cq), 72.6 (Cq), 60.8 (CH2), 60.7 
(CH2), 59.6 (CH3), 59.2 (CH3), 55.5 (CH), 55.4 (CH), 34.1 (CH2), 34.0 (CH2), 21.3 (CH3), 21.1 
(CH3), 14.1 (CH3), 14.1 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = – (114.6–114.7) (m), – (116.0–116.1) (m).  
IR (neat): 3369, 3306, 1712, 1509, 1240, 1179, 1032, 818, 526 cm-1.  
MS (EI) m/z (relative intensity): 419 (10) [M+], 297 (100), 224 (55), 209 (30), 123 (35).  
HR-MS (ESI) m/zcalcd for C26H26FNO3 [M










Intermolecular Competition Experiment between 104a and 104c 
 
(E)-4-Methoxy-N-[1-(p-tolyl)ethylidene]aniline (104a) (120 mg, 0.5 mmol), 
(E)-N-[1-(4-fluorophenyl)ethylidene]-4-methoxyaniline (104c) (122 mg, 0.5 mmol), ethyl 
acrylate (38a) (54 μL, 0.5 mmol), Mn2(CO)10 (9.8 mg, 5.0 mol %) and toluene (2.0 mL) were 
placed in a 25 mL Schlenk tube under N2 and were then stirred at 120 °C for 18 h. At ambient 
temperature, the reaction mixture was transferred into a round bottom flask with EtOAc (20 
mL) and concentrated under reduced pressure, purified by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1→5/1) to afford the products 105aa (95 mg, 56%) and 105ca (69 
mg, 40%). 
Intermolecular Competition Experiment between 104m and 104r 
 
(E)-N-(4-methoxyphenyl)-1-(m-tolyl)ethan-1-imine (104m) (120 mg, 0.5 mmol), 
(E)-1-(3-fluorophenyl)-N-(4-methoxyphenyl)ethan-1-imine (104r) (122 mg, 0.5 mmol), ethyl 
acrylate (38a) (54 μL, 0.5 mmol), Mn2(CO)10 (9.8 mg, 5.0 mol %) and toluene (2.0 mL) were 
placed in a 25 mL Schlenk tube under N2 and were then stirred at 120 °C for 18 h. At ambient 
temperature, the crude GC was measured to obtain the GC conversion of the products 
(105ma+105ma’) [44%, (4:1)] and (105ra+105ra’) [56%, (5:1)], the ratio of 




ate (105ra):  
1
H-NMR (300 MHz, CDCl3) δ = 7.22–7.15 (m, 1H), 6.97 (dd, J = 8.9, 8.4 Hz, 1H), 6.86 (d, J = 
7.5 Hz, 1H), 6.64–6.55 (m, 2H), 6.39–6.25 (m, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.78 (sbr, 1H), 3.71 





C-NMR (75 MHz, CDCl3) δ = 172.2 (Cq), 159.5 (
1JC–F = 244 Hz, Cq), 154.8 (Cq), 149.8 (
3JC–F 
= 6 Hz, Cq), 138.2 (Cq), 128.6 (
3JC–F = 7 Hz, CH), 127.4 (
2JC–F = 19 Hz, Cq), 123.4 (CH), 119.7 
(4JC–F = 3 Hz, CH), 114.5 (
2JC–F = 21 Hz, CH), 113.7 (CH), 68.1 (
4JC–F = 2 Hz, Cq), 60.7 (CH2), 
55.4 (CH3), 55.3 (
4JC–F = 1 Hz, CH), 29.0 (CH2), 28.2 (CH3), 14.2 (CH3).  
19
F-NMR (283 MHz, CDCl3) δ = –(118.3–114.4) (m).  
IR (neat): 2988, 1722, 1508, 1238, 905, 725 cm-1.  
MS (EI) m/z (relative intensity): 343 (30) [M+], 221 (10), 149 (50), 123 (100), 108 (30). 
HR-MS (ESI) m/z calcd for C20H22FNO3 [M
+] 343.1584, found 343.1591. 
 
Manganese-Catalyzed H/D Exchange Experiment 
 
(E)-4-Methoxy-N-[1-(p-tolyl)ethylidene]aniline (104a) (120 mg, 0.5 mmol), ethyl acrylate 
(38a) (107 μL, 1.0 mmol), Mn2(CO)10 (9.8 mg, 5.0 mol %), toluene (0.9 mL) and D2O (0.1 mL) 
were placed in a 25 mL Schlenk tube under N2 and were then stirred at 120 °C for 3 h. At 
ambient temperature, 1 M HCl (5.0 mL) was added and the mixture was stirred at ambient 
temperature for 20 min. The reaction mixture was diluted with H2O (10 mL) and extracted 
with EtOAc (3 x 15 mL). The combined organic layer was dried with Na2SO4 and 
concentrated under reduced pressure. Purification by column chromatography on silica gel 


















To a solution of 1-(2-bromophenyl)ethanone (10 mmol) in toluene (100 mL) was added 
ethane-1,2-diol (20 mmol) and para-toluenesulfonic acid monohydrate (2.0 mol %). The 
resulting mixture was stirred at 130 °C for 18 h using a Dean-Stark apparatus, and then cooled 
to ambient temperature and quenched by the addition of saturated NaHCO3 solution (10 mL). 
The mixture was extracted with Et2O (3 × 25 mL) and the combined organic phase was dried 
over Na2SO4, and filtered. After concentration under reduced pressure, purification by column 
chromatography on silica gel (n-hexane/EtOAc: 20/1) afforded 
2-(2-bromophenyl)-2-methyl-1,3-dioxolane (2.06 g, 85 %) as a colorless oil. 
To a solution of 2-(2-bromophenyl)-2-methyl-1,3-dioxolane (1.95 g, 8.0 mmol) in Et2O (15 mL) 
was slowly added a solution of nBuLi in hexane (3.5 mL, 8.8 mmol, 2.5 M) at −78 ºC. The 
mixture was stirred at the same temperature for 1 h and then CD3OD (1.0 mL) was added. The 
reaction mixture was allowed to warm to 0 ºC and stirred for 1.5 h. Then the mixture was 
diluted with H2O (15 mL) and diethyl ether (15 mL). The organic phase was separated and HCl 
(3 N, 15 mL) was added. The resulting mixture was vigorously stirred for 12 h and the organic 
phase was separated, which was then washed with brine (10 mL) and dried over Na2SO4. The 
solvents were evaporated and the residue was purified by column chromatography on silica gel 
(n-hexane/EtOAc: 20/1) to afford [D]1-acetophenone (806 mg, 83 %) as a colorless oil. 







[D]6-Benzene (1.2 ml, 12.8mmol), AlCl3 (2.14 g, 16mmol), and anhydrous CS2 (3.0 mL) were 
added to a 25-mL flask under N2 atmosphere. To the mixture was dropwise added a solution 
of acetyl chloride (1.26 g, 16 mmol) in anhydrous CS2 (5.0 mL) at 0 °C. The resulting mixture 
was allowed to warm to ambient temperature and was stirred for 5 h. Then the mixture was 
heated to 50 °C for 3 h. After cooling to ambient temperature, the resulting mixture was 
poured into ice water and extracted with CH2Cl2 (3 × 30 mL). The organic layer was washed 




After concentration under reduced pressure, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 20/1) afforded [D]5-acetophenone (1.39 g, 87 %) as colorless oil. 
The compound [D]5-104b was synthesized from [D]5-acetophenone according to previously 
described methods.[115b] 
 
Kinetic Isotope Effect 
 
[D]1-4-Methoxy-N-[1-(p-tolyl)ethylidene]aniline ([D]1-104b) (226 mg, 1.0 mmol), ethyl 
acrylate (38a) (214 μL, 2.0 mmol), Mn2(CO)10 (19.6 mg, 5.0 mol %) and toluene (3.0 mL) 
were placed in a 25 mL Schlenk tube under N2, and then stirred at 120 °C for 3 h. At ambient 
temperature, the reaction mixture was transferred into a round flask with EtOAc and 
concentrated under reduced pressure, purified by column chromatography on silica gel 
(n-hexane/EtOAc: 10/1→5/1) to afford the [D]n-105ba (77 mg, 24%). The kinetic isotope 









KIE Determined by GC 
 
Two parallel reactions of 38a with 104b and [D]5-104b respectively were performed to 
determine the corresponding KIE value. 104b (225 mg, 1.0mmol) or [D]5-104b (230 mg, 1.0 
mmol), ethyl acrylate (38a) (214 μL, 2.0 mmol), Mn2(CO)10 (19.6 mg, 5.0 mol %), 
1,3,5-trimethoxybenzene (168 mg, 1.0 mmol) and toluene (3.0 mL) were placed in a 25 mL 
Schlenk tube. The mixture was stirred at 120 °C, a periodic aliquot (0.05 mL) was taking out 
by syringe and analyzed by GC to provide the following conversions: 
 
Time (min) 30 60 80 100 120 140 160 180 
105ba 19 35 44 50 59 64 69 76 
[D]4-105ba 5 11 15 17 19 22 24 26 
 
 
KIE Determined by in situ react IR 
 
Two parallel reactions of 38a with 104b and [D]5-104b, respectively, were performed to 
determine the corresponding KIE value. 104b (225 mg, 1.0mmol) or [D]5-104b (230mg, 1.0 
mmol), ethyl acrylate (38a) (214 μL, 2.0 mmol), Mn2(CO)10 (19.6 mg, 5.0 mol %), and toluene 
(3.0 mL) were placed in a 25 mL Schlenk tube, which was then equipped with the in situ react 
y = 0.3669x + 12.098 



































IR under N2. The mixture was stirred at 120 °C. The reaction rate was followed by integration 
of a vibrational band at 1350−1335 cm-1. The kinetic isotope effect of this reaction was 
determined to be kH/kD ≈ 2.1. 
 
Diversification of Product 105aa 
 
Reaction a: A solution of 105aa (85 mg, 0.25 mmol) in MeCN (8 mL) was added dropwise 
within 10 min to a solution of CAN (343 mg, 2.5 equiv) in H2O (8 mL) at 0 °C. After 3 h stirring 
at ambient temperature, the reaction mixture was basified with NaOH (1 N) to pH = 12. Then 
the solution was extracted with CH2Cl2 (3 × 10 mL). The combined organic phases were 
acidified with HCl (1 N) until pH = 2, and then washed by HCl (1 N, 3 × 10 mL). The aqueous 
phase was basified with Na2CO3 solid to pH = 12, and then extracted with CH2Cl2 (4 × 10 mL). 
The combined organic phases were then dried over Na2SO4, and the solvent was removed 






Ethyl 1-amino-1,5-dimethyl-2,3-dihydro-1H-indene-2-carboxylate (120):  
1
H-NMR (300 MHz, CDCl3) δ = 7.15 (d, J = 8.3 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 7.02 (s, 1H) 
4.27–4.17 (m, 2H), 3.36 (dd, J = 15.8, 8.8 Hz, 2H), 3.15 (dd, J = 8.8, 8.1 Hz, 1H), 2.97 (dd, J = 
15.8, 8.1 Hz, 1H), 2.32 (s, 3H), 1.69 (sbr, 2H), 1.64 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 172.7 (Cq), 145.7 (Cq), 140.2 (Cq), 137.6 (Cq), 127.8 (CH), 
125.3 (CH), 121.9 (CH), 63.0 (Cq), 60.5 (CH2), 56.3 (CH), 32.4 (CH2), 28.6 (CH3), 21.3 (CH3), 
14.5 (CH3).  
IR (neat): 2975, 1725, 1371, 1191, 1158, 1034, 815 cm-1.  
MS (EI) m/z (relative intensity): 233 (15) [M+], 218 (100), 158 (30), 145 (85), 128 (30), 115 
(20).  
HR-MS (ESI) m/z calcd for C14H19NO2 [M
+] 233.1416, found 233.1424. 
 
Reaction b: 105aa (85 mg, 0.25 mmol) and toluene (0.5 mL) were placed in a 25 mL sealed 
tube under N2 and then stirred at 160 °C for 14 h. At ambient temperature, the reaction 
mixture was transferred into a round bottom flask with EtOAc (20 mL) and concentrated 
under reduced pressure, purified by column chromatography on silica gel (n-hexane/EtOAc: 
50/1) to afford the product 121 (45 mg, 83%) as colorless oil. 
 
 
Ethyl 3,6-dimethyl-1H-indene-2-carboxylate (121):  
1
H-NMR (300 MHz, CDCl3) δ = 7.38 (d, J = 7.8 Hz, 1H), 7.29 (s, 1H), 7.18 (d, J = 7.8 Hz, 1H), 
4.30 (q, J = 7.2 Hz, 2H), 3.62 (q, J = 2.5 Hz, 2H), 2.54 (t, J = 2.5 Hz, 3H), 2.43 (s, 3H), 1.37 (t, 
J = 7.2 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 165.9 (Cq), 151.3 (Cq), 143.7 (Cq), 142.7 (Cq), 137.6 (Cq), 
128.7 (Cq), 127.3 (CH), 124.6 (CH), 120.7 (CH), 59.8 (CH2), 38.5 (CH2), 21.7 (CH3), 14.5 
(CH3), 12.5 (CH3).  
IR (neat): 2980, 1696, 1253, 1197, 1051, 812, 755 cm-1.  
MS (EI) m/z (relative intensity): 216 (50) [M+], 171 (23), 143 (100), 128 (65), 115 (23).  
HR-MS (ESI) m/z calcd for C14H16O2 [M
+] 216.1150, found 216.1150.  




Reaction c: A solution of LiHMDS (1.5 equiv, 0.38 mL, 1 N in THF) was slowly added to a 
solution of 105aa (85 mg, 0.25 mmol) in THF (3 mL) at 0 °C. The mixture was stirred for 1 h at 




mixture was extracted with CH2Cl2 (3 × 10 mL) and the combined organic phases were dried 
over Na2SO4 and filtered. The solvent was removed in vacuo. Purification by column 
chromatography on silica gel (n-hexane/EtOAc: 10/1→1/1) afforded product 122 (63 mg, 






H-NMR (300 MHz, CDCl3) δ = 7.42 (d, J = 8.8 Hz, 2H), 7.35 (d, J = 7.8 Hz, 1H), 7.07 (s, 1H), 
7.03 (d, J = 7.8 Hz, 1H), 6.82 (d, J = 8.8 Hz, 2H), 3.74 (s, 3H), 3.69 (d, J = 10.2 Hz, 1H), 3.33 (d, 
J = 17.4 Hz, 1H), 3.09 (dd, J = 17.3, 10.2 Hz, 1H), 2.31 (s, 3H), 1.96 (s, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 167.1 (Cq), 156.1 (Cq), 144.4 (Cq), 139.0 (Cq), 138.5 (Cq), 
130.4 (Cq), 127.5 (CH), 127.0 (CH), 124.1 (CH), 119.7 (CH), 114.2 (CH), 71.8 (Cq), 59.4 (CH3), 
55.4 (CH), 29.9 (CH2), 21.4 (CH3), 20.5 (CH3).  
IR (neat): 2926, 1726, 1507, 1368, 1238, 1029, 824, 518 cm-1.  
MS (EI) m/z (relative intensity): 293 (8) [M+], 145 (45), 144 (100), 129 (95), 128 (58), 78 (13).  
HR-MS (ESI) m/z calcd for C19H19NO2 [M
+] 293.1416, found 293.1426. 
4.6 Manganese(I)-Catalyzed C–H Aminocarbonylation of Heteroarenes 
Characterization Data of Products 107 and 124 
 
N-Phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107aa): The representative procedure 
was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), isocyanatobenzene 
(106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column chromatography 
(n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107aa (149 mg, 95%) as a white 
solid. The reaction using nBu2O instead of Et2O yielded 107aa (142 mg, 91%).  
M.p. = 176–177 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 9.32 (s, 1H), 8.54 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 7.87 (td, J = 
7.7, 1.9 Hz, 1H), 7.51–7.41 (m, 3H), 7.36–7.26 (m, 3H), 7.25–7.13 (m, 3H), 7.07–6.99 (m, 2H), 
6.98 (s, 1H).  
13
C-NMR (125 MHz, CDCl3) δ = 160.0 (Cq), 151.2 (Cq), 149.1 (CH), 138.6 (Cq), 138.5 (CH), 
137.9 (Cq), 133.7 (Cq), 128.7 (CH), 126.8 (Cq), 125.0 (CH), 124.2 (CH), 122.5 (CH), 122.0 




IR (neat): 3242, 1661, 1593, 1542, 1470, 1435, 1308, 1218, 739, 688, 508 cm-1.  
MS (EI) m/z (relative intensity): 313 (5) [M+], 221 (100), 192 (20).  
HR-MS (EI) m/z calcd for C20H15N3O [M
+] 313.1215, found 313.1221. 
 
 
N-(4-Fluorophenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ab): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-fluoro-4-isocyanatobenzene (106b) (76 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation 
by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 
107ab (152 mg, 92%) as a white solid. The reaction using nBu2O instead of Et2O yielded 
107ab (136 mg, 82%).  
M.p. = 197–198 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 9.55 (s, 1H), 8.51 (dd, J = 5.1, 1.8 Hz, 1H), 7.91 (dt, J = 7.7, 
1.9 Hz, 1H), 7.51 (d, J = 8.0 Hz, 1H), 7.45–7.13 (m, 6H), 7.00 (dt, J = 7.4, 1.1 Hz, 1H), 6.95 (s, 
1H), 6.89–6.83 (m, 2H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.4 (Cq), 158.1 (
1JC–F = 240 Hz, Cq), 150.9 (Cq), 148.8 
(CH), 138.5 (CH), 137.8 (Cq), 135.3 (
4JC–F = 3 Hz, Cq), 133.5 (Cq), 126.4 (Cq), 124.9 (CH), 
122.4 (CH), 122.0 (CH), 121.6 (3JC–F = 7 Hz, CH), 121.5 (CH), 120.6 (CH), 115.1 (
2JC–F = 20 Hz, 
CH), 111.2 (CH), 108.3 (CH).  
19
F-NMR (283 MHz, DMSO-d6) δ = –(118.9–119.0) (m).  
IR (neat): 3184, 1662, 1569, 1541, 1502, 1469, 1201, 888, 734, 711, 513 cm-1.  
MS (EI) m/z (relative intensity): 331 (5) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C20H14FN3O [M
+] 331.1121, found 331.1121. 
 
 
1-(Pyridin-2-yl)-N-(p-tolyl)-1H-indole-2-carboxamide (107ac): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
1-isocyanato-4-methylbenzene (106c) (74 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by 
column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ac 
(113 mg, 69%) as a white solid.  
M.p. = 192–193 °C.  
1
H-NMR (300 MHz, DMSO-d6) δ = 10.49 (s, 1H), 8.63–8.47 (m, 1H), 7.98 (td, J = 7.7, 2.0 Hz, 
1H), 7.77 (d, J = 7.8 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 7.55–7.35 (m, 4H), 7.29 (t, J = 7.5 Hz, 





C-NMR (125 MHz, DMSO-d6) δ = 159.3 (Cq), 150.9 (Cq), 148.7 (CH), 138.4 (CH), 137.8 
(Cq), 136.4 (Cq), 133.8 (Cq), 132.4 (Cq), 128.9 (CH), 126.5 (Cq), 124.8 (CH), 122.3 (CH), 121.9 
(CH), 121.5 (CH), 120.6 (CH), 119.8 (CH), 111.1 (CH), 108.1 (CH), 20.4 (CH3).  
IR (neat): 3017, 1659, 1591, 1534, 1470, 1442, 1307, 801, 737, 511 cm-1.  
MS (EI) m/z (relative intensity): 327 (8) [M+], 221 (100), 192 (18), 98 (18).  
HR-MS (EI) m/z calcd for C21H17N3O [M
+] 327.1372, found 327.1358. 
 
 
N-(4-Methoxyphenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ad): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-isocyanato-4-methoxybenzene (106d) (82 mg, 0.55 mmol) and Et2O (1.0 mL). 
Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 107ad (162 mg, 94%) as a white solid.  
M.p. = 164–165 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 9.34 (s, 1H), 8.51 (dd, J = 4.9, 1.8 Hz, 1H), 7.87 (ddd, J = 7.7, 
7.8, 1.9 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.38–7.14 (m, 6H), 7.01 (dd, J = 7.3, 7.1 Hz, 1H), 
6.92 (s, 1H), 6.70 (d, J = 9.0 Hz, 2H), 3.71 (s, 3H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.1 (Cq), 155.4 (Cq), 150.9 (Cq), 148.7 (CH), 138.4 
(CH), 137.8 (Cq), 133.9 (Cq), 132.0 (Cq), 126.5 (Cq), 124.7 (CH), 122.3 (CH), 121.9 (CH), 
121.5 (CH), 121.3 (CH), 120.6 (CH), 113.7 (CH), 111.1 (CH), 107.9 (CH), 55.1 (CH3).  
IR (neat): 3272, 1651, 1538, 1436, 1243, 1021, 824, 738, 550 cm-1.  
MS (EI) m/z (relative intensity): 343 (8) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C21H17N3O2 [M
+] 343.1321, found 343.1320. 
 
 
1-(Pyridin-2-yl)-N-[4-(trifluoromethyl)phenyl]-1H-indole-2-carboxamide (107ae): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-isocyanato-4-(trifluoromethyl)benzene (106e) (103 mg, 0.55 mmol) and Et2O (1.0 
mL). Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 107ae (144 mg, 76%) as a white solid.  
M.p. = 229–230 °C.  
1
H-NMR (300 MHz, DMSO-d6) δ = 10.86 (s, 1H), 8.63–8.49 (m, 1H), 8.02 (td, J = 7.7, 1.9 Hz, 
1H), 7.92 (d, J = 8.5 Hz, 2H), 7.81 (dd, J = 7.6, 1.2 Hz, 1H), 7.68 (d, J = 8.6 Hz, 2H), 7.57 (d, J 
= 8.0 Hz, 1H), 7.53–7.39 (m, 3H), 7.33 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.29–7.20 (m, 1H).  
13




(CH), 138.0 (Cq), 133.1 (Cq), 126.4 (Cq), 125.8 (q, 
3JC-F = 3.8 Hz, CH), 125.4 (t, 
1JC-F = 270 Hz, 
Cq), 125.2 (CH), 123.5 (m, Cq), 122.5 (CH), 122.1 (CH), 121.6 (CH), 120.7 (CH), 119.6 (CH), 
111.1 (CH), 108.9 (CH).  
19
F-NMR (282 MHz, DMSO-d6) δ = -55.64.  
IR (neat): 2998, 1669, 1592, 1537, 1470, 1441, 1310, 1107, 824, 738, 415 cm-1.  
MS (EI) m/z (relative intensity): 381 (8) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C21H14F3N3O [M
+] 381.1089, found 381.1071. 
 
 
N-(3-Chlorophenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107af): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-chloro-3-isocyanatobenzene (106f) (85 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation 
by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 
107af (137 mg, 79%) as a white solid.  
M.p. = 184–185 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 10.70 (s, 1H), 8.57 (ddd, J = 4.8, 2.0, 0.9 Hz, 1H), 8.03 (td, 
J = 7.7, 1.9 Hz, 1H), 7.87 (s, 1H), 7.81 (dd, J = 7.9, 1.0 Hz, 1H), 7.62 (ddd, J = 8.3, 2.0, 0.9 Hz, 
1H), 7.56 (dt, J = 8.0, 1.0 Hz, 1H), 7.50–7.41 (m, 3H), 7.40–7.28 (m, 2H), 7.25 (ddd, J = 8.0, 
7.0, 1.0 Hz, 1H), 7.14 (ddd, J = 8.0, 2.2, 0.9 Hz, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.7 (Cq), 150.7 (Cq), 148.8 (CH), 140.4 (Cq), 138.5 
(CH), 137.9 (Cq), 133.2 (Cq), 132.9 (Cq), 130.2 (CH), 126.4 (Cq), 125.1 (CH), 123.1 (CH), 
122.5 (CH), 122.1 (CH), 121.6 (CH), 120.6 (CH), 119.1 (CH), 118.1 (CH), 111.1 (CH), 108.7 
(CH).  
IR (neat): 3229, 1662, 1588, 1529, 1469, 1420, 1303, 1287, 776, 737, 569 cm-1.  
MS (EI) m/z (relative intensity): 347 (8) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C20H14ClN3O [M
+] 347.0825, found 347.0818. 
 
 
N-(3-Iodophenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ag): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
1-iodo-3-isocyanatobenzene (106g) (135 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by 
column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ag 
(162 mg, 74%) as a white solid.  
M.p. = 160–161 °C.  
1




2H), 7.50 (dt, J = 8.0, 0.9 Hz, 1H), 7.40–7.31 (m, 5H), 7.26–7.18 (m, 1H), 7.06 (ddd, J = 8.0, 
6.9, 1.1 Hz, 1H), 7.01 (s, 1H), 6.90 (t, J = 8.0 Hz, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.6 (Cq), 150.8 (Cq), 148.8 (CH), 140.4 (Cq), 138.5 
(CH), 137.9 (Cq), 133.2 (Cq), 132.0 (CH), 130.6 (CH), 127.8 (CH), 126.4 (Cq), 125.1 (CH), 
122.4 (CH), 122.1 (CH), 121.6 (CH), 120.6 (CH), 118.9 (CH), 111.1 (CH), 108.7 (CH), 94.3 
(Cq).  
IR (neat): 3239, 1651, 1583, 1527, 1468, 1439, 1188, 772, 737, 551 cm-1.  
MS (EI) m/z (relative intensity): 439 (8) [M+], 221 (100), 192 (15), 43 (16).  
HR-MS (EI) m/z calcd for C20H14IN3O [M
+] 439.0182, found 439.0191. 
 
 
N-(2-Methoxyphenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ah): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-isocyanato-2-methoxybenzene (106h) (82 mg, 0.55 mmol) and Et2O (1.0 mL). 
Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 107ah (148 mg, 86%) as a white solid.  
M.p. = 146–147 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 8.67 (s, 1H), 8.64–8.58 (m, 1H), 8.38 (dd, J = 8.0, 1.7 Hz, 1H), 
7.87 (td, J = 7.7, 2.0 Hz, 1H), 7.73 (dd, J = 7.8, 1.1 Hz, 1H), 7.47 (d, J = 8.1 Hz, 2H), 7.34–7.30 
(m, 2H), 7.28–7.19 (m, 2H), 7.05 (td, J = 7.8, 1.7 Hz, 1H), 6.99–6.84 (m, 2H), 3.88 (s, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 159.2 (Cq), 151.2 (Cq), 149.2 (CH), 147.8 (Cq), 138.9 (Cq), 
138.1 (CH), 133.8 (Cq), 127.6 (Cq), 126.8 (Cq), 125.2 (CH), 123.7 (CH), 122.4 (CH), 122.0 
(CH), 121.7 (CH), 121.1 (CH), 120.9 (CH), 119.6 (CH), 111.3 (CH), 109.8 (CH), 108.2 (CH), 
55.6 (CH3).  
IR (neat): 3398, 3057, 1660, 1530, 1435, 1220, 1025, 734, 535 cm-1.  
MS (EI) m/z (relative intensity): 343 (3) [M+], 221 (100), 192 (20).  
HR-MS (EI) m/z calcd for C21H17N3O2 [M
+] 343.1321, found 343.1319. 
 
 
1-(Pyridin-2-yl)-N-(o-tolyl)-1H-indole-2-carboxamide (107ai): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
1-isocyanato-2-methylbenzene (106i) (74 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by 
column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ai 




M.p. = 157–158 °C.  
1
H-NMR (400 MHz, CDCl3) δ = 8.53 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 8.32 (s, 1H), 7.84 (ddd, J 
= 8.0, 7.5, 1.9 Hz, 1H), 7.77 (d, J = 7.0 Hz, 1H), 7.64–7.55 (m, 1H), 7.46 (dt, J = 8.0, 1.0 Hz, 
1H), 7.43–7.38 (m, 1H), 7.33–7.25 (m, 2H), 7.22–7.11 (m, 4H), 7.06 (td, J = 7.4, 1.4 Hz, 1H), 
2.25 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 159.8 (Cq), 151.2 (Cq), 149.2 (CH), 138.7 (Cq), 138.3 (CH), 
135.5 (Cq), 133.7 (Cq), 130.4 (CH), 129.4 (Cq), 126.8 (Cq), 126.6 (CH), 125.2 (CH ×2), 123.1 
(CH), 122.5 (CH), 122.0 (CH), 121.8 (CH), 121.1 (CH), 111.1 (CH), 108.4 (CH), 17.7 (CH3).  
IR (neat): 3240, 3018, 1654, 1544, 1444, 1431, 1294, 1264, 739, 680, 436 cm-1.  
MS (EI) m/z (relative intensity): 327 (5) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C21H17N3O [M
+] 327.1372, found 327.1370. 
 
 
N-(2-Iodophenyl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107aj): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
1-iodo-2-isocyanatobenzene (106j) (135 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by 
column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107aj 
(173 mg, 79%) as a white solid. When using nBu2O instead of Et2O yielded 107aj (158 mg, 
72%).  
M.p. = 199–200 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 10.11 (s, 1H), 8.59 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 
8.02–7.98 (m, 1H), 7.92 (dd, J = 7.9, 1.30 Hz, 1H), 7.81 (d, J = 7.9 Hz, 1H), 7.53 (dt, J = 8.0, 
0.9 Hz, 1H), 7.50–7.39 (m, 5H), 7.32 (ddd, J = 8.4, 7.0, 1.2 Hz, 1H), 7.24 (td, J = 7.5, 7.0, 1.0 
Hz, 1H), 7.03 (td, J = 7.6, 1.7 Hz, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.6 (Cq), 150.9 (Cq), 148.7 (CH), 139.1 (Cq), 138.8 
(CH), 138.4 (CH), 138.0 (Cq), 133.1 (Cq), 128.6 (CH), 128.0 (CH), 127.8 (CH), 126.4 (Cq), 
124.9 (CH), 122.4 (CH), 122.0 (CH), 121.6 (CH), 120.9 (CH), 111.4 (CH), 108.3 (CH), 97.6 
(Cq).  
IR (neat): 3199, 3040, 1660, 1592, 1543, 1440, 1203, 830, 733, 515, 480 cm-1.  
MS (EI) m/z (relative intensity): 439 (5) [M+], 312 (5), 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C20H14N3OI [M
+] 439.0182, found 439.0185. 
 
 




procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
1-isocyanatooctane (106k) (86 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ak (106 mg, 
61%) as a white solid.  
M.p. = 125–126 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 8.56 (s, 1H), 7.82 (t, J = 7.6 Hz, 1H), 7.56 (d, J = 7.8 Hz, 1H), 
7.38 (dd, J = 8.1, 6.0 Hz, 2H), 7.30–7.21 (m, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.97 (s, 1H), 6.76 (s, 
1H), 3.30–3.22 (m, 2H), 1.53–1.41 (m, 2H), 1.32–1.19 (m, 10H), 0.91–0.85 (m, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 161.7 (Cq), 151.4 (Cq), 148.9 (CH), 138.4 (Cq), 138.1 (CH), 
133.9 (Cq), 126.9 (Cq), 124.6 (CH), 122.4 (CH), 121.8 (CH), 121.4 (CH), 121.2 (CH), 111.0 
(CH), 107.3 (CH), 39.6 (CH2), 31.7 (CH2), 29.4 (CH2), 29.2 (CH2), 29.1 (CH2), 26.8 (CH2), 
22.5 (CH2), 14.0 (CH3).  
IR (neat): 3297, 2919, 2850, 1642, 1548, 1471, 1439, 1273, 1225, 733, 720, 685, 525, 443 cm-1.  
MS (EI) m/z (relative intensity): 349 (8) [M+], 221 (100), 192 (20).  
HR-MS (EI) m/z calcd for C22H27N3O [M
+] 349.2154, found 349.2155. 
 
 
N-(Naphthalen-1-yl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107am): The 
representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 
mmol), 1-isocyanatonaphthalene (106m) (93 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by 
column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107am 
(141 mg, 78%) as a white solid.  
M.p. = 225–226 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 10.64 (s, 1H), 8.63 (dd, J = 5.0, 1.7 Hz, 1H), 8.16 (d, J = 
8.2 Hz, 1H), 8.01 (t, J = 7.7 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.86–7.83 (m, 2H), 7.72–7.47 (m, 
7H), 7.43 (dd, J = 7.4, 4.9 Hz, 1H), 7.35 (t, J = 7.7 Hz, 1H), 7.28 (t, J = 7.5 Hz, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 160.6 (Cq), 150.9 (Cq), 148.8 (CH), 138.4 (CH), 137.7 
(Cq), 133.9 (Cq), 133.7 (Cq), 133.2 (Cq), 128.8 (Cq), 127.9 (CH), 126.7 (Cq), 126.0 (CH), 125.9 
(CH), 125.8 (CH), 125.4 (CH), 124.8 (CH), 123.3 (CH), 123.1 (CH), 122.3 (CH), 122.0 (CH), 
121.5 (CH), 120.6 (CH), 111.1 (CH), 108.2 (CH).  
IR (neat): 3217, 3012, 1650, 1536, 1466, 1271, 1209, 795, 738, 550 cm-1.  
MS (EI) m/z (relative intensity): 363 (8) [M+], 221 (100), 192 (15).  
HR-MS (EI) m/z calcd for C24H17N3O [M
+






N-(Furan-2-yl)-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107an): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), 
2-isocyanatofuran (106n) (60 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107an (94 mg, 
62%) as a white solid.  
M.p. = 190–191 °C.  
1
H-NMR (300 MHz, DMSO-d6) δ = 11.36 (s, 1H), 8.56 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 8.01 
(ddd, J = 8.0, 7.4, 1.9 Hz, 1H), 7.83–7.72 (m, 1H), 7.51 (d, J = 8.0 Hz, 1H), 7.48–7.35 (m, 4H), 
7.34–7.26 (m, 1H), 7.22 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 6.44 (dd, J = 3.3, 2.0 Hz, 1H), 6.18 (dd, 
J = 3.3, 0.9 Hz, 1H).  
13
C-NMR (75 MHz, DMSO-d6) δ = 157.6 (Cq), 150.8 (Cq), 148.8 (CH), 146.2 (Cq), 138.5 (CH), 
138.1 (Cq), 135.8 (CH), 132.2 (Cq), 126.3 (Cq), 125.1 (CH), 122.5 (CH), 122.1 (CH), 121.5 
(CH), 120.9 (CH), 111.2 (CH), 111.1 (CH), 108.8 (CH), 95.2 (CH).  
IR (neat): 2992, 1660, 1551, 1472, 1441, 1295, 1274, 1236, 1145, 739, 593 cm-1.  
MS (EI) m/z (relative intensity): 303 (5) [M+], 221 (100), 192 (15).  
HR-MS (ESI) m/z calcd for C18H13N3O2Na [M+Na
+] 326.0899, found 326.0900. 
 
 
5-Methoxy-N-phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ba): The 
representative procedure was followed using 5-methoxy-1-(pyridin-2-yl)-1H-indole (84b) 
(112 mg, 0.50 mmol), isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). 
Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 111ba (140 mg, 82%) as a white solid. When using nBu2O instead of Et2O yielded 
107ba (110 mg, 64%).  
M.p. = 160–161 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 10.50 (s, 1H), 8.55 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.99 
(ddd, J = 8.0, 7.7, 1.9 Hz,1H), 7.68 (d, J = 8.6 Hz, 2H), 7.49 (d, J = 8.0 Hz, 1H), 7.45–7.37 (m, 
2H), 7.35–7.29 (m, 3H), 7.27 (d, J = 2.5 Hz, 1H), 7.08 (tt, J = 7.4, 1.2 Hz, 1H), 6.96 (dd, J = 9.0, 
2.5 Hz, 1H), 3.82 (s, 3H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.5 (Cq), 154.9 (Cq), 151.0 (Cq), 148.7 (CH), 138.9 (Cq), 
138.4 (CH), 134.0 (Cq), 133.0 (Cq), 128.5 (CH), 127.0 (Cq), 123.4 (CH), 122.2 (CH), 120.4 
(CH), 119.8 (CH), 115.2 (CH), 112.2 (CH), 108.1 (CH), 103.0 (CH), 55.4 (CH3).  
IR (neat): 3054, 1649, 1547, 1462, 1437, 1294, 1181, 1121, 757, 690, 546, 505 cm-1.  




HR-MS (EI) m/z calcd for C21H17N3O2 [M
+] 343.1321, found 343.1334. 
 
 
5-Fluoro-N-phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ca): The representative 
procedure was followed using 5-fluoro-1-(pyridin-2-yl)-1H-indole (84c) (106 mg, 0.50 mmol), 
isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ca (137 mg, 
83%) as a white solid.  
M.p. = 173–174 °C.  
1
H-NMR (300 MHz, DMSO-d6) δ = 10.56 (s, 1H), 8.56 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 8.01 (td, 
J = 7.7, 1.9 Hz, 1H), 7.68 (d, J = 8.0 Hz, 2H), 7.60 (dd, J = 9.3, 2.6 Hz, 1H), 7.56–7.41 (m, 3H), 
7.39 (s, 1H), 7.32 (t, J = 7.9 Hz, 2H), 7.17 (td, J = 9.3, 2.6 Hz, 1H), 7.08 (t, J = 7.3 Hz, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.2 (Cq), 157.9 (
1JC–F = 234 Hz, Cq), 150.6 (Cq), 148.8 
(CH), 138.8 (Cq), 138.6 (CH), 135.2 (Cq), 134.4 (Cq), 128.5 (CH), 126.8 (
3JC–F = 10 Hz, Cq), 
123.6 (CH), 122.6 (CH), 120.6 (CH), 119.8 (CH), 113.2 (2JC–F = 26 Hz, CH), 112.6 (
3JC–F = 9 Hz, 
CH), 108.0 (4JC–F = 4 Hz, CH), 106.5 (
2JC–F = 23 Hz, CH).  
19
F-NMR (283 MHz, DMSO-d6) δ = –(121.9–122.0) (m).  
IR (neat): 3064, 1645, 1593, 1547, 1462, 1443, 1319, 1201, 777, 542 cm-1.  
MS (EI) m/z (relative intensity): 331 (5) [M+], 239 (100), 210 (15).  
HR-MS (EI) m/z calcd for C20H14FN3O [M
+] 331.1121, found 331.1117. 
 
 
5-Bromo-N-phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107da): The representative 
procedure was followed using 5-bromo-1-(pyridin-2-yl)-1H-indole (84d) (137 mg, 0.50 
mmol), isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107da (152 mg, 
78%) as a white solid.  
M.p. = 196–197 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 9.71 (s, 1H), 8.51 (dd, J = 4.9, 1.8 Hz, 1H), 7.92 (td, J = 7.7, 
1.9 Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.44–7.26 (m, 5H), 7.19–7.07 (m, 3H), 6.97 (t, J = 7.3 Hz, 
1H), 6.78 (s, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.1 (Cq), 150.4 (Cq), 148.8 (CH), 138.8 (Cq), 138.7 
(CH), 136.4 (Cq), 134.8 (Cq), 128.5 (CH), 128.3 (Cq), 127.4 (CH), 124.1 (CH), 123.6 (CH), 
122.7 (CH), 120.6 (CH), 119.8 (CH), 113.8 (Cq), 113.3 (CH), 107.4 (CH).  




MS (EI) m/z (relative intensity): 393 (5) [M+] (81Br), 391 (5) [M+] (79Br), 301 (100) (81Br), 299 
(100) (79Br), 220 (15), 192 (35).  
HR-MS (EI) m/z calcd for C20H14BrN3O [M
+] 391.0320, found 391.0321. 
 
 
5-Iodo-N-phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ea): The representative 
procedure was followed using 5-iodo-1-(pyridin-2-yl)-1H-indole (84e) (160 mg, 0.50 mmol), 
isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ea (171 mg, 
78%) as a white solid.  
M.p. = 199–200 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 9.76 (s, 1H), 8.53 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 7.91 (td, J = 
7.8, 1.9 Hz, 1H), 7.51–7.42 (m, 3H), 7.40–7.36 (m, 2H), 7.33 (ddd, J = 7.4, 4.9, 1.0 Hz, 1H), 
7.12 (dd, J = 8.5, 7.2 Hz, 2H), 7.03 (d, J = 8.7 Hz, 1H), 6.99–6.93 (m, 1H), 6.76 (s, 1H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.1 (Cq), 150.4 (Cq), 148.8 (CH), 138.8 (Cq), 138.6 
(CH), 136.8 (Cq), 134.3 (Cq), 132.8 (CH), 130.3 (CH), 129.0 (Cq), 128.5 (CH), 123.6 (CH), 
122.6 (CH), 120.6 (CH), 119.8 (CH), 113.6 (CH), 107.2 (CH), 85.3 (Cq).  
IR (neat): 3292, 1656, 1596, 1530, 1435, 1379, 1312, 1181, 786, 746, 688, 502 cm-1.  
MS (EI) m/z (relative intensity): 439 (8) [M+], 347 (100), 220 (35), 192 (20), 78 (10).  
HR-MS (EI) m/z calcd for C20H14IN3O [M
+] 439.0182, found 439.0191. 
 
 
1-(4-Methylpyridin-2-yl)-N-phenyl-1H-indole-2-carboxamide (107fa): The representative 
procedure was followed using 1-(4-methylpyridin-2-yl)-1H-indole (84f) (104 mg, 0.50 mmol), 
isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107fa (162 mg, 
99%) as a white solid.  
M.p. = 178–179 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 9.29 (s, 1H), 8.43 (d, J = 5.1 Hz, 1H), 7.49 (d, J = 7.9 Hz, 2H), 
7.41 (d, J = 7.9 Hz, 1H), 7.33 (d, J = 8.3 Hz, 2H), 7.30–7.13 (m, 4H), 7.11–7.01 (m, 3H), 2.45 (s, 
3H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.5 (Cq), 150.9 (Cq), 149.5 (Cq), 148.4 (CH), 139.0 (Cq), 
137.8 (Cq), 133.8 (Cq), 128.5 (CH), 126.4 (Cq), 124.7 (CH), 123.4 (CH), 123.3 (CH), 121.9 




IR (neat): 3054, 1659, 1597, 1538, 1440, 1308, 1237, 737, 689, 509 cm-1.  
MS (EI) m/z (relative intensity): 327 (5) [M+], 235 (100), 208 (15), 43 (40).  
HR-MS (EI) m/z calcd for C21H17N3O [M
+] 327.1372, found 327.1377. 
 
 
1-(5-Methylpyridin-2-yl)-N-phenyl-1H-indole-2-carboxamide (107ga): The representative 
procedure was followed using 1-(5-methylpyridin-2-yl)-1H-indole (84g) (104 mg, 0.50 
mmol), isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) yielded 107ga (125 mg, 
76%) as a white solid.  
M.p. = 184–185 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 9.46 (s, 1H), 8.35 (s, 1H), 7.66 (dd, J = 8.1, 2.3 Hz, 1H), 7.46 
(d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.1 Hz, 1H), 7.28 (d, J = 8.4 Hz, 2H), 7.23–7.10 (m, 3H), 
7.03–6.99 (m, 2H), 6.96 (s, 1H), 2.35 (s, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 160.1 (Cq), 149.2 (CH), 148.9 (Cq), 139.1 (CH), 138.5 (Cq), 
138.0 (Cq), 133.5 (Cq), 132.3 (Cq), 128.6 (CH), 126.6 (Cq), 124.8 (CH), 124.0 (CH), 121.9 (CH), 
121.5 (CH), 120.6 (CH), 120.5 (CH), 110.5 (CH), 108.4 (CH), 18.0 (CH3).  
IR (neat): 3337, 3050, 1663, 1596, 1520, 1484, 1437, 1313, 1186, 751, 689, 542, 503 cm-1.  
MS (EI) m/z (relative intensity): 327 (5) [M+], 235 (100), 206 (5), 192 (5).  
HR-MS (EI) m/z calcd for C21H17N3O [M
+] 327.1372, found 327.1376. 
 
 
Methyl 2-(phenylcarbamoyl)-1-(pyridin-2-yl)-1H-indole-6-carboxylate (107ha): The 
representative procedure was followed using methyl 1-(pyridin-2-yl)-1H-indole-6-carboxylate 
(84h) (126 mg, 0.50 mmol), isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). 
Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 107ha (153 mg, 82%) as a white solid.  
M.p. = 201–202 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 10.07 (s, 1H), 8.49 (dd, J = 5.0, 1.8 Hz, 1H), 7.96–7.86 (m, 
2H), 7.52 (dd, J = 8.4, 1.4 Hz, 1H), 7.48 (dd, J = 8.0, 0.9 Hz, 1H), 7.38 (dd, J = 8.4, 1.2 Hz, 2H), 
7.31 (ddd, J = 7.5, 4.9, 0.9 Hz, 1H), 7.09 (dd, J = 8.5, 7.2 Hz, 2H), 7.01 (d, J = 8.4 Hz, 1H), 
6.99–6.90 (m, 1H), 6.78 (s, 1H), 3.90 (s, 3H).  
13




(CH), 138.7 (Cq), 137.0 (Cq), 136.6 (Cq), 130.1 (Cq), 128.6 (CH), 125.7 (Cq), 123.8 (CH), 123.0 
(CH), 122.1 (CH), 121.9 (CH), 120.9 (CH), 119.9 (CH), 112.9 (CH), 107.8 (CH), 52.0 (CH3).  
IR (neat): 3283, 2945, 1721, 1657, 1514, 1426, 1229, 1187, 1090, 748, 688, 550 cm-1.  
MS (EI) m/z (relative intensity): 371 (5) [M+], 279 (100), 220 (5), 192 (10).  
HR-MS (EI) m/z calcd for C22H17N3O3 [M
+] 371.1270, found 371.1258. 
 
 
4-Methoxy-N-phenyl-1-(pyridin-2-yl)-1H-indole-2-carboxamide (107ia): The 
representative procedure was followed using 4-methoxy-1-(pyridin-2-yl)-1H-indole (84i) 
(112 mg, 0.50 mmol), isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). 
Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 10/1/1/1→10/2/2/1) 
yielded 107ia (122 mg, 71%) as a white solid.  
M.p. = 195–196 °C. 
1
H-NMR (300 MHz, CDCl3) δ = 9.03 (s, 1H), 8.55 (dd, J = 4.9, 2.0 Hz, 1H), 7.87 (td, J = 7.7, 
2.0 Hz, 1H), 7.49–7.43 (m, 3H), 7.30 (dd, J = 7.7, 7.3 Hz, 1H), 7.26–7.09 (m, 4H), 7.06–6.97 
(m, 1H), 6.92 (d, J = 8.4 Hz, 1H), 6.45 (d, J = 7.8 Hz, 1H), 3.86 (s, 3H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.2 (Cq), 153.7 (Cq), 151.1 (Cq), 148.7 (CH), 139.4 (Cq), 
139.0 (Cq), 138.4 (CH), 132.0 (Cq), 128.5 (CH), 126.2 (CH), 123.4 (CH), 122.5 (CH), 120.9 
(CH), 119.7 (CH), 117.1 (Cq), 105.6 (CH), 104.1 (CH), 101.4 (CH), 55.3 (CH3).  
IR (neat): 3298, 1659, 1591, 1529, 1438, 1258, 1193, 1183, 779, 755, 690, 556 cm-1.  
MS (EI) m/z (relative intensity): 343 (15) [M+], 251 (100), 236 (30), 180 (10).  
HR-MS (EI) m/z calcd for C21H17N3O2 [M




The representative procedure was followed using 
1-(pyridin-2-yl)-1,5,6,7-tetrahydro-4H-indol-4-one (123a) (106 mg, 0.50 mmol), 
isocyanatobenzene (106a) (66 mg, 0.55 mmol) and Et2O (1.0 mL). Isolation by column 
chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 5/1/1/1→5/5/5/1) yielded 124aa (134 mg, 
81%) as a white solid.  
M.p. = 274–275 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 10.12 (s, 1H), 8.54 (dd, J = 5.0, 1.2 Hz, 1H), 7.99 (td, J = 
7.7, 1.9 Hz, 1H), 7.61 (d, J = 7.8 Hz, 2H), 7.55–7.46 (m, 2H), 7.40 (s, 1H), 7.26 (dd, J = 8.5, 7.3 




2.06–2.01 (m, 2H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 193.2 (Cq), 158.3 (Cq), 150.3 (Cq), 148.6 (CH), 147.8 (Cq), 
138.9 (Cq), 138.4 (CH), 128.9 (Cq), 128.4 (CH), 123.6 (CH), 123.2 (CH), 121.6 (CH), 119.7 
(CH), 119.6 (Cq), 110.0 (CH), 37.5 (CH2), 22.9 (CH2), 21.9 (CH2).  
IR (neat): 3284, 2949, 1651, 1593, 1454, 1463, 1435, 1314, 1186, 757, 691, 507 cm-1.  
MS (EI) m/z (relative intensity): 331 (5) [M+], 239 (100), 183 (15), 78 (15).  
HR-MS (EI) m/z calcd for C20H17N3O2 [M
+] 331.1321, found 331.1323. 
 
 
N-Phenyl-1-(pyridin-2-yl)-1H-pyrrole-2-carboxamide (124ba): The representative 
procedure was followed using 2-(1H-pyrrol-1-yl)pyridine (123b) (72 mg, 0.50 mmol), 
isocyanatobenzene (106a) (119 mg, 1.00 mmol), MnBr(CO)5 (27.4 mg, 20 mol %) and Et2O 
(1.0 mL). Isolation by column chromatography (n-hexane/EtOAc/CH2Cl2/Et3N: 
10/1/1/1→5/1/1/1) yielded 124ba (79 mg, 60%) as a white solid.  
M.p. = 142–143 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 8.76 (s, 1H), 8.49 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 7.77 (td, J = 
7.8, 1.9 Hz, 1H), 7.55–7.45 (m, 2H), 7.32 (dt, J = 8.0, 0.9 Hz, 1H), 7.29–7.21 (m, 3H), 7.17 (dd, 
J = 2.9, 1.7 Hz, 1H), 7.10–7.00 (m, 1H), 6.90 (dd, J = 3.8, 1.7 Hz, 1H), 6.28 (dd, J = 3.7, 2.8 Hz, 
1H).  
13
C-NMR (125 MHz, CDCl3) δ = 159.2 (Cq), 152.1 (Cq), 148.2 (CH), 138.4 (CH), 138.2 (Cq), 
128.9 (CH), 127.9 (Cq), 127.2 (CH), 123.9 (CH), 122.5 (CH), 119.9 (CH), 119.3 (CH), 116.4 
(CH), 109.7 (CH).  
IR (neat): 3232, 3060, 1666, 1576, 1479, 1440, 1317, 1136, 786, 727, 522 cm-1.  
MS (EI) m/z (relative intensity): 263 (5) [M+], 171 (100), 116 (20), 78 (20).  
HR-MS (EI) m/z calcd for C16H13N3O [M
+] 263.1059, found 263.1057. 
 
Manganese-Catalyzed H/D Exchange Experiment 
 
5-Methoxy-1-(pyridin-2-yl)-1H-indole (84b) (112 mg, 0.5 mmol), MnBr(CO)5 (13.7 mg, 10 
mol %), Et2O (0.9 mL) and D2O (0.1 mL) were placed in a 20 mL sealed tube under N2 and 




with H2O (10 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layer was 
dried with Na2SO4 and concentrated under reduced pressure. Purification by column 
chromatography on silica gel (n-hexane/EtOAc:10/1) yielded [D]n-84b (106 mg, 95%). The D 
incorporation was determined by 1H-NMR spectroscopy. 
 
 
Manganese-Free H/D Exchange Experiment 
 
5-Methoxy-1-(pyridin-2-yl)-1H-indole (84b) (112 mg, 0.5 mmol), Et2O (0.9 mL) and D2O 
(0.1 mL) were placed in a 20 mL sealed tube under N2 and were then stirred at 100 °C for 3 h. 
At ambient temperature, the reaction mixture was diluted with EtOAc (15 mL) and was dried 
with Na2SO4 then concentrated under reduced pressure yielded [D]n-84b (110 mg, 98%). The 








Five parallel independent reactions of 84a or [D]1-84a with 106a respectively were performed 
to determine the corresponding KIE value. 84a (97 mg, 0.50 mmol) or [D]1-84a (97 mg, 0.50 
mmol), 107a (66 mg, 0.55 mmol), MnBr(CO)5 (13.7 mg, 10 mol %), and Et2O (1.0 mL) were 
placed in 20 mL sealed tubes. The mixtures were stirred at 100 °C. After cooling to ambient 
temperature, the GC conversions were measured by using 2-phenylpyridine as the standard: 
 
Time (min) 30 60 80 100 120 
107aa 34 50 57 61 74 






Intermolecular Competition Experiment between 106b and 106c 
 
1-Fluoro-4-isocyanatobenzene (106b) (68.5 mg, 0.5 mmol), 1-isocyanato-4-methyl benzene 
(106c) (65.5 mg, 0.5 mmol), 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.5 mmol), MnBr(CO)5 
(13.7 mg, 10 mol %) and Et2O (1.0 mL) were placed in a 20 mL sealed tube under N2 and 
were then stirred at 100 °C for 3 h. At ambient temperature, the reaction mixture was filtered 
through a short pad of silica gel (CH2Cl2/EtOAc: 1/1) and the solvent was evaporated in vacuo 
to give the crude products. The NMR conversion was determined by 1H-NMR spectroscopy 
using CH2Br2 (17.6 µL) as the standard to give 107ab (43%) and 107ac (27%). 
 
Intermolecular Competition Experiment between 84b and 84c 
 
5-Methoxy-1-(pyridin-2-yl)-1H-indole (84b) (112 mg, 0.5 mmol), 
5-fluoro-1-(pyridin-2-yl)-1H-indole (84c) (106 mg, 0.5 mmol), isocyanatobenzene (106a) (55 
y = 0.4164x + 22.721 

































μL, 0.5 mmol), MnBr(CO)5 (13.7 mg, 10 mol %) and Et2O (1.0 mL) were placed in a 20 mL 
sealed tube under N2 and were then stirred at 100 °C for 3 h. At ambient temperature, the 
reaction mixture was filtered through a short pad of silica gel (CH2Cl2/EtOAc: 1/1) and the 
solvent was evaporated in vacuo to give the crude products. The NMR conversion was 
determined by 1H-NMR spectroscopy using CH2Br2 (17.6 µL) as the standard to give 107ba 
(40%) and 107ca (18%). 
 
Removal of Directing Group 
Methyl trifluoromethanesulfonate (0.36 mmol, 1.2 equiv) was added dropwise to a solution of 
107 (0.30 mmol, 1.0 equiv) in CH2Cl2 (7.5 mL) at 0 °C, and the resulting solution was stirred 
for 12 h at ambient temperature. The solvent was removed under vacuo. Then, PhSNa (200 mg, 
5.0 equiv) and MeOH (5.0 mL) were added and the resulting mixture was stirred at 100 °C for 
24 h with a reflux condenser. The solvents were removed, and the resulting residue was 
acidified until pH = 7 by using HCl (1.0 M), then extracted with CH2Cl2 (4 × 20 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated in 
vacuo. The residue was purified by column chromatography to afford 129. 
 
 
N-Phenyl-1H-indole-2-carboxamide (129aa): Isolation by column chromatography 
(n-hexane/EtOAc/CH2Cl2: 20/1/1→5/1/1) yielded 129aa (50 mg, 71%) as a white solid.  
M.p. = 188–189 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 11.71 (s, 1H), 10.17 (s, 1H), 7.82 (dd, J = 8.6, 1.2 Hz, 2H), 
7.68 (dd, J = 8.0, 1.0 Hz, 1H), 7.49 (dd, J = 8.3, 0.9 Hz, 1H), 7.43 (dd, J = 2.2, 0.9 Hz, 1H), 7.37 
(dd, J = 8.5, 7.3 Hz, 2H), 7.23 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H), 7.15–7.02 (m, 2H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.7 (Cq), 138.9 (Cq), 136.8 (Cq), 131.4 (Cq), 128.6 (CH), 
127.0 (Cq), 123.7 (CH), 123.4 (CH), 121.6 (CH), 120.1 (CH), 119.8 (CH), 112.3 (CH), 103.8 
(CH).  
IR (neat): 3419, 3339, 1642, 1595, 1525, 1444, 1308, 1225, 815, 743, 617, 478 cm-1.  
MS (EI) m/z (relative intensity): 236 (70) [M+], 144 (100), 116 (25), 89 (47).  
HR-MS (EI) m/z calcd for C15H12N2O [M
+] 236.0950, found 236.0949. 
The spectral data are in accordance with those reported in the literature.[129] 
 
 




(n-hexane/EtOAc/CH2Cl2: 20/1/1→10/1/1) yielded 129ag (67 mg, 61%) as a light yellow solid.  
M.p. = 234–235 °C.  
1
H-NMR (500 MHz, DMSO-d6) δ = 11.73 (s, 1H), 9.92 (s, 1H), 7.95 (dd, J = 7.9, 1.4 Hz, 1H), 
7.68 (dd, J = 8.0, 1.0 Hz, 1H), 7.54 (dd, J = 7.9, 1.6 Hz, 1H), 7.49–7.44 (m, 2H), 7.38 (d, J = 1.6 
Hz, 1H), 7.24–7.21 (m, 1H), 7.09–7.05 (m, 2H).  
13
C-NMR (125 MHz, DMSO-d6) δ = 159.7 (Cq), 139.3 (Cq), 138.8 (CH), 136.8 (Cq), 131.1 (Cq), 
128.7 (CH), 128.1 (CH), 128.0 (CH), 127.0 (Cq), 123.7 (CH), 121.6 (CH), 119.9 (CH), 112.3 
(CH), 103.8 (CH), 98.2 (Cq).  
IR (neat): 3379, 3292, 1662, 1576, 1526, 1421, 1342, 1232, 1195, 1009, 731, 549 cm-1.  
MS (EI) m/z (relative intensity): 362 (25) [M+], 235 (100), 144 (75), 89 (50).  
HR-MS (EI) m/z calcd for C15H11IN2O [M
+] 361.9916, found 361.9914. 
The spectral data are in accordance with those reported in the literature.[130] 
 
C–H Activation Product Diversification 
 
5-(Phenyl)indolo[1,2-a]quinoxalin-6(5H)-one (130a): A mixture of 
N-phenyl-1H-indole-2-carboxamide (129aa) (47.3 mg, 0.2 mmol), 1-fluoro-2-nitrobenzene (34 
mg, 0.24 mmol) and CsCO3 (228 mg, 0.7 mmol) in MeCN (3 mL) was stirred in 90 °C for 12h. 
Then, the mixture was cooled to ambient temperature, diluted with brine (12 mL) and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layers were dried with Na2SO4 and evaporated 
under vacuo. Isolation by column chromatgraphy (n-hexane/EtOAc/CH2Cl2: 20/1/1→10/1/1) 
yielded 130a (50 mg, 80%) as a colorless solid.  
M.p. = 214–215 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 8.42 (dd, J = 8.4, 1.3 Hz, 1H), 8.35 (dd, J = 8.6, 0.9 Hz, 1H), 
7.94 (dt, J = 8.0, 1.1 Hz, 1H), 7.67 (d, J = 0.9 Hz, 1H), 7.65–7.60 (m, 2H), 7.58–7.52 (m, 2H), 
7.43–7.36 (m, 3H), 7.33 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.12 (ddd, J = 8.5, 7.3, 1.3 Hz, 1H), 6.74 
(dd, J = 8.3, 1.4 Hz, 1H).  
13
C-NMR (125 MHz, CDCl3 ) δ = 156.6 (Cq), 136.8 (Cq), 134.6 (Cq), 131.3 (Cq), 130.3 (CH), 
129.5 (Cq), 129.5 (CH), 129.2 (CH), 128.5 (Cq), 126.6 (Cq), 125.7 (CH), 124.0 (CH) 123.6 (CH), 
123.5 (CH), 122.7 (CH), 117.8 (CH), 115.6 (CH), 114.4 (CH), 107.7 (CH).  
IR (neat): 3054, 1661, 1589, 1390, 1299, 748, 709, 525, 434 cm-1.  
MS (EI) m/z (relative intensity): 310 (100) [M+], 173 (10).  
HR-MS (EI) m/z calcd for C21H14N2O [M




4.7 Manganese(I)-Catalyzed Substitutive C–H Allylation 
Characterization Data of Products 109, 110 and 131 
 
1-(2-Allyl-4-methylphenyl)ethan-1-one (109aa): The representative procedure was followed 
using N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 0.50 mmol) and allyl 
methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109aa (77 mg, 88%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.58 (d, J = 8.3 Hz, 1H), 7.08–7.05 (m, 2H), 5.97 (ddt, J =17.8, 
11.2, 6.5 Hz, 1H), 5.00 (ddt, J =11.2, 1.6, 1.6 Hz, 1H), 4.98 (ddt, J =17.8, 1.6, 1.6 Hz, 1H), 3.64 
(dt, J = 6.5, 1.6 Hz, 2H), 2.53 (s, 3H), 2.34 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 201.2 (Cq), 142.1 (Cq), 140.2 (Cq), 137.6 (CH), 134.8 (Cq), 
131.9 (CH), 129.7 (CH), 126.7 (CH), 115.4 (CH2), 38.1 (CH2), 29.4 (CH3), 21.3 (CH3).  
IR (neat): 2920, 1679, 1608, 1431, 1354, 1257, 911, 814 cm-1.  
MS (ESI) m/z (relative intensity): 175 (100) [M+H+].  
HR-MS (ESI) m/z calcd for C12H15O [M+H
+] 175.1117, found 175.1116. 
 
 
1-(2-Allylphenyl)ethan-1-one (109ba): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-phenylethan-1-imine (104b) (113 mg, 0.50 mmol) and allyl methyl 
carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
50/1→20/1) yielded 109ba (69 mg, 86%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.62 (dd, J = 7.8, 1.4 Hz, 1H), 7.39 (ddd, J = 7.6, 7.3, 1.4 Hz, 
1H), 7.31–7.18 (m, 2H), 5.97 (ddt, J = 16.7, 10.2, 6.5 Hz, 1H), 5.01 (ddt, J = 10.2, 1.5, 1.5 Hz, 
1H), 4.98 (ddt, J = 16.7, 1.5, 1.5 Hz, 1H), 3.63 (dt, J = 6.5, 1.5 Hz, 2H), 2.54 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 202.0 (Cq), 139.6 (Cq), 138.0 (Cq), 137.4 (CH), 131.4 (CH), 
131.1 (CH), 128.9 (CH), 126.1 (CH), 115.6 (CH2), 37.9 (CH2), 29.7 (CH3).  
IR (neat): 3074, 1683, 1355, 1249, 955, 913, 757, 598 cm-1.  
MS (EI) m/z (relative intensity): 160 (5) [M+], 145 (100), 127 (20), 115 (45), 91 (20).  
HR-MS (ESI) m/z calcd for C11H13O [M+H
+] 161.0961, found 161.0961. 







1-(2-Allyl-4-methoxyphenyl)ethan-1-one (109sa): The representative procedure was 
followed using N,1-bis(4-methoxyphenyl)ethan-1-imine (104s) (128 mg, 0.50 mmol) and 
allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→10/1) yielded 109sa (69 mg, 72%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.71 (d, J = 8.1 Hz, 1H), 6.76 (d, J = 2.5 Hz, 1H), 6.75 (dd, J 
= 8.1, 2.5 Hz, 1H), 5.97 (ddt, J = 17.7, 9.5, 6.5 Hz, 1H), 5.02 (dd, J = 9.5, 1.5 Hz, 1H), 4.99 (dd, 
J = 17.7, 1.5 Hz, 1H), 3.81 (s, 3H), 3.69 (d, J = 6.5 Hz, 2H), 2.51 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 199.6 (Cq), 162.0 (Cq), 143.5 (Cq), 137.3 (CH), 132.4 (CH), 
129.8 (Cq), 116.7 (CH), 115.6 (CH2), 110.8 (CH), 55.2 (CH3), 38.6 (CH2), 29.2 (CH3).  
IR (neat): 2970, 2839, 1673, 1600, 1566, 1235, 1133, 913, 809 cm-1.  
MS (EI) m/z (relative intensity): 189 (5) [M-H+], 175 (100), 160 (25), 147 (20), 115 (15), 91 
(15).  
HR-MS (EI) m/z calcd for C12H14O [M
+] 190.0994, found 190.0994. 





1-[2-Allyl-4-(dimethylamino)phenyl]ethan-1-one (109ta): The representative procedure 
was followed using 4-{1-[(4-methoxyphenyl)imino]ethyl}-N,N-dimethylaniline (104t) (134 
mg, 0.50 mmol) and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 50/1→10/1) yielded 109ta (65 mg, 64%) as a colorless 
solid.  
M. p. = 43–44 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.71 (d, J = 8.2 Hz, 1H), 6.50 (dd, J = 8.2, 2.8 Hz, 1H), 6.48 (d, 
J = 2.8 Hz, 1H), 6.03 (ddt, J = 16.7, 10.1, 6.5 Hz, 1H), 5.01 (ddt, J = 16.7, 1.5, 1.4 Hz, 1H), 4.99 
(ddt, J = 10.1, 1.5, 1.4 Hz, 1H), 3.76 (dt, J = 6.5, 1.5 Hz, 2H), 3.01 (s, 6H), 2.50 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 198.3 (Cq), 152.4 (Cq), 143.6 (Cq), 138.1 (CH), 133.2 (CH), 
124.1 (Cq), 114.9 (CH2), 113.7 (CH), 108.3 (CH), 39.9 (CH3), 39.5 (CH2), 28.7 (CH3).  
IR (neat): 2899, 1648, 1595, 1543, 1370, 1261, 1199, 1052, 843, 814 cm-1.  
MS (EI) m/z (relative intensity): 203 (25) [M+], 188 (100), 173 (20), 160 (30), 144 (15), 115 
(15).  
HR-MS (EI) m/z calcd for C13H17NO [M






1-[3-Allyl-(1,1'-biphenyl)-4-yl]ethan-1-one (109fa): The representative procedure was 
followed using 1-[(1,1'-biphenyl)-4-yl]-N-(4-methoxyphenyl)ethan-1-imine (104f) (151 mg, 
0.50 mmol) and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 50/1→20/1) yielded 109fa (92 mg, 78%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.75 (d, J = 8.5 Hz, 1H), 7.65–7.58 (m, 2H), 7.52 (s, 1H), 
7.51–7.34 (m, 4H), 6.05 (ddt, J = 17.5, 9.5, 6.5 Hz, 1H), 5.07 (ddt, J = 17.5, 1.5, 1.5 Hz, 1H), 
5.05 (ddt, J = 9.5, 1.5, 1.5 Hz, 1H), 3.76 (dt, J = 6.5, 1.5 Hz, 2H), 2.60 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 201.3 (Cq), 144.2 (Cq), 140.6 (Cq), 139.8 (Cq), 137.3 (CH), 
136.3 (Cq), 130.0 (CH), 129.9 (CH), 128.8 (CH), 128.0 (CH), 127.1 (CH), 124.6 (CH), 115.8 
(CH2), 38.2 (CH2), 29.6 (CH3).  
IR (neat): 3031, 1679, 1604, 1354, 1248, 913, 761, 696 cm-1.  
MS (EI) m/z (relative intensity): 236 (5) [M+], 221 (100), 178 (35), 165 (25), 115 (13).  
HR-MS (ESI) m/z calcd for C17H16O [M
+] 236.1201, found 236.1213. 
 
 
1-(2-Allyl-4-fluorophenyl)ethan-1-one (109ca): The representative procedure was followed 
using 1-(4-fluorophenyl)-N-(4-methoxyphenyl)ethan-1-imine (104c) (122 mg, 0.50 mmol) 
and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109ca (69 mg, 78%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.68 (dd, J = 8.4, 5.8 Hz, 1H), 7.03–6.82 (m, 2H), 5.93 (ddt, J 
= 16.8, 10.2, 6.5 Hz, 1H), 5.04 (dd, J = 10.2, 1.5 Hz, 1H), 5.00 (ddt, J = 16.8, 1.5 Hz, 1H), 3.65 
(d, J = 6.5 Hz, 2H), 2.53 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 200.1 (Cq), 164.1 (Cq, 
1JC-F = 253 Hz), 143.9 (Cq, 
3JC-F = 8 Hz), 
136.5 (CH), 133.8 (Cq, 
4JC-F = 3 Hz), 131.7 (CH, 
3JC-F = 9 Hz), 118.0 (CH, 
2JC-F = 22 Hz), 116.4 
(CH2), 112.9 (CH, 
2JC-F = 22 Hz), 38.0 (CH2, 
4JC-F = 2 Hz), 29.6 (CH3).  
19
F-NMR (282 MHz, CDCl3) δ = –(107.5–107.6) (m).  
IR (neat): 3081, 1683, 1581, 1415, 1355, 1233, 977, 816, 583 cm-1.  
MS (ESI) m/z (relative intensity): 179 (100) [M+H+].  
HR-MS (ESI) m/z calcd for C11H12FO [M+H






1-(2-Allyl-4-chlorophenyl)ethan-1-one (109da): The representative procedure was followed 
using 1-(4-chlorophenyl)-N-(4-methoxyphenyl)ethan-1-imine (104d) (130 mg, 0.50 mmol) 
and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109da (79 mg, 81%) as a colorless oil.  
1
H-NMR (400 MHz, CDCl3) δ = 7.57 (d, J = 8.1 Hz, 1H), 7.24 (d, J = 2.1 Hz, 1H), 7.23 (dd, J 
= 8.1, 2.1 Hz, 1H), 5.91 (ddt, J = 16.8, 10.1, 6.5 Hz, 1H), 5.04 (ddt, J = 10.1, 1.6, 1.6 Hz, 1H), 
4.99 (ddt, J = 16.8, 1.6, 1.6 Hz, 1H), 3.60 (dt, J = 6.5, 1.6 Hz, 2H), 2.52 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 200.6 (Cq), 142.1 (Cq), 137.4 (Cq), 136.4 (CH), 136.0 (Cq), 
131.1 (CH), 130.5 (CH), 126.2 (CH), 116.4 (CH2), 37.7 (CH2), 29.6 (CH3).  
IR (neat): 3083, 2979, 1684, 1590, 1558, 1355, 1246, 1104, 959, 917, 815 cm-1.  
MS (EI) m/z (relative intensity): 193 (5) [M-H+], 179 (100), 144 (40), 115 (50).  
HR-MS (ESI) m/z calcd for C11H12ClO [M+H
+] 195.0571, found 195.0564. 
 
 
1-(2-Allyl-4-bromophenyl)ethan-1-one (109ea): The representative procedure was followed 
using 1-(4-bromophenyl)-N-(4-methoxyphenyl)ethan-1-imine (104e) (152 mg, 0.50 mmol) 
and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109ea (87 mg, 73%) as a colorless oil.  
1
H-NMR (400 MHz, CDCl3) δ = 7.49 (d, J = 8.1 Hz, 1H), 7.40 (d, J = 2.0 Hz, 1H), 7.39 (dd, J 
= 8.1, 2.0 Hz, 1H), 5.91 (ddt, J = 16.7, 10.1, 6.5 Hz, 1H), 5.04 (ddt, J = 10.1, 1.5, 1.5 Hz, 1H), 
4.99 (ddt, J = 16.7, 1.5, 1.5 Hz, 1H), 3.59 (dt, J = 6.5, 1.5 Hz, 2H), 2.51 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 200.8 (Cq), 142.1 (Cq), 136.5 (Cq), 136.4 (CH), 134.0 (CH), 
130.5 (CH), 129.2 (CH), 126.0 (Cq), 116.4 (CH2), 37.6 (CH2), 29.6 (CH3).  
IR (neat): 3079, 1683, 1584, 1554, 1354, 1250, 1094, 957, 916, 813, 595 cm-1.  
MS (EI) m/z (relative intensity): 237 (5) [M+], 223 (95), 144 (100), 116 (70), 89 (15).  
HR-MS (ESI) m/z calcd for C11H11BrNaO [M+Na
+] 260.9885, found 260.9885. 
 
 
1-(2-Allyl-4-iodophenyl)ethan-1-one (109ua): The representative procedure was followed 




allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109ua (118 mg, 83%) as a colorless oil.  
1
H-NMR (400 MHz, CDCl3) δ = 7.62 (d, J = 1.8 Hz, 1H), 7.61 (dd, J = 8.8, 1.8 Hz, 1H), 7.33 (d, 
J = 8.8 Hz, 1H), 5.90 (ddt, J = 16.7, 10.1, 6.5 Hz, 1H), 5.04 (ddt, J = 10.1, 1.6, 1.6 Hz, 1H), 4.99 
(ddt, J = 16.7, 1.6, 1.6 Hz, 1H), 3.56 (dt, J = 6.5, 1.6 Hz, 2H), 2.50 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 201.1 (Cq), 141.8 (Cq), 140.0 (CH), 137.1 (Cq), 136.5 (CH), 
135.2 (CH), 130.3 (CH), 116.4 (CH2), 98.7 (Cq), 37.5 (CH2), 29.6 (CH3).  
IR (neat): 3076, 2977, 1682, 1578, 1547, 1476, 1249, 955, 915, 811, 595 cm-1.  
MS (ESI) m/z (relative intensity): 309 (100) [M+Na+].  
HR-MS (ESI) m/z calcd for C11H11INaO [M+Na
+] 308.9747, found 308.9745. 
 
 
4-Acetyl-3-allylbenzonitrile (109va): The representative procedure was followed using 
4-{1-[(4-methoxyphenyl)imino]ethyl}benzonitrile (104v) (125 mg, 0.50 mmol) and allyl 
methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 30/1→10/1) yielded 109va (81 mg, 87%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.63 (d, J = 8.7 Hz, 1H), 7.56 (dd, J = 8.7, 1.7 Hz, 1H), 7.54 (d, 
J = 1.7 Hz, 1H), 5.88 (ddt, J = 17.0, 10.6, 6.5 Hz, 1H), 5.09 (ddt, J = 10.6, 1.4, 1.4 Hz, 1H), 4.99 
(ddt, J = 17.0, 1.4, 1.4 Hz, 1H), 3.58 (dt, J = 6.3, 1.4 Hz, 2H), 2.54 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 201.1 (Cq), 142.1 (Cq), 140.3 (Cq), 135.7 (CH), 134.4 (CH), 
129.8 (CH), 128.6 (CH), 117.9 (Cq), 117.2 (Cq), 114.6 (CH2), 37.1 (CH2), 29.9 (CH3).  
IR (neat): 3083, 2232, 1691, 1357, 1248, 917, 830, 613 cm-1.  
MS (EI) m/z (relative intensity): 184 (5) [M-H+], 170 (100), 142 (20), 115 (30), 89 (10).  
HR-MS (ESI) m/z calcd for C12H12NO [M+H
+] 186.0913, found 186.0911. 
 
 
1-(2-Allylphenyl)propan-1-one (109ga): The representative procedure was followed using 
N-(4-methoxyphenyl)-1-phenylpropan-1-imine (104g) (120 mg, 0.50 mmol) and allyl methyl 
carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography (n-hexane/EtOAc: 
50/1→20/1) yielded 109ga (79 mg, 91%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.54 (dd, J = 8.0, 1.5 Hz, 1H), 7.37 (ddd, J = 8.0, 7.1, 1.5 Hz, 
1H), 7.29–7.17 (m, 2H), 5.95 (ddt, J = 16.8, 10.3, 6.5 Hz, 1H), 5.01 (ddt, J = 10.3, 1.6, 1.6 Hz, 
1H), 4.96 (ddt, J = 16.8, 1.6, 1.6 Hz, 1H), 3.57 (dt, J = 6.5, 1.6 Hz, 2H), 2.86 (q, J = 7.2 Hz, 2H), 





C-NMR (75 MHz, CDCl3) δ = 205.5 (Cq), 139.1 (Cq), 138.6 (Cq), 137.4 (CH), 131.0 (CH), 
130.9 (CH), 127.8 (CH), 126.0 (CH), 115.6 (CH2), 37.8 (CH2), 35.0 (CH2), 8.2 (CH3).  
IR (neat): 2978, 2938, 1687, 1435, 1222, 954, 915, 753 cm-1.  
MS (ESI) m/z (relative intensity): 175 (100) [M+H+].  
HR-MS (ESI) m/z calcd for C12H15O [M+H
+] 175.1117, found 175.1117. 





The representative procedure was followed using N-(4-methoxyphenyl)-1-(m-tolyl) 
ethan-1-imine (104o) (120 mg, 0.50 mmol) and allyl methyl carbonate (108a) (174 μL, 1.5 
mmol). Isolation by column chromatography (n-hexane/EtOAc: 50/1→20/1) yielded 109oa 
and 109oa’ (66 mg, 76%, 6:1) as a colorless oil.  
IR (neat): 3002, 2921, 1682, 1431, 1265, 996, 911, 828, 613 cm-1.  
MS (EI) m/z (relative intensity): 174 (5) [M+], 159 (100), 131 (30), 115 (25), 91 (20), 43 (25).  
HR-MS (EI) m/z calcd for C12H14O [M
+] 174.1045, found 174.1036. 
1-(2-Allyl-5-methylphenyl)ethan-1-one (109oa):  
1
H-NMR (300 MHz, CDCl3) δ = 7.42 (s, 1H), 7.28–7.12 (m, 2H), 5.95 (ddt, J = 16.8, 10.4, 6.4 
Hz, 1H), 4.99 (ddt, J = 10.4, 1.5, 1.5 Hz, 1H), 4.96 (ddt, J = 16.8, 1.5, 1.5 Hz, 1H), 3.58 (dt, J = 
6.4, 1.5 Hz, 2H), 2.53 (s, 3H), 2.35 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 202.2 (Cq), 138.0 (Cq), 137.6 (CH), 136.5 (Cq), 135.6 (Cq), 
132.1 (CH), 131.1 (CH), 129.5 (CH), 115.3 (CH2), 37.5 (CH2), 29.7 (CH3), 20.9 (CH3). 
The spectral data are in accordance with those reported in the literature.
[131]
 
1-(2-Allyl-3-methylphenyl)ethan-1-one (109oa’):  
1
H-NMR (300 MHz, CDCl3) δ = 7.38 (dd, J = 7.8, 1.4 Hz, 1H), 7.28–7.12 (m, 2H), 5.95 (ddt, J 
= 16.8, 10.4, 6.4 Hz, 1H), 4.90–4.80 (m, 2H), 3.55 (dt, J = 6.4, 1.5 Hz, 2H), 2.52 (s, 3H), 2.32 (s, 
3H).  
13
C-NMR (75 MHz, CDCl3) δ = 203.6 (Cq), 139.9 (Cq), 138.4 (Cq), 136.3 (CH), 136.1 (Cq), 
132.9 (CH), 129.5 (CH), 125.8 (CH), 115.0 (CH2), 33.5 (CH2), 30.4 (CH3), 19.7 (CH3). 
 
 
1-(3-Allylnaphthalen-2-yl)ethan-1-one (109na): The representative procedure was followed 




and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 50/1→20/1) yielded 109na (90 mg, 86%, 12:1) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 8.16 (s, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.77 (d, J = 8.1 Hz, 1H), 
7.66 (s, 1H), 7.60–7.38 (m, 2H), 6.06 (ddt, J = 16.5, 10.1, 6.4 Hz, 1H), 5.08 (ddt, J = 10.1, 1.1, 
1.1 Hz, 1H), 5.03 (ddt, J = 16.5, 1.1, 1.1 Hz, 1H), 3.82 (dt, J = 6.4, 1.1 Hz, 2H), 2.67 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 201.7 (Cq), 137.6 (CH), 136.4(Cq), 136.1 (Cq), 134.6 (Cq), 
131.1 (Cq), 130.2 (CH), 129.5 (CH), 128.4 (CH), 128.1 (CH), 127.2 (CH), 126.1 (CH), 115.8 
(CH2), 38.0 (CH2), 29.6 (CH3).  
IR (neat): 3057, 1678, 1494, 1354, 1268, 1164, 885, 745, 475 cm-1.  
MS (ESI) m/z (relative intensity): 211 (100) [M+H+].  
HR-MS (ESI) m/z calcd for C15H15O [M+H
+] 211.1117, found 211.1115. 
 
 
1-(4-Allylbenzo[d][1,3]dioxol-5-yl)ethan-1-one (109pa): The representative procedure was 
followed using 1-(benzo[d][1,3]dioxol-5-yl)-N-(4-methoxyphenyl)ethan-1-imine (104p) (135 
mg, 0.50 mmol) and allyl methyl carbonate (108a) (174 μL, 1.5 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 50/1→10/1) yielded 109pa (70 mg, 68%) as a colorless 
solid.  
M. p. = 58–59 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 7.34 (d, J = 8.2 Hz, 1H), 6.69 (d, J = 8.2 Hz, 1H), 5.99 (s, 2H), 
5.98 (ddt, J = 17.1, 10.1, 6.2 Hz, 1H), 4.98 (ddt, J = 17.1, 1.6, 1.6 Hz, 1H), 4.96 (ddt, J = 10.1, 
1.6, 1.6 Hz, 1H), 3.64 (dt, J = 6.2, 1.6 Hz, 2H), 2.50 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 199.2 (Cq), 149.8 (Cq), 147.3 (Cq), 136.0 (CH), 131.6 (Cq), 
125.8 (CH), 122.2 (Cq), 115.1 (CH2), 105.5 (CH), 101.5 (CH2), 30.7 (CH2), 29.1 (CH3).  
IR (neat): 2915, 1662, 1595, 1447, 1260, 1050, 1008, 919, 810, 570 cm-1.  
MS (EI) m/z (relative intensity): 204 (5) [M+], 189 (50), 161 (30), 131 (32), 103 (25), 43 (100).  
HR-MS (EI) m/z calcd for C12H12O3 [M
+] 204.0786, found 204.0788. 
 
 
(E)-1-[2-(But-2-en-1-yl)-4-methylphenyl]ethan-1-one (E-109ab): The representative 
procedure was followed using N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 
0.50 mmol) and but-3-en-2-yl methyl carbonate (108b) (195 mg, 1.5 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 50/1→20/1) yielded (E/Z)-109ab (62 mg, 66%, 





H-NMR (600 MHz, CDCl3) δ = 7.55 (d, J = 8.6 Hz, 1H), 7.06 (s, 1H), 7.04 (d, J = 8.6 Hz, 1H), 
5.58 (dtq, J = 15.4, 6.5, 1.4 Hz, 1H), 5.45 (dqt, J = 15.4, 6.2, 1.3 Hz, 1H), 3.55 (dd, J = 6.5, 1.4 
Hz, 2H), 2.53 (s, 3H), 2.34 (s, 3H), 1.64 (dd, J = 6.2, 1.3 Hz, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 201.5 (Cq), 141.9 (Cq), 141.1 (Cq), 135.0 (Cq), 131.8 (CH), 
130.0 (CH), 129.5 (CH), 126.5 (CH), 126.1 (CH), 36.9 (CH2), 29.6 (CH3), 21.4 (CH3), 17.9 
(CH3).  
IR (neat): 2917, 1680, 1608, 1435, 1354, 1255, 966, 814 cm-1.  
MS (ESI) m/z (relative intensity): 189 (100) [M+H+].  
HR-MS (ESI) m/z calcd for C13H17O [M+H
+] 189.1274, found 189.1272. 
 
 
(E)-1-[2-(Hept-2-en-1-yl)-4-methylphenyl]ethan-1-one (E-109ac): The representative 
procedure was followed using N-(4-methoxyphenyl)-1-(p-tolyl)ethan-1-imine (104a) (120 mg, 
0.50 mmol) and hept-1-en-3-yl methyl carbonate (108c) (258 mg, 1.5 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 50/1→20/1) yielded (E/Z)-109ac (72 mg, 62%, 
E/Z = 12/1 by 1H NMR) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 7.54 (d, J = 7.7 Hz, 1H), 7.07 (s, 1H), 7.05 (d, J = 7.7 Hz, 1H), 
5.54 (dt, J = 15.4, 6.2 Hz, 1H), 5.43 (dt, J = 15.4, 6.8 Hz, 1H), 3.56 (d, J = 6.2 Hz, 2H), 2.52 (s, 
3H), 2.34 (s, 3H), 2.05–1.84 (m, 2H), 1.40–1.19 (m, 4H), 0.86 (t, J = 7.0 Hz, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 201.5 (Cq), 141.9 (Cq), 141.2 (Cq), 135.1 (Cq), 131.9 (CH), 
131.8 (CH), 129.4 (CH), 128.7 (CH), 126.4 (CH), 36.9 (CH2), 32.2 (CH2), 31.6 (CH2), 29.6 
(CH3), 22.2 (CH2), 21.4 (CH3), 13.9 (CH3).  
IR (neat): 2957, 2925, 1681, 1608, 1354, 1256, 968, 813, 577 cm-1.  
MS (EI) m/z (relative intensity): 230 (10) [M+], 215 (35), 159 (100), 145 (20).  
HR-MS (ESI) m/z calcd for C16H23O [M+H
+] 231.1743, found 231.1736. 
 
 
2-Allyl-1-(pyridin-2-yl)-1H-indole (110aa): The representative procedure was followed 
using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol) and allyl methyl carbonate (108a) 
(116 μL, 1.0 mmol). Isolation by column chromatography (n-hexane/CH2Cl2: 3/1→1/1) 
yielded 110aa (112 mg, 96%) as a colorless solid.  
M. p. = 79–81 °C.  
1
H-NMR (300 MHz, CDCl3) δ = 8.64 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.86 (ddd, J = 8.1, 7.5, 2.0 




2H), 6.46 (d, J = 0.9 Hz, 1H), 5.89 (ddt, J = 16.8, 10.5, 6.5 Hz, 1H), 4.99 (ddt, J = 10.5, 1.3, 1.3 
Hz, 1H), 4.95 (ddt, J = 16.8, 1.3, 1.3 Hz, 1H), 3.64 (dt, J = 6.6, 1.3 Hz, 2H).  
13
C-NMR (75 MHz, CDCl3) δ = 151.4 (Cq), 149.5 (CH), 139.0 (Cq), 138.2 (CH), 137.3 (Cq), 
134.8 (CH), 128.5 (Cq), 122.0 (CH), 121.8 (CH), 121.0 (CH), 120.6 (CH), 120.0 (CH), 116.5 
(CH2), 110.1 (CH), 103.1 (CH), 32.1 (CH2).  
IR (neat): 3049, 1578, 1553, 1470, 1455, 1436, 1352, 908, 745, 601 cm-1.  
MS (EI) m/z (relative intensity): 234 (32) [M+], 219 (100), 78 (15).  
HR-MS (EI) m/z calcd for C16H14N2 [M
+] 234.1157, found 234.1165. 





2-Allyl-5-methoxy-1-(pyridin-2-yl)-1H-indole (110ba): The representative procedure was 
followed using 5-methoxy-1-(pyridin-2-yl)-1H-indole (84b) (112 mg, 0.50 mmol) and allyl 
methyl carbonate (108a) (116 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/CH2Cl2: 3/1→1/1) yielded 110ba (125 mg, 95%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 8.67–8.55 (m, 1H), 7.83 (ddd, J = 8.0, 2.0, 0.5 Hz, 1H), 7.39 
(d, J = 8.0 Hz, 1H), 7.31–7.19 (m, 2H), 7.05 (d, J = 2.5 Hz, 1H), 6.79 (dd, J = 8.9, 2.5 Hz, 1H), 
6.39 (s, 1H), 5.89 (ddt, J = 17.0, 10.7, 6.5 Hz, 1H), 4.99 (ddt, J = 10.7, 1.2, 1.2 Hz, 1H), 4.96 
(ddt, J = 17.0, 1.2, 1.2 Hz, 1H), 3.84 (s, 3H), 3.63 (dt, J = 6.5, 1.2 Hz, 2H).  
13
C-NMR (75 MHz, CDCl3) δ = 154.7 (Cq), 151.4 (Cq), 149.4 (CH), 139.5 (Cq), 138.1 (CH), 
134.8 (CH), 132.3 (Cq), 129.0 (Cq), 121.7 (CH), 120.6 (CH), 116.5 (CH2), 111.3 (CH), 110.9 
(CH), 103.0 (CH), 102.2 (CH), 55.8 (CH3), 32.2 (CH2).  
IR (neat): 2940, 1580, 1468, 1434, 1201, 1170, 1032, 913, 743, 570 cm-1.  
MS (EI) m/z (relative intensity): 264 (35) [M+], 249 (100), 206 (15), 78 (15).  
HR-MS (EI) m/z calcd for C17H16N2O [M
+] 264.1263, found 264.1262. 
 
 
5-Allyl-1-(pyridin-2-yl)-1H-pyrrole-2-carbaldehyde (131ca): The representative procedure 
was followed using 1-(pyridin-2-yl)-1H-pyrrole-2-carbaldehyde (123c) (86 mg, 0.50 mmol), 
allyl methyl carbonate (108a) (116 μL, 1.0 mmol). Isolation by column chromatography 
(n-hexane/EtOAc: 20/1→5/1) yielded 131ca (91 mg, 86%) as a colorless oil.  
1
H-NMR (300 MHz, CDCl3) δ = 9.40 (s, 1H), 8.56 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 7.80 (ddd, J 
= 7.7, 7.7, 1.9 Hz, 1H), 7.35 (ddd, J = 7.5, 4.9, 1.1 Hz, 1H), 7.28 (d, J = 7.9 Hz, 1H), 7.02 (d, J 
= 3.9 Hz, 1H), 6.18 (d, J = 3.9 Hz, 1H), 5.75 (ddt, J = 16.7, 10.1, 6.7 Hz, 1H), 4.96 (dd, J = 10.1, 





C-NMR (75 MHz, CDCl3) δ = 177.9 (CHO), 150.6 (Cq), 148.9 (CH), 142.2 (Cq), 137.9 (CH), 
133.5 (CH), 132.9 (Cq), 123.6 (CH), 123.4 (CH), 122.8 (CH), 117.2 (CH2), 110.1 (CH), 31.1 
(CH2).  
IR (neat): 2781, 1662, 1472, 1445, 1323, 809, 786 cm‒1.  
MS (EI) m/z (relative intensity): 212 (95) [M+], 197 (50), 183 (100), 169 (80), 78 (90), 51 (55).  
HR-MS (EI) m/z calcd for C13H12N2O [M
+] 212.0950, found 212.0945. 
 
 
2-(3-Methylbut-2-en-1-yl)-1-(pyridin-2-yl)-1H-indole (110ad): The representative 
procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 0.50 mmol), methyl 
(2-methylbut-3-en-2-yl) carbonate (108d) (144 μL, 1.0 mmol), Mn2(CO)10 (19.6 mg, 10 mol %) 
and NaOAc (16.4 mg, 40 mol %). Isolation by column chromatography (n-hexane/EtOAc: 
50/1→20/1) yielded 110ad (76 mg, 58%) as a colorless oil.  
1
H-NMR (400 MHz, CDCl3) δ = 8.66 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.86 (ddd, J = 8.1, 7.5, 2.0 
Hz, 1H), 7.60–7.54 (m, 1H), 7.43 (ddd, J = 8.0, 1.0, 1.0 Hz, 1H), 7.36–7.26 (m, 2H), 7.16–7.10 
(m, 2H), 6.45 (d, J = 0.9 Hz, 1H), 5.25 (t, J = 7.1 Hz, 1H), 3.56 (dd, J = 7.2, 0.9 Hz, 2H), 1.68 (s, 
3H), 1.57 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 151.5 (Cq), 149.6 (CH), 140.6 (Cq), 138.1 (CH), 137.4 (Cq), 
133.5 (Cq), 128.6 (Cq), 121.9 (CH), 121.5 (CH), 121.1 (CH), 120.6 (CH), 120.5 (CH), 119.9 
(CH), 110.0 (CH), 102.4 (CH), 26.7 (CH2), 25.6 (CH3), 17.7 (CH3).  
IR (neat): 2971, 1585, 1468, 1454, 1435, 1148, 780, 736 cm-1.  
MS (EI) m/z (relative intensity): 262 (25) [M+], 247 (22), 219 (100), 206 (20).  
HR-MS (EI) m/z calcd for C18H18N2 [M
+] 262.1470, found 262.1464. 
 
 
The representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 
0.50 mmol) and but-3-en-2-yl methyl carbonate (108b) (130 mg, 1.0 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 50/1→20/1) yielded (E/Z)-110ab (120 mg, 97%, 
E/Z = 3/1 by 1H NMR) as a colorless oil.  
IR (neat): 2914, 1711, 1585, 1468, 1455, 1435, 1316, 1210, 965, 735 cm-1.  
MS (EI) m/z (relative intensity): 248 (75) [M+], 233 (35), 219 (100), 206 (20), 78 (15).  
HR-MS (EI) m/z calcd for C17H16N2 [M
+] 248.1313, found 248.1310. 
(E)-2-(But-2-en-1-yl)-1-(pyridin-2-yl)-1H-indole (E-110ab):  
1
H-NMR (300 MHz, CDCl3) δ = 8.65 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.91–7.77 (m, 1H), 




= 15.1, 6.5, 1.4 Hz, 1H), 5.52 (dqt, J = 15.1, 6.1, 1.1 Hz, 1H), 3.57 (dd, J = 6.5, 1.1 Hz, 2H), 
1.60 (dd, J = 6.1, 1.4 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 151.3 (Cq), 149.3 (CH), 139.9 (Cq), 137.9 (CH), 137.2 (Cq), 
128.5 (Cq), 127.1 (CH), 127.0 (CH), 121.8 (CH), 121.6 (CH), 120.9 (CH), 120.5 (CH), 119.9 
(CH), 110.0 (CH), 102.7 (CH), 31.0 (CH2), 17.8 (CH3). 
(Z)-2-(But-2-en-1-yl)-1-(pyridin-2-yl)-1H-indole (Z-110ab):  
1
H-NMR (300 MHz, CDCl3) δ = 8.65 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.91–7.77 (m, 1H), 
7.64–7.53 (m, 1H), 7.49–7.20 (m, 3H), 7.20–7.06 (m, 2H), 6.48 (d, J = 0.9 Hz, 1H), 5.62–5.28 
(m, 2H), 3.65 (dd, J = 6.5, 1.1 Hz, 2H), 1.61 (d, J = 6.1 Hz, 3H).  
13
C-NMR (125 MHz, CDCl3) δ = 152.4 (Cq), 149.5 (CH), 139.8 (Cq), 138.0 (CH), 137.3 (Cq), 
128.5 (Cq), 126.4 (CH), 125.6 (CH), 121.8 (CH), 121.6 (CH), 120.9 (CH), 120.5 (CH), 119.9 
(CH), 109.9 (CH), 102.6 (CH), 25.7 (CH2), 12.8 (CH3). 
 
 
The representative procedure was followed using 1-(pyridin-2-yl)-1H-indole (84a) (97 mg, 
0.50 mmol) and hept-1-en-3-yl methyl carbonate (108c) (172 mg, 1.0 mmol). Isolation by 
column chromatography (n-hexane/EtOAc: 50/1→20/1) yielded (E/Z)-110ac (102 mg, 70%, 
E/Z = 3/1 by 1H NMR) as a colorless oil.  
IR (neat): 2955, 1585, 1468, 1455, 1435, 1272, 1211, 1022, 779, 734 cm-1.  
MS (EI) m/z (relative intensity): 290 (50) [M+], 247 (45), 233 (25), 219 (100), 206 (50).  
HR-MS (EI) m/z calcd for C20H22N2 [M
+] 290.1783, found 290.1785. 
(E)-2-(Hept-2-en-1-yl)-1-(pyridin-2-yl)-1H-indole (E-110ac):  
1
H-NMR (300 MHz, CDCl3) δ = 8.64 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.84 (ddd, J = 7.6, 5.4, 2.0 
Hz, 1H), 7.63–7.52 (m, 1H), 7.47–7.38 (m, 1H), 7.38–7.26 (m, 2H), 7.17–7.08 (m, 2H), 6.45 (d, 
J = 0.7 Hz, 1H), 5.51–5.43 (m, 1H), 5.33 (dt, J = 15.4, 6.4 Hz, 1H), 3.58 (d, J = 6.4 Hz, 2H), 
1.91 (ddd, J = 7.2, 6.2, 6.2 Hz, 2H), 1.34–1.16 (m, 4H), 0.93–0.81 (m, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 151.5 (Cq), 149.5 (CH), 140.1 (Cq), 138.1 (CH), 137.3 (Cq), 
132.8 (CH), 128.5 (Cq), 125.9 (CH), 121.9 (CH), 121.6 (CH), 121.0 (CH), 120.6 (CH), 120.0 
(CH), 110.1 (CH), 102.9 (CH), 32.1 (CH2), 31.5 (CH2), 31.0 (CH2), 22.1 (CH2), 13.9 (CH3). 
(Z)-2-(hept-2-en-1-yl)-1-(pyridin-2-yl)-1H-indole (Z-110ac):  
1
H-NMR (300 MHz, CDCl3) δ = 8.66 (ddd, J = 4.9, 2.0, 0.9 Hz, 1H), 7.86 (ddd, J = 7.6, 5.4, 2.0 
Hz, 1H), 7.63–7.52 (m, 1H), 7.47–7.38 (m, 1H), 7.38–7.26 (m, 2H), 7.17–7.08 (m, 2H), 6.46 (d, 
J = 0.7 Hz, 1H), 5.54–5.26 (m, 2H), 3.62 (d, J = 5.6 Hz, 2H), 1.99 (ddd, J = 7.2, 6.2, 6.2 Hz, 2H), 





C-NMR (75 MHz, CDCl3) δ = 151.5 (Cq), 149.6 (CH), 140.0 (Cq), 138.2 (CH), 137.3 (Cq), 
131.8 (CH), 128.6 (Cq), 125.4 (CH), 122.0 (CH), 121.6 (CH), 121.1 (CH), 120.6 (CH), 120.0 
(CH), 110.0 (CH), 102.6 (CH), 31.7 (CH2), 26.9 (CH2), 25.9 (CH2), 22.3 (CH2), 14.0 (CH3). 
 
Intermolecular Competition Experiments between Arenes 104s and 104f 
 
4-Methoxy-N-[1-(4-methoxyphenyl)ethylidene]aniline (104s) (128 mg, 0.5 mmol), 
N-[1-(4-fluorophenyl)ethylidene]-4-methoxyaniline (104f) (122 mg, 0.5 mmol), allyl methyl 
carbonate (108a) (58 μL, 0.5 mmol), MnBr(CO)5 (13.7 mg, 10 mol %), KO2CMes (20.2 mg, 20 
mol %) and 1,4-dioxane (1.0 mL) were placed in a 25 mL Schlenk tube under N2 and were 
then stirred at 100 °C for 14 h. At ambient temperature, the reaction mixture was diluted with 
EtOAc (10 mL), then 1,3,5-trimethoxybenzene (84 mg, 0.5 mmol) was added as internal 
standard, the crude mixture was analyzed to obtain the GC conversion of the products 132sa 
(61%) and 132fa (32%). 
 
4-Methoxy-N-[1-(4-methoxyphenyl)ethylidene]aniline (104s) (128 mg, 0.5 mmol), 
N-[1-(4-fluorophenyl)ethylidene]-4-methoxyaniline (104f) (122 mg, 0.5 mmol), allyl methyl 
carbonate (108a) (58 μL, 0.5 mmol), [Mn2(CO)10] (9.8 mg, 5.0 mol %), NaOAc (8.2 mg, 20 
mol %) and 1,4-dioxane (1.0 mL) were placed in a 25 mL Schlenk tube under N2 and were 
then stirred at 100 °C for 14 h. At ambient temperature, the reaction mixture was diluted with 
EtOAc (10 mL), then 1,3,5-trimethoxybenzene (84 mg, 0.5 mmol) was added as internal 
standard, the crude mixture was analyzed to obtain the GC conversion of the products 132sa 





Manganese-Catalyzed H/D Exchange Experiments 
 
(E)-4-Methoxy-N-(1-phenylethylidene)aniline (104b) (113 mg, 0.5 mmol), allyl methyl 
carbonate (108a) (174 μL, 1.5 mmol), MnBr(CO)5 (13.7 mg, 10 mol %), KO2CMes (20.2 mg, 
20 mol %), 1,4-dioxane (0.9 mL) and CD3OD (0.1 mL) were placed in a 25 mL Schlenk tube 
under N2 and were stirred at 100 °C for 7 h. At ambient temperature, the reaction mixture was 
diluted with Et2O (5 mL), then HCl (5 mL, 1 M) was added, the mixture was vigorously 
stirred at ambient temperature for 20 min, and the resulting mixture was extracted with Et2O 
(3 × 10 mL). The combined organic layer was washed with brine (10 mL) and dried over 
Na2SO4. After concentration under reduced pressure, purification by column chromatography 
on silica gel (n-hexane/EtOAc: 50/1→20/1) yielded [D]n-5b (10 mg, 17%) and [D]n-109ba 







(E)-4-Methoxy-N-(1-phenylethylidene)aniline (104b) (113 mg, 0.5 mmol), allyl methyl 
carbonate (108a) (174 μL, 1.5 mmol), [Mn2(CO)10] (9.8 mg, 5.0 mol %), NaOAc (8.2 mg, 20 
mol %), 1,4-dioxane (0.9 mL) and CD3OD (0.1 mL) were placed in a 25 mL Schlenk tube 
under N2 and were stirred at 100 °C for 7 h. At ambient temperature, the reaction mixture was 
diluted with Et2O (5 mL), then HCl (5 mL, 1 M) was added, the mixture was vigorously 
stirred at ambient temperature for 20 min, and the resulting mixture was extracted with Et2O 
(3×10 mL). The combined organic layer was washed with brine (10 mL) and dried over 
Na2SO4. After concentration under reduced pressure, purification by column chromatography 
on silica gel (n-hexane/EtOAc: 50/1→20/1) yielded [D]n-5b (21 mg, 35%) and [D]n-109ba 















Kinetic Isotope Effect 
Intramolecular KIE (a) 
 
[D]1-(E)-4-Methoxy-N-(1-phenylethylidene)aniline ([D]1-104b) (113 mg, 0.5 mmol), allyl 
methyl carbonate (108a) (174 μL, 1.5 mmol), MnBr(CO)5 (13.7 mg, 10 mol %), KO2CMes 
(20.2 mg, 20 mol %), and 1,4-dioxane (1.0 mL) were placed in a 25 mL Schlenk tube under 
N2, and then stirred at 100 °C for 7 h. At ambient temperature, the reaction mixture was 
diluted by Et2O (5 mL), then HCl (5 mL, 1 M) was added, the mixture was stirred vigorously 
at ambient temperature for 20 min, the resulting mixture was extracted with Et2O (3 × 10 mL). 
The combined organic layer was washed with brine (10 mL), and then dried over Na2SO4. 
After concentration under reduced pressure, purification by column chromatography on silica 
gel (n-hexane/EtOAc: 50/1→20/1) afforded the [D]n-109ba (60 mg, 74%). The kinetic isotope 









Intramolecular KIE (b) 
 
[D]1-(E)-4-Methoxy-N-(1-phenylethylidene)aniline ([D]1-104b) (113 mg, 0.5 mmol), allyl 
methyl carbonate (108a) (174 μL, 1.5 mmol), [Mn2(CO)10] (9.8 mg, 5.0 mol %), NaOAc (8.2 
mg, 20 mol %), and 1,4-dioxane (1.0 mL) were placed in a 25 mL Schlenk tube under N2, and 
then stirred at 100 °C for 7 h. At ambient temperature, the reaction mixture was diluted by 
Et2O (5 mL), then HCl (5 mL, 1 M) was added, the mixture was stirred vigorously at ambient 
temperature for 20 min, the resulting mixture was extracted with Et2O (3 × 10 mL). The 
combined organic layer was washed with brine (10 mL), and then dried over Na2SO4. After 
concentration under reduced pressure, purification by column chromatography on silica gel 
(n-hexane/EtOAc: 50/1→20/1) afforded the [D]n-109ba (52 mg, 65%). The kinetic isotope 











Intermolecular KIE by Independent Experiments (a) 
 
Two parallel reactions of 108a with 104b and [D]5-104b respectively were performed to 
determine the corresponding KIE value. 104b (113 mg, 0.5 mmol) or [D]5-104b (115 mg, 0.5 
mmol), allyl methyl carbonate (108a) (174 μL, 1.5 mmol), MnBr(CO)5 (13.7 mg, 10 mol %), 
KO2CMes (20.2 mg, 20 mol %), 1,3,5-trimethoxybenzene (84 mg, 0.5 mmol) and 1,4-dioxane 
(1.0 mL) were placed in a 25 mL Schlenk tube. The mixture was stirred at 100 °C, a periodic 
aliquot (0.02 mL) was removed by syringe and analyzed by GC to provide the following 
conversions: 
Time (min) 20 40 60 80 100 120 140 160 
132ba 4 11 21 29 36 40 45 50 
[D]4-132ba 5 14 22 30 35 40 45 49 
 
 
Intermolecular KIE by Independent Experiments (b) 
 
Two parallel reactions of 108a with 104b and [D]5-104b respectively were performed to 
determine the corresponding KIE value. 104b (113 mg, 0.5 mmol) or [D]5-104b (115 mg, 0.5 
mmol), allyl methyl carbonate (108a) (174 μL, 1.5 mmol), [Mn2(CO)10] (9.8 mg, 5.0 mol %), 
y = 0.331x - 0.2857 































NaOAc (8.2 mg, 20 mol %), 1,3,5-trimethoxybenzene (84 mg, 0.5 mmol) and 1,4-dioxane (1.0 
mL) were placed in a 25 mL Schlenk tube. The mixture was stirred at 100 °C, a periodic 
aliquot (0.02 mL) was removed by syringe and analyzed by GC to provide the following 
conversions: 
 
Time (min) 40 60 80 100 120 140 
132ba 3 6 10 16 23 28 
[D]4-132ba 3 7 10 15 23 30 
 
 
C–H Allylations with Cyclometalated Complex 126 
 
 
MnBr(CO)5 (1.0 mmol, 274 mg), 1-(pyridin-2-yl)-1H-indole 84a (1.0 mmol, 194 mg), 
dicyclohexylamine (362 mg, 2.0 mmol) and 1,4-dioxane (2.0 mL) were placed in a 25 mL 
Schlenk tube under N2 and then stirred at 100 °C for 14 h. At ambient temperature, the 
mixture was diluted with EtOAc (20 ml) and filtered through a short pad of celite. The solvent 
was removed by rotary evaporation and the residue was purified by column chromatography on 
silica gel (n-hexane/EtOAc: 20/1) afforded 126 (210 mg, 58%). 
1
H-NMR (500 MHz, CDCl3) δ = 8.44 (dd, J = 5.7, 1.7 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.85 
(ddd, J = 8.5, 7.0, 1.7 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H), 7.49 (dd, J = 7.6, 1.2 Hz, 1H), 7.18 (dd, 
J = 7.6, 7.1 Hz, 1H), 7.11 (ddd, J = 7.6, 7.2, 1.3 Hz, 1H), 6.91 (ddd, J = 7.0, 5.6, 1.3 Hz, 1H), 
6.82 (s, 1H).  
13
C-NMR (125 MHz, CDCl3) δ = 218.9 (Cq), 213.3 (Cq), 211.2 (Cq), 166.3 (Cq), 156.9 (Cq), 
153.9 (CH), 140.1 (CH), 137.8 (Cq), 136.5 (Cq), 121.9 (CH), 120.1 (CH), 118.1 (CH), 117.8 
(CH), 117.6 (CH), 110.7 (CH), 110.6 (CH).  
y = 0.26x - 9.0667 































IR (neat): 2076, 1968, 1925, 1483, 1441, 791, 733, 653, 618 cm‒1.  
MS (EI) m/z (relative intensity): 360 (5) [M+], 248 (30), 194 (100), 167 (15), 89 (15).  
HR-MS (EI) m/z calcd for C17H9MnN2O4 [M
+] 359.9943, found 359.9955. 
 
 
1-(Pyridin-2-yl)-1H-indole 84a (97 mg, 0.5 mmol), allyl methyl carbonate 108a (116 μL, 1.0 
mmol), 126 (18 mg, 10 mol %), NaOAc (8.2 mg, 20 mol %) and 1,4-dioxane (1.0 mL) were 
placed in a 25 mL Schlenk tube under N2. The mixture was stirred at 100 °C for 14 h. At 
ambient temperature, the reaction mixture was transferred into a round flask with EtOAc and 
concentrated under reduced pressure. Purification by column chromatography on silica gel 
afforded the desired product 110aa (124 mg, 96% based on 0.55 mmol). 
 
 
126 (72 mg, 0.2 mmol), allyl methyl carbonate 108a (24 μL, 0.2 mmol), and 1,4-dioxane (0.5 
mL) were placed in a 25 mL Schlenk tube under N2. The mixture was stirred at 100 °C for 
14 h. At ambient temperature, the reaction mixture was transferred into a round flask with 
EtOAc and concentrated under reduced pressure. Purification by column chromatography on 













Diversification of C–H Activation Products 
 
Reaction (a): i) A solution of 109aa (174 mg, 1.0 mmol) in Et2O (4 mL) was added to a stirred 
suspension of LiAlH4 (80 mg, 2.1 mmol) in Et2O (4 mL), and the reaction was stirred at 
ambient temperature for 12 h under N2 atmosphere. Then the reaction was treated with NaOH 
(10 mL, 1 M) and stirred for additional 10 min, the white precipitate was removed by filtration 
and the filtrate was extracted with Et2O (3×10 mL). The combined organic layer was washed 
with brine (10 mL), and then dried over Na2SO4. After concentration under reduced pressure, 
purification by column chromatography on silica gel (n-hexane/EtOAc: 20/1→5/1) afforded 
the corresponding alcohol 1-(2-allyl-4-methylphenyl)ethan-1-ol (156 mg, 89%) as a colorless 
oil. 
ii) 1-(2-Allyl-4-methylphenyl)ethan-1-ol (71 mg, 0.4 mmol), KOtBu (135 mg, 1.5 mmol) and 
NMP (5.0 mL) were placed in a 25 mL Schlenk tube under N2. The mixture was stirred at 
100 °C for 2 h. At ambient temperature, the reaction mixture was quenched with H2O (10 
mL), and the resulting mixture extracted with Et2O (3×10 mL). The combined organic layer 
was washed with brine (10 mL), and dried over Na2SO4. After concentration under reduced 
pressure, purification by column chromatography on silica gel (n-hexane/EtOAc: 50/1→20/1) 
afforded the desired product 136 [57 mg, 81% (dr = 3:1)] as a colorless oil. 
 
 
1,3,6-Trimethylisochromane (136):  
IR (neat): 2972, 2927, 1616, 1446, 1381, 1135, 1099, 812, 557 cm‒1.  




HR-MS (EI) m/z calcd for C12H16O [M
+] 176.1201, found 176.1199. 
Major isomer: 1H-NMR (300 MHz, CDCl3) δ = 7.00–6.89 (m, 3H), 5.01 (q, J = 6.7 Hz, 1H), 
4.14–3.96 (m, 1H), 2.76–2.51 (m, 2H), 2.30 (s, 3H), 1.51 (d, J = 6.7 Hz, 3H), 1.31 (d, J = 6.2 Hz, 
3H). 13C-NMR (75 MHz, CDCl3) δ = 136.1 (Cq), 135.6 (Cq), 133.0 (Cq), 129.2 (CH), 126.7 
(CH), 125.1 (CH), 70.6 (CH), 63.8 (CH), 36.0 (CH2), 22.2 (CH3), 21.3 (CH3), 20.9 (CH3). 
Minor isomer: 1H-NMR (300 MHz, CDCl3) δ = 7.00–6.89 (m, 3H), 4.84 (q, J = 6.6 Hz, 1H), 
3.86–3.75 (m, 1H), 2.76–2.51 (m, 2H), 2.30 (s, 3H), 1.53 (d, J = 6.6 Hz, 3H), 1.35 (d, J = 6.1 Hz, 
3H). 13C-NMR (75 MHz, CDCl3) δ = 136.4 (Cq), 135.7 (Cq), 133.7 (Cq), 129.1 (CH), 126.9 
(CH), 124.2 (CH), 73.0 (CH), 70.5 (CH), 36.6 (CH2), 21.8 (CH3), 21.3 (CH3), 20.9 (CH3). 
Reaction (b): To a solution of 109aa (87 mg, 0.5 mmol), Ni(cod)2 (27.5 mg, 20 mol %) and 
PCy3 (28 mg, 20 mol %) in THF (5 mL) was added drop wise AlMe3 (0.5 mL, 1.0 M in heptane). 
The reaction mixture was stirred at ambient temperature for 15 min, and then quenched with 
MeOH (1 mL). The solution was transferred into a round bottom flask with Et2O and 
concentrated under reduced pressure. Purification by column chromatography on silica gel 




1,5-Dimethyl-2-methylene-2,3-dihydro-1H-inden-1-ol (137):  
1
H-NMR (300 MHz, CDCl3) δ = 7.30 (d, J = 7.7 Hz, 1H), 7.08 (d, J = 7.7 Hz, 1H), 7.04 (s, 1H), 
5.44 (t, J = 2.3 Hz, 1H), 5.16 (t, J = 2.3 Hz, 1H), 3.62 (d, J = 2.3 Hz, 2H), 2.35 (s, 3H), 1.96 (s, 
1H), 1.54 (s, 3H).  
13
C-NMR (75 MHz, CDCl3) δ = 157.4 (Cq), 145.2 (Cq), 139.4 (Cq), 138.3 (Cq), 128.1 (CH), 
125.1 (CH), 123.0 (CH), 107.9 (CH2), 79.8 (Cq), 36.0 (CH2), 28.8 (CH3), 21.4 (CH3).  
IR (neat): 3392, 2969, 1614, 1426, 1118, 1081, 871, 816, 586 cm‒1.  
MS (EI) m/z (relative intensity): 174 (5) [M+], 159 (100), 131 (25), 115 (20), 91 (15), 43 (25).  
HR-MS (EI) m/z calcd for C12H14O [M
+] 174.1045, found 174.1039. 
 
Reaction (c): A solution of 109aa (87 mg, 0.5 mmol) in THF (1 mL) was treated with 9-BBN 
(1.05 mL, 1.05 equiv, 0.5 M in THF,) at ambient temperature, and then the mixture was stirred 
for 24 h at ambient temperature. The crude product was followed by successive additions of aq. 
NaOH (2.2 mL, 2 M) and aq. H2O2 (30%, 1.1 mL) at 0 
oC, the reaction mixture was allowed to 
warm to ambient temperature and stirred for further 24 h. Then the mixture was treated with 
saturated aq. Na2S2O3 (5 mL) and stirred for another 10 min. The mixture was extracted with 
Et2O (3×10 mL), the combined organic layer was washed with brine (10 mL), and dried over 








1-[2-(3-Hydroxypropyl)-4-methylphenyl]ethan-1-one (138):  
1
H-NMR (300 MHz, CDCl3) δ = 7.58 (d, J = 7.8 Hz, 1H), 7.07 (s, 1H), 7.05 (d, J = 7.8 Hz, 1H), 
3.57 (t, J = 5.9 Hz, 2H), 2.90 (t, J = 7.4 Hz, 2H), 2.76 (s, 1H), 2.54 (s, 3H), 2.33 (s, 3H), 
1.92–1.70 (m, 2H).  
13
C-NMR (125 MHz, CDCl3) δ = 201.9 (Cq), 142.4 (Cq), 142.2 (Cq), 134.7 (Cq), 132.1 (CH), 
129.9 (CH), 126.5 (CH), 61.5 (CH2), 34.6 (CH2), 29.7 (CH3), 29.6 (CH2), 21.4 (CH3).  
IR (neat): 3411, 2924, 1675, 1355, 1251, 1229, 1054, 814, 731, 576 cm‒1.  
MS (EI) m/z (relative intensity): 192 (5) [M+], 177 (25), 159 (100), 146 (55), 131 (58), 105 (30), 
91 (35).  
HR-MS (EI) m/z calcd for C12H16O2 [M
+] 192.1150, found 192.1148. 
 
Reaction (d): Hydroxylamine hydrochloride (79 mg, 1.15 mmol), 109aa (87 mg, 0.5 mmol), 
NaOAc (103 mg, 1.25 mmol), MeOH (1 mL) and H2O (0.5 mL) were added to a 25 mL Schlenk 
tube. The reaction mixture was stirred at 100 °C for 1 h. At ambient temperature, the mixture 
was extracted with Et2O (3×10 mL) and the combined organic layer was washed with brine and 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
dissolved in MeCN (3.0 mL) and added to a Schlenk tube which contained cyanuric chloride 
(4.5 mg, 0.025 mmol) and ZnCl2 (6.8 mg, 0.05 mmol). The reaction mixture was stirred at 
90 °C for 2 h. At ambient temperature, the mixture was extracted with Et2O (3×10 mL) and the 
combined organic layer was washed with brine, dried over Na2SO4 and filtered. After 
concentration under reduced pressure, purification by column chromatography on silica gel 




N-(2-Allyl-4-methylphenyl)acetamide (139):  
M. p. = 107–108 °C. 
1
H-NMR (400 MHz, CDCl3) δ = 7.56 (d, J = 8.1 Hz, 1H), 7.25 (d, J = 2.0 Hz, 1H), 7.01 (dd, J 




10.1, 1.7, 1.7 Hz, 1H), 5.05 (ddt, J = 17.2, 1.7, 1.7 Hz, 1H), 3.30 (dt, J = 6.2, 1.7 Hz, 2H), 2.27 
(s, 3H), 2.09 (s, 3H).  
13
C-NMR (100 MHz, CDCl3) δ = 168.4 (Cq), 136.4 (CH), 135.1 (Cq), 133.2 (Cq), 130.7 (Cq), 
130.6 (CH), 127.8 (CH), 124.3 (CH), 116.2 (CH2), 36.7 (CH2), 24.0 (CH3), 20.8 (CH3).  
IR (neat): 3270, 2916, 1637, 1526, 1364, 1285, 993, 907, 811, 703, 605, 505 cm−1.  
MS (EI) m/z (relative intensity): 189 (25) [M+], 146 (70), 132 (50), 58 (30), 43 (100).  
HR-MS (EI) m/z calcd for C12H15NO [M
+] 189.1154, found 189.1145. 
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